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STELLINGEN 
1. De tetrachloorbenzochinonen zijn de enige metabolieten van hexachloorbenzeen 
welke In s taat zijn tot covalente binding aan eiwit . 
dit proefschrift 
2. Covalente eiwitbinding van metabolieten van hexachloorbenzeen speelt geen 
directe rol b i j de ontwikkeling van de door deze stof geinduceerde lever-
porfyrie. 
dit proefschrift 
3 . De door Takazawa et a l . vermelde spectrale bindingsconstante voor hexachloor-
benzeen aan microsamaal cytochroom P-450 i s te hoog omdat de oplosbaarheid 
van hexachloorbenzeen overschat i s . 
R.S. Takazawa en E.W. Strobel, Biochemistry 25, 4804-4809 (1986) 
4 . De conclusie van Lunte et a l . dat superoxide dismutase geen effect heeft op 
de oxidatie van net p-hydrochinon berust op een verkeerde in terpre ta t ie van 
hun resul ta ten. 
S.M. Lunte en D.T. Kissinger, Chemico-Biological Interactions 47, 
195-212 (1983) 
5. Het f e i t dat haem-achtige verbindingen sterke remmers zijn van glutathion S-
transferases geeft aanleiding tot een herbezinning op de ro l van deze enzymen 
in de biotransformatie van porfyrinogene stoffen. 
6. Het ontbreken van een spectrale lijnverbredlng van het FMN-semichinon ten 
31 
opzichte van de geoxideerde vorin in het P-NMR-spectrum van het cytochroom 
P-450 reductase wordt door Otvos et a l . niet voldoende verklaard, met name 
omdat de rol van fosfolipiden buiten beschouwing wordt gelaten. 
J.D. Otvos, D.P. Krwn en B.S.S. Masters, Biochemistry 25, 7220-
7228 (1986) 
7. De kloof tussen wetenschap en praktijk blijkt bijvoorbeeld uit het f e i t dat 
voor het commercieel belangrijkste enzym, het protease s u b t i l i s i n e , 
honderden modelmatige assays zijn ontwikkeld, terwijl de proteolytische 
act iv i te i t ten opzichte van slechts twee Intacte eiwitten Is beschreven. 
M. Philipp en M.L. Bender, Molecular and Cellular Biochemistry 
51, 5-32 (1983) 
8. Het gebruik van de "oxidant waarde" als maat voor de hoeveelheid oxiderende 
luchtverontreinlging i s vanuit toxicologisch oogpunt gezien weinig relevant. 
9. Biochemische oxidatie van veel hydrochinonen blijkt alleen bewerkstelligd te 
worden door een reductor. 
10. De publieke afkeer van synthetlsch bereide doch natuuridentieke geur- en 
sraaakstoffen en de affectie voor vitaminepreparaten i s blijkbaar niet alleen 
gebaseerd op het f e l t dat beide groepen verbindingen afkomstlg zijn van de 
chemische Industrie. 
11. Aan in v i t r o onderzoek naar react ieve intermediairen dient aandacht te 
worden besteed in een vroege fase van het toxicologisch onderzoek. 
12. Versnippering van het toxicologisch onderzoek dient vermeden te worden. 
Diepgaand toxicologisch onderzoek behoeft echter niet per definitie inter-
disciplinair te zijn. 
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Het is een goede zaak'om in dit voorwoord duldelijk te maken dat meerdere 
mensen hun stempel op dit werk gedrukt hebben. In de eerste plaats geldt 
dit voor mijn wetenschappelijke steunpilaar en klankbord, Peter van 
Bladeren. Beste Peter, zonder jou had dit boekje er waarschijnlijk heel 
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verzorgden de plaatjes in en op dit proefschrift, en tot mijn genoegen is 
gebleken dat Manon, Janneke, Loes, Marleen, letje en Gre veel sneller 
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SUMMARY 
Hexachlorobenzene (HCR) has become a major environmental pollutant due to 
Its formation as an unwanted byproduct in the industrial production of a 
number of chlorinated compounds, and because of its former use as 
fungicide. In laboratory animals, HCB induces tumor formation. In man and 
animals, HCB disturbes the hepatic heme biosynthesis, resulting in massive 
excretion of porphyrins. This porphyrinogenic action of HCB was shown to 
be due to a selective inhibition of the enzyme uroporphyrinogen 
decarboxylase. Evidence has been presented for the involvement of 
cytochrome P-450 in the porphyrinogenic action of HCB: in vivo induction 
of this enzyme by phenobarbital increased, and Inhibition with piperonyl 
butoxide decreased the amount of excreted porphyrins. This led to the 
assumption that the inactivation of uroporhyrinogen decarboxylase could be 
attributed to a metabolite or a reactive intermediate formed during the 
oxidative biotransformation of HCB. The aim of the present study was to 
investigate the in vitro oxidative biotransformation of HCB, with special 
attention to the formation of reactive intermediates. In doing so, a more 
balanced evaluation could be made regarding the involvement of 
biotransformation in the toxic action of HCB. 
As tools in the present study of the biotransformation of HCB, use has 
been made of, on the one hand, rat liver microsomes (particles of the 
endoplasmatic reticulum, which contain the cytochrome P-450 complex) and 
purified cytochrome P-450 isoenzymes, and on the other hand, a primary 
culture of chick embryo hepatocytes. Throughout the investigations, 
radiolabeled HCB and metabolites have been applied. This proved to be of 
great advantage in the tracing and quantification of very small amounts of 
products. 
Evidence was obtained that rat liver microsomes were able to hydroxylate 
HCB. Pentachlorophenol (PCP) was detected in very small amounts (10 - 350 
pmoles, depending on the type of microsomes used, in a 30 minute 
incubation of 50 nmoles of HCB). The hydroxylation of HCB appeared to be 
cytochrome P-450 dependent, as saturation of the microsomes with carbon 
monoxide, an inactivator of cytochrome P-450, almost completely inhibited 
the reaction. The formation of PCP amounted to 80-90% of the total 
metabolite formation. As a minor metabolite, 
t e t r a e h l o r o - 1 , 4-hydroquinone (1,4-TCHQ) was i d e n t i f i e d . The apparent 
Km-values for the formation of PCP and 1,4-TCHQ were both determined to be 
34 uM, with Vmax-values of 24 pmoles PCP/min/mg p ro t e in and 1.9 pmole 
1,4-TCHQ/min/mg p r o t e i n . Using O-labeled ^ 0 , the o r ig in of the oxygen 
atoms incorporated in PCP and 1,4-THCQ was determined to be molecular 
oxygen, i nd i ca t ing a sequent ia l hydroxylat ion by cytochrome P-450. 
Furthermore, a small amount (5-10% of a l l me tabo l i t e s ) was detected to be 
covalent ly bound to microsomal p r o t e i n . Since t h i s binding was 
metabolism-dependent, a t t e n t i o n became focussed on the i d e n t i t y of the 
metabol i te or r e ac t i ve in termediate involved. 
Reductive dech lor ina t ion of HCB, r e s u l t i n g from a one e l e c t r o n reduct ion 
of HCB by cytochrome P-450, and giving r i s e to a pentachlorophenyl 
r a d i c a l , was proven not to be involved in the process of covalent binding. 
Under anaerobic cond i t ions , which in general s t imula te reduct ive 
dehalogenat ion, the enzymatic hydroxylat ion was g r e a t l y reduced, while 
covalent binding a lso disappeared. Pentachlorobenzene, as a product of 
reduct ive dehalogenat ion, could not be de tec ted . 
Covalent binding to microsomal p ro te in was a lso detected as a r e su l t of 
microsomal °CP-hydroxylation. If PCP was incubated a t concent ra t ions 
comparable to those formed in HCB-incubations, the amount of covalent 
binding was s imi la r to the amount detected a f t e r HCB-incubations. This 
indicated tha t the covalent binding r e s u l t i n g from the microsomal 
conversion of HCB was due to a r eac t ion product of PCP, formed in these 
incuba t ions . Because no covalent binding could be a t t r i b u t e d to the 
hydroxylat ion of HCB to PCP, the formation of r eac t ive species during t h i s 
r e ac t i on i s improbable. 
The covalent binding as a r e s u l t of microsomal conversion of HCB could be 
prevented by add i t i on of ascorb ic acid to the incubat ion mixtures . The 
disappearance of covalent binding was accompanied by a propor t ional 
increase in the amount of TCHQ formed. Glutathione a l so i n h i b i t e d covalent 
b inding, but no increase in formation of 1,4-TCHQ was observed. These 
r e s u l t s led to the conclusion tha t the benzoquinone or semiquinone forms 
of the te trachlorohydroquinones are the species involved in covalent 
binding to p r o t e i n . Ascorbic acid prevents the oxidat ion of hydroquinones, 
while g lu t a th ione r e a c t s with the benzoquinone, forming conjugates . The 
r eac t ion of g lu t a th ione with te t rachloro-1 ,4-benzoquinone was studied 
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chemically, and evidence was obtained for the formation of mono-, d i - and 
t r i - s u b s t i t u t e d conjugates , s t i l l in the oxidized form. 
Microsomal hydroxylat ion of PCP r e s u l t e d , in add i t i on to covalent b inding, 
in the formation of te t rachloro-1 ,4-hydroquinone and 
te t rach loro-1 ,2-hydroquinone . The apparent Km-values for the formation of 
these hydroquinones was 13 uM, a value a l so measured for the formation of 
covalent ly bound products in PCP-incubations. Ascorbic acid influenced the 
covalent binding in the same way as observed in HCB-incubations. A 
conversion-dependent covalent binding to DNA was observed in incubat ions 
with DNA, which was 0.2 times the amount of binding to p ro t e in . 
Using l i v e r microsomes from r a t s t r ea ted with d i f f e r e n t inducers of 
cytochrome P-450, not only d i f f e r en t r a tes of conversion of HCB and PCP 
were measured, but i nd ica t ions were a lso obtained for a p r e f e r e n t i a l 
formation of e i t h e r of the two isomers of the hydroquinone by d i f f e r e n t 
isoenzymes of cytochrome P-450. This matter has been studied in more 
d e t a i l , using pur i f ied cytochrome P-450 isoenzymes and monoclonal 
an t ibodies aga ins t cytochrome P-450b+e and cytochrome P-450c. I t appeared 
tha t a t l e a s t three d i f f e ren t isoenzymes are involved in the hydroxylation 
of HCB. Puri f ied cytochromes P-450b and P-450e exhibi ted a (very low) 
c a t a l y t i c a c t i v i t y towards HCB, while s e l e c t i v e i n h i b i t i o n of these 
isoenzymes in microsomes a lso r e su l t ed in a moderate decrease in formation 
of PCP. Moreover, microsomes from r a t s t r ea ted with dexamethasone, which 
induces cytochrome P-450p, displayed a 4.4 times higher r a t e of 
hydroxylat ion than microsomes t r ea ted with phenobarb i ta l , which induces 
cytochromes P-450b and P-450e. I t seems l i k e l y that P-450p i s the major 
cytochrome P-450 isoenzyme Involved in the hydroxylat ion of HCB. In a 
r e c o n s t i t u t e d system, PCP was converted to the hydroquinones by pur i f ied 
cytochromes P-450c and P-450d, and to a much l e s s e r ex tent by cytochromes 
P-450b and P-450e. The f i r s t two isoenzymes mentioned p r e f e r e n t i a l y 
produced the 1 ,4 -d io l , while the l a t t e r two form more 1,2-TCHQ than 
1,4-THCQ. Se lec t ive i n h i b i t i o n of the c a t a l y t i c a c t i v i t y of P-450c in 
microsomes from r a t s t r ea ted with 3-methylcholanthrene (a potent inducer 
of cytochrome P-450c), and i n h i b i t i o n of P-450b+e in microsomes from 
phenobarbi ta l t r e a t e d r a t s did not r e s u l t in a decrease in formation of 
d i o l s , i nd i ca t i ng t h a t these isoenzymes were not involved in the 
microsomal hydroxyla t ion. Microsomes from dexamethasone induced r a t s again 
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were the most potent in converting PCP, indicating the importance of 
cytochrome P-450p. These microsomes almost exclusively produce the 
1,4-dlol. 
A high reactivity of tetrachloro-1,4-benzoquinone towards protein was 
detected. The oxidation of tetrachloro-1,4-hydroquinone to its 
benzoquinone was studied. Purified cytochrome P-450b appeared to be able 
to catalyze this reaction. However, in microsomes, cytochrome P-450 is not 
the only enzyme involved: carbon monoxide only partially inhibited the 
oxidation, as measured by covalent binding to microsomal protein, while 
even under anearobic conditions binding was still 39% of the amount found 
under aerobic conditions. Superoxide dismutase inhibited covalent binding 
in microsomes to almost the same extent, while oxidation by purified 
cytochrome P-450 was completely inhibited. This indicated that all 
oxygen-mediated oxidation of 1,4-TCHQ can be ascribed to the superoxide 
anion radical. However, covalent binding as a result of microsomal 
hydroxylation of PCP was not influenced by superoxide dismutase. This 
might indicate that TCHQ, as formed from PCP, is oxidized in the active 
site of cytochrome P-450, by superoxide anion radicals generated by this 
enzyme. The finding that 1,4-TCHQ stimulated the oxidase activity of 
cytochrome P-450 supports this hypothesis. 
In order to obtain more insight in the biotransformation of HCB and the 
cellular protective mechanisms against alkylation damage, the metabolic 
route of HCB leading to the formation of the metabolites reacting with 
protein has been studied in a primary culture of chick embryo hepatocytes, 
using radiolabeled HCB, PCP and 1,4-TCHQ. Although covalent binding as a 
result of biotransformation of these compounds was detected, the relative 
amount was lower than found during microsomal incubations. It is clear 
that a number of mechanisms are available to protect against this binding. 
The hydroxylation of HCB and PCP in these cultures resembled the 
microsomal hydroxylation: the same inducers were effective, and PCP was 
the only extractable product detected. However, biotransformation of PCP 
did not result in accumulation of diols. Instead, a number of conjugation 
reactions prevented covalent binding by either a reaction with PCP or with 
the benzoquinones. Incubations with 1,4-TCHQ supported these findings: 
although a high degree of biotransformation was measured, only a 
relatively small amount of covalent binding was detected. 
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In view of these results, it is unlikely that covalent binding to protein, 
as caused by the oxidative biotransformation of HCB, is of major 
importance in vivo. A direct alkylation of uroporphyrinogen decarboxylase 
by TCBQ is most probably not involved in the process of HCB-induced 
porphyria. However, a relation between covalent binding of the 
tetrachlorobenzoquinones and the carcinogenicity of HCB and the 
mutagenicity of PC? may exist 
13 
CHAPTER 1 
GENERAL INTRODUCTION 
Hexachtorobenzene has been used as a fungicide, especially for the 
protection of seed grains against bunt fungi. The production of HCB for 
this purpose was estimated to be about 7 tons annually (Quinlivan, 1977). 
Of greater importance is the production of HCB as an unwanted byproduct in 
the synthesis of a number of halogenated compounds such as 
perchloroethylene, carbon tetrachloride, chlorine, chlorinated solvents 
and pesticides. In the production of the pesticide pentachloronitrobenzene 
for example, 2000 tons of HCB were produced annually in the early 
seventies (Quinlivan, 1977). In many countries, including the Netherlands 
(since 1973), the use of HCB as a fungicide has been prohibited and its 
production as a byproduct strictly regulated. 
However, due to the large amounts of HCB introduced into the environment 
in the past and its poor biodegradability, HCB has become a major 
pollutant (NAS, 1975). For instance, HCB has been shown to be present in 
human adipose tissue, wild mammals, birds, fish and soil (for an overview: 
Courtney, 1979). The residual character has been the main reason for its 
restriction. The concern over HCB has even given rise to an international 
conference on this compound only (Morris and Cabral, 1987). 
GENERAL TOXICITY 
The (sub)acute toxicity of HCB is relatively low. LD50 values range from 
2600-4000 mg/kg bodyweight (Strik, 1987). Chronic exposure, however, 
reveals a wide range of toxic effects. These effects include 
immunotoxicity (Vos, 1983), teratogenic effects (Khera, 1975), 
neurotoxicity (Peters, 1987), porphyria and tumor formation. The last two 
effects mentioned will be discussed in some detail. For a review of all 
toxicological data on HCB see Courtney (1979^. 
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THE PORPHYRINOGEN]!C ACTION OF HEXACHLOROBENZENE 
The best known toxic effect of HCR is its porphyrinogenic action in man 
and animals. Hepatic porphyria, the accumulation and excretion o£ 
porphyrins as a result of a disturbance of heme synthesis (figure 1), can 
either be the result of exposure to certain chemicals or be of congenital 
origin. A variety of porphyrinogenic compounds is known. Apart from HCB, 
well-known representatives are the polychlorinated biphenyls (PCB's), 
polychlorinated dibenzodioxins (PCDD's) and the polychlorinated 
dibenzofurans (PCDF's) (Strik, 1980). 
The porphyrinogenic action of HCB in humans was discovered after a case of 
massive poisoning in the south-eastern part of Turkey in 1955-1959 
(Peters, 1976, Peters, 1982, Crips, 1984). Consumption of grain dressed 
with HCB resulted in at least 3000 cases of porphyria, with a 10 percent 
mortality rate. Among infants the mortality amounted to 95 percent. 
Eversince, the porphyrinogenic action of HCB has been the subject of a 
large number of studies. 
Chronic exposure of rats to 500 mg/kg food of HCB results in the 
appearance of large amounts of porphyrins after 6-10 weeks (Goerz, 1977, 
Koss, 1978). The mechanism of HCB-induced porphyria has only been 
partially resolved. The accumulation of porphyrins in the liver is due to 
a selective, irreversible inhibition of the enzyme uroporphyrinogen 
deaminase* 
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figure 1. Part of the porphyrin biosynthetic pathway 
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decarboxylase (URO-D, EC 4.1.1.37), which catalyses the four successive 
decarboxylations of uroporphyrin (with 8 carboxyl groups) to 
coproporphyria (with 4 carboxyl groups) (Smith and Francis, 1981). The 
excreted porphyrins predominantly consist of 8, 7, 6 and 5 carboxyl group 
containing porphyrins. The mechanism of inhibition is not clear. Kawanishi 
(1984) reported the direct inhibition on purified URO-D of HCB, Billy 
(1986) found no effect of HCB on cytosolic URO-D. Smith (1986) reported 
that mouse liver URO-D in vivo is not radiolabeled by C-HCB. However, 
Rios de Molina (1987) showed that partially purified URO-D from 
HCB-porphyric rats is structurally different from the enzyme from 
untreated rats. Elder (1982), finally, showed that the amount of 
immunodetectable URO-D is unchanged after HCB-exposure, although its 
activity is greatly diminished. 
THE EFFECT OF IRON ON THE PORPHYRINOGENIC ACTION OF HCB 
Iron stimulates the development of HCB-induced porphyria (Taljaard, 1972, 
Smith, 1983). Khanna (1985) reported that iron stimulates the HCB 
biotransformation, although the time course of metabolite excretion did 
not coincide with the development of porphyria. Muckerji (1984) showed 
7+ that 0.1 mM Fe had a 50% inhibitory effect on URO-D. This inhibition 
could be a direct effect (binding to sulfhydryl groups of URO-D), or could 
be an indirect effect. Iron is known to stimulate the production of 
reactive oxygen species in the liver. A number of authors mentioned the 
hypothesis of HCB-porphyria mediated through lipid peroxidation (Smith 
1986) or oxidation of porphyrinogens to porphyrins, which are competitive 
inhibitors of URO-D (Ferioli, 1984, Muckerji, 1984, Jones, 1981). However, 
Cantoni (1987) showed that URO-D is also inactivated in the absence of 
porphyrins. 
There is a striking sex difference in the HCB-induced development of 
porphyria in the rat. After 103 days of exposure to HCB, female rats 
excrete 40 times more porphyrins in the urine than male rats, while the 
amount of porphyrins in the liver is more than 300-fold higher in females 
than in males (Rizzardini, 1982). Untreated female rats contain 3-5 times 
more hepatic non-heme iron than male rats (Smith, 1985),while the amount 
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of heme bound iron does not change after treatment with HCB (Wainstock de 
Calmanovici, 1985). Preloading' of males with iron, however, did not 
stimulate the porphyric action of HCB, while long-term exposure to HCB 
resulted in a decrease in hepatic iron content in both males and females 
(Smith, 1985). 
THE RELATION BETWEEN PORPHYRIA AND BIOTRANSFORMATION OF HEXACHLOROBENZENE 
In the rat, the porphyrinogenic action of HCB can be enhanced by the 
cytochrome P-450 inducer phenobarbital (Kerklaan, 1979, Debets, 1981, 
Wainstock de Calmanovici, 1984). The Japanese quail, a species which 
develops porphyria in response to HCB very rapidly, excretes porphyrins 
much earlier and to a greater extent after treatment with 
beta-naphthoflavone. Phenobarbital pretreatment shows an inhibitory effect 
on the development of porphyria in this species (Carpenter, 1984). In a 
culture of primary chicken hepatocytes, SKF-525A and piperonyl butoxide, 
both selective inhibitors of cytochrome P-450, inhibit the porphyrinogenic 
action of chlorinated hydrocarbons (Sinclair, 1974) and HCB (Debets, 
1981a), while addition of 3-methylcholanthrene (Sinclair, 1984) and 
beta-naphthof lavone (Debets, 1981a) , inducers of a cytochrome P-450 
isoenzyme, together with HCB, also Induced porphyria. Piperonyl butoxide 
also inhibits the development of porphyria in vivo (Smith, 1986). These 
findings have led to the hypothesis that biotransformation of HCB is a 
prerequisite for its porphyrinogenic action. A number of metabolites have 
therefore been tested for their ability to induce porphyria or to inhibit 
URO-D. Although in early studies pentachlorophenol was reported to be 
porphyrinogenic, later reports showed that this was due to chemical 
impurities, especially PCDD's and PCDF's. Pure pentachlorophenol does not 
cause porphyria in rats (Goldstein, 1977, Goertz, 1978, Wainstock de 
Calmanovici, 1980). Pentachlorothiophenol, pentachlorothioanisol and its 
sulfoxide and sulfone were also found to be non-porphyrinogenic (Koss, 
1979). Pentachlorophenol and tetrachlorohydroquinone, although not 
porphyrinogenic by themselves, are able to increase the porphyrinogenic 
action of HCB (Debets, 1980, Carpenter, 1985), the latter being the 
strongest synergist. In ovo exposure of chick embryo's to 
tetrachloro-1,4-hydroquinone, and to a lesser extent for other phenolic 
1! 
metabolites, resulted in accumulation of porphyrins. HCB itself showed no 
porphyrinogens effect (Billy, 1985). As far as the direct effect on URO-D 
is concerned, only tetrachlorohydroquinone and pentachlorophenol had an 
inhibitory effect (Billy, 1986). However, the concentrations used by far 
exceed the concentrations these compounds may reach in the liver as 
metabolites of HCB. HCB itself, although reported to inhibit purified 
URO-D (Kawanishi, 1984), caused no decrease in activity of cytosolic DRO-D 
(Billy, 1986). 
Summarizing the data presented so far, it is clear that HCB does not by 
itself inactivate URO-D, but whether a metabolite or reactive intermediate 
is involved, or by which mechanism iron is involved in this inactivation 
remains to be resolved. 
THE CARCINOGENIC ACTION OF HEXACHLOROBENZENE 
HCB has been shown to be carcinogenic in rats (Smith, 1980, 1985, 
Lambrecht, 1983, Arnold, 1985), mice (Cabral, 1979), and hamsters (Cabral, 
1977). In all species the incidence of liver tumors was significantly 
increased after chronic exposure to at least 75 ppm HCB, while in hamsters 
and rats (Arnold, 1985), thyroid adenomas were reported as well. In the 
rat, renal cell adenomas were detected (Lambrecht, 1982). 
The sex differences in tumor development are noteworthy. Whereas in 
hamsters and mice hepatomas occurred predominantly in males, in the rat 
HCB induced more liver tumors in females than in males (Smith, 1985). This 
phenomenon is strikingly similar to the development of HCB-induced 
porphyria. Of the three species mentioned, only in the rat females 
developed hepatic porphyria to a larger extent than males (Rizzardini, 
1982). However, in the rat both renal and thyroid tumors were induced to a 
larger extent in males than in females. 
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THE BIOTRANSFORMATION OF HEXACHLOROBENZENE 
GENERAL 
In general, the nature of the process of biotransformation of foreign 
compounds is to increase the polarity of the xenobiotic, resulting in a 
faster elimination from the body of the product than its parent compound. 
Two kinds of reactions have been identified for this purpose: 
1) transformation reactions (phase I reactions). The introduction of a 
polar functional group into the molecule. The reactions catalysed by 
cytochrome P-450 form the majority of this class. 
2) conjugation reactions (phase II reactions). The xenobiotic, or the 
product of a phase I reaction, is linked to a polar endogenic molecule, 
mostly in an enzyme catalysed reaction. 
An overview of the phase I and phase II reactions is given in table 1. 
A fascinating phenomenon is that the biotransformation described above 
should not only be considered as a detoxification process, since there are 
TABLE 1. PHASE I AND PHASE II REACTIONS INVOLVED 
IN BIOTRANSFORMATION OF XENOBIOTICS 
reaction enzyme substrates 
PHASE I REACTIONS (TRANSFORMATIONS) 
oxidation mixed function oxidases alkanes, alkenes, arenes, 
amines, thiones, thioethers 
FAD-containing raonooxygenases amines 
alcohol dehydrogenases alcohols 
aldehyde dehydrogenases aldehydes 
reduction mixed function oxidases azo and nitro groups, N-oxides 
arene-oxides, alkyl halogenides 
aldehydes, ketones 
alcohol dehydrohgenases aldehydes, ketones 
hydrolysis esterases esters 
PHASE II REACTIONS (CONJUGATIONS) 
with H2O epoxide hydrolase epoxides 
with glutathione glutathione-S-transferases electrofiles 
with glucuronic acid glucuronyl transferases OH, COOH, NH 
with sulfuric acid sulfotransferases NH, OH 
with acetic acid N- and O-methyl transferases NH, OH 
with acetic acid N-acetyl transferases NH 
Adapted from Van Bladeren (1981) 
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a large number of examples ava i l ab le in which the foreign compound becomes 
toxic only a f t e r b iot ransformat ion (metabolic a c t i v a t i o n ) . Many of the 
examples known re fe r to substances which have mutagenic or carcinogenic 
p r o p e r t i e s . For example, from benzo(a)pyrene carcinogenic diolepoxides are 
formed by 1) oxidat ion catalyzed by cytochrome P-450, 2) hydrolys is of the 
epoxide by epoxide hydrolase and 3) oxida t ion by cytochrome P-450 of the 
remaining double bond (see f igure 2 ) ( J e r i n a , 1984). 
V epoxide hydrolase 
Ha'' 
benzo(a)pyrene (+)-7,8-oxide -7,8-dihydrodiol )-7,8-diol-9,10-epoxide-2 
figure 2. The metabolic activation of benzo(a)pyrene. Adapted from 
Jerina, 1984. 
Another example of a bioactivation reaction, in which glutathione is 
involved is represented by 1,2-dibromoethane. This compound has been shown 
to be carcinogenic in rats and mice (Olson, 1973). In vitro studies 
suggested glutathione conjugation, resulting in a reactive thiiranium ion, 
to be responsible for this action (Van Bladeren, 1980, figure 3 ) . The DNA 
adduct of this intermediate has been isolated and characterized (Koga, 
1986). Metabolic activation is dependent on the chemical structure of the 
compound. Examples are known for every enzyme involved in 
biotransformation. 
•SG 
figure 3. The metabolic activation of dibromoethane. A reactive 
thiiranium ion is formed after conjugation with glutathione. 
Adapted from Van Bladeren (1980). 
covalent binding 
to macromolecules 
GSSG • C2Ht 
A noteworthy kind of activation occurs with a number of olefins, 
acetylenes and hydrazines. These compounds act as suicide inhibitors 
toward cytochrome P-450 because during the catalytic turnover of the 
substrate a reactive product is formed which covalently binds to the 
prosthetic heme group of the cytochrome P-450, thus inactivating the 
enzyme (Ortiz de Montellano, 1983). 
CYTOCHROME P-450 
The term cy tochrome P - 4 5 0 , o r P - 4 5 0 , i s commonly used to d e n o t e a g roup of 
isoenzymes sharing a number of characteristics: 
-all are iron containing hemoproteins of about 50,000 dalton molecular 
weight, showing an absorption maximum of approximately 450 nm, when carbon 
monoxide is bound to the reduced iron; 
-all are membrane proteins, localized in the endoplasmatic reticulum, 
together with an electron donating system consisting of the 
NADPH-cytochrome P-450 reductase, cytochrome b5 reductase and cytochrome 
b5; 
-besides a role in the metabolism of endogenous compounds, an important 
function is the oxygenase activity towards xenobiotics. They are 
monooxygenases, which implies the incorporation of a single oxygen atom, 
TABLE 2 . SUBSTRATE S P E C I F I C I T Y OF THE CYTOCHROME P - 4 5 0 ISOENZYMES 
SUBSTRATE REACTION ISOENZYME ( r a t e i n n m o l e / m i n / n m o l e P - 4 5 0 ) 
a b c d e f g h i j 
benzo(a)pyrene 3/9-hydrox. 0.2 0.4 23.4 0.3 0.1 0.1 0.1 1.8 <0.1 <0.1 
hexobarbital 3-hydrox. <0.5 42.0 0.0 <0.6 8.2 <0.5 1.1 22.6 1.0 <0.5 
benzphetamine N-demethyl. 2.3 132.0 0.7 3.9 19.8 1.3 4.9 52.1 2.8 5-5 
7-ethoxucoumarin O-deethyl. 0.6 9.6 97.0 0.6 2.0 <0.5 1.1 0.9 0.7 1.2 
p-nitroanisol O-demethyl <0.5 1.8 21.6 0.7 <0.5 <0.5 <0.5 1.5 <0.5 1.6 
aniline p-hydrox. <0.5 1.8 1.0 9.6 <0.5 <0.5 <0.5 1.5 <0.5 12.7 
zoxazolamine 6-hydrox. 0.9 3.3 60.8 21.1 1.1 0.9 <0.5 7.4 0.7 3.4 
estradiol 17B 2-nydrox. <0.5 <0.5 1.7 13.8 0-9 0.5 0.6 8.0 1.3 0.8 
Data taken from Ryan et al (Ryan, 1984, + refs) 
d e r i v e d from m o l e c u l a r oxygen , i n t o t h e s u b s t r a t e , and c a t a l y s e t he 
f o l l o w i n g r e a c t i o n : 
RH + NADPH + 0 2 + H -=»• ROH + NADP + H20 
The h i g h e s t c o n c e n t r a t i o n of cy tochrome P-450 i s found i n t h e l i v e r , 
a l t h o u g h i n many o t h e r o r g a n s i t s p r e s e n c e h a s a l s o been e s t a b l i s h e d . 
I n t h e r a t , i n which t h e cy tochrome P-450 sys t em i s most t h o r o u g h l y 
s t u d i e d , a t l e a s t 11 h e p a t i c P-450 i soenzymes have been p u r i f i e d , a l l w i t h 
d i f f e r e n t a c t i v i t i e s toward a number of s p e c i f i c s u b s t r a t e s ( t a b l e 2 ) . 
A l though not u n i f o r m l y a d o p t e d , t h e most w i d e l y used n o m e n c l a t u r e i s t h e 
one from Lev in and c o - w o r k e r s , naming t h e i soenzymes a l p h a b e t i c a l l y . 
Most cy tochrome P-450 i soenzymes a r e i n d u c i b l e . Form b , c , d and e , which 
a r e p r e s e n t o n l y i n t r a c e amounts i n n o n - i n d u c e d r a t s , a r e t h e i soenzymes 
which a r e most f r e q u e n t l y induced by x e n o b i o t i c s ( t a b l e 3 ) . P - 4 5 0 b , t h e 
p h e n o b a r b i t a l i n d u c i b l e i s o e n z y m e , i s t h e most w i d e l y s t u d i e d form. 
Cytochrome P-448 i s t h e o b s o l e t e name f o r P - 4 5 0 c , t h e i soenzyme i n d u c i b l e 
by p o l y c y c l i c h y d r o c a r b o n s . I soenzymes f, g , h and i a r e s o - c a l l e d 
" c o n s t i t u t i v e " P - 4 5 0 ' s , and a r e i s o l a t e d from non induced r a t s . At l e a s t 
one isoenzyme i s known which i s n o t named and c h a r a c t a r i z e d by Lev in e t 
TABLE 3 . INDUCTION OF CYTOCHROME P - 4 5 0 ISOENZYMES 
INDUCER TOTAL CYTOCHROME 
P - 4 5 0 
( n m o l e / m g ) 
n o n e 
i s o s a f r o l e 
3 - m e t h y l c h o l a n t h r e n e 
b e t a - n a p h t h o f l a v o n e 
TCDD 
a r o c l o r 1 2 5 4 
g a m m a - c h l o r d a n e 
p h e n o b a r b i t a l 
SKF 5 2 5 - A 
PCN 
0 . 8 6 
2 . 3 3 
1 . 8 3 
1 . 9 6 
2 . 5 1 
3 . 6 7 
1 . 8 8 
2 . 18 
2 . 2 6 
1 . 3 4 
a 
(% o f 
6 
5 
14 
9 
13 
7 
4 
6 
4 
5 
b + e 
t o t a l 
4 
17 
<1 
<1 
<1 
37 
4 6 
5 5 
35 
3 
ISOENZYME 
c 
a m o u n t 
3 
16 
78 
71 
60 
27 
3 
1 
4 
2 
o f 
d 
c y t o c h r 
5 
38 
24 
24 
20 
22 
1 
2 
1 
1 
u n k n o w n 
ame P - 4 5 0 ) 
82 
24 
- 1 6 
- 4 
7 
7 
4 6 
36 
5 6 
8 9 
Data taken from Thomas et al, 1983 
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al. This isoenzyme, P-450-PCN or P-450p is induced by glucocorticoids and 
raacrolide antibiotics (Wrighton, 1985, 1985a). The mechanism of induction 
has only been estabished for P-450c and d, for which it is 
receptor-mediated. For a state of the art of mechanisms of induction, see 
Goldstein (1984). 
Against most of the purified cytochrome P-450 isoenzymes, specific 
monoclonal antibodies have been produced (Thomas, 1981, 1983). These 
antibodies are well suited as probes for the structure and function of 
different forms of cytochrome P-450. They can be used for 
immunoquantitation purposes (Parkinson, 1983), as well as for specific 
inhibition of isoenzymes (Thomas, 1984, Reik, 1985, chapter 7 of this 
thesis). 
The P-450 active site is characterized by its hydrophobic!ty. In general, 
apolar molecules have a high binding affinity toward P-450. The very broad 
substrate specificity (Nebert 1979) can only he partly explained by the 
existence of multiple isoenzymes. Most individual isoenzymes are able to 
react with a large number of substrates. Jerina and co-workers (Van 
Bladeren, 1984) have established a model for the dimensions of the active 
site and the stereoselectivity toward polycyclic hydrocarbons of 
cytochrome P-450c. It appears that the active site is a relatively open 
structure, with physical limitations at only a few sites. The 
stereoselectivity of the isoenzyme is due to the limited possibilities of 
orientation of the substrates towards the heme-iron (figure 4). 
figure 4. Model of the active site of cytochrome P-450. a) The model as 
derived from stereochemical fittings of epoxidation sites of polycyclic 
hydrocarbons, b). Benzo(a)pyrene positioned for the 9,10-epoxidation. 
c) Benzo(a)pyrene positioned for the (favoured) (+)-7,9-epoxidation. 
Adapted Van Bladeren (1984). 
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P-450g 
P-450 h-
f igure 5. The d i f f e r en t s t e r e o s e l e c t i v e hydroxylat lon s i t e s of 
t e s to s t e rone by a number of cytochrome P-450 isoenzymes. Adapted from 
Waxman (1983) and the work of Levin and co-workers. 
Another s t r i k i n g example of s u b s t r a t e s p e c i f i c i t y and s t e r e o s e l e c t i v i t y of 
the P-450 isoenzymes i s the hydroxylat ion of t e s t o s t e r o n e . This s t e ro id is 
a subs t r a t e for a number of isoenzymes. Each isoenzyme, however, has i t s 
own favoured s t e r e o s e l e c t i v e s i t e of hydroxylat ion. For example, P-450a 
has a high a f f i n i t y toward the 7-alpha pos i t i on , while P-450b mostly 
hydroxylates the 16-alpha site (figure 5). 
Three oxida t ive functions of cytochrome P-450 can be d i s t ingu i shed : 
- t h e monooxygenase function; 
- the oxidase function; 
- t h e peroxidase funct ion. 
A scheme of these functions is presented in f igure 6. 
Acting as an oxygenase, the e s s e n t i a l ac t ion of p -450 i s present ing a 
highly r e a c t i v e oxygen species to the s u b s t r a t e (White and Coon, 1980). 
The heme-iron is used to bind, reduce and s t a b i l i z e oxygen, while the 
s t r u c t u r e of the heme pocket i s organized to present the s u b s t r a t e to the 
r eac t ive oxygen. S t a r t i n g in the oxidized (Fe ) form, the s u b s t r a t e binds 
close to the heme, thus causing the i ron to sh i f t from a low spin to a 
high spin s t a t e . In t h i s s t a t e , the iron can be one-e lec t ron reduced, 
accepting an e l e c t r o n from the NADPH-cytochrome P-450 reduc tase . This 
reductase i s a unique enzyme in t ha t i t possesses two f lav in p r o s t h e t i c 
groups, FAD and FMN, both of which play a ro le in t r anspor t ing the 
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electrons from NADPH to P-450. Oxygen binds to the reduced iron and a 
second electron is presented, after which an iron stabilized oxene complex 
is formed, which reacts with the substrate. The product dissociates 
together with a molecule of HoO, leaving the Iron again in the oxidized 
form. 
As an oxidase, the same reaction cycle is followed, but the oxygen, 
instead of reacting with the substrate, dissociates from the active site 
as a superoxide anion, leaving the iron in the oxidized form, with the 
substrate still bound to the active site. It appears that for many 
hydroxylation reactions of cytochrome P-450, the stoichiometry of the 
reaction (the amount of oxygen and NADPH used versus the amount of 
product) is not 1:1:1, as it should be, but a surplus of oxygen and 
reduction equivalents is used. This indicates the partial uncoupling of 
the oxygenase reaction (Gorsky, 1984), resulting in the formation of 
activated oxygen species. For example, the ethanol inducible P-450h (Ryan, 
1984) exhibits a hydroxyl radical mediated oxidation of ethanol (Morgan, 
1982). 
Besides using molecular oxygen and reductase derived electrons, P-450 is 
also able to substitute O2 and NADPH for organic peroxides, like cumene 
hydroperoxide (O'Brien, 1978). 
H20 ROH 
R 2H + 
oxygenase 
Fe2t-02 .A I y oxidase 
Fe^ -R 
figure 6. Oxygenase, oxidase and peroxidase activity of cytochrome 
P-450. Adapted from Estabrook (1982). 
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Apart from the oxidative reactions, cytochrome P-450 sometimes acts as a 
reductive enzyme. If the substrate has a high affinity for the first 
electron donated to the complex, the iron returns to the oxidized form, 
preventing the binding of oxygen, and the substrate is reduced. Carbon 
tetrachloride, for example, dissociates into a CClo' radical and a 
chloride ion (Uehleke, 1973). Some substrates, for example halothane and 
DDT, need anaerobic conditions to let the reductive route prevail (Baker 
and Van Dyke, 1984, 1984a). The reductive pathway is illustrated in figure 
7 for DTT. 
ci ^ ^ a a ~ / \ ci a / . ,. a 
I -o2 ae | I 
a— c — a a—c —a a-c—a 
i ; i 
I 
DDT BINDING TO LIPID DDD 
f i g u r e 7 . R e d u c t i v e d e c h l o r i n a t i o n o f DOT. Adapted from Baker ( 1 9 8 4 ) , 
INDUCTION OF CYTOCHROME P-450 BY HEXACHLOROBENZENE 
H e x a c h l o r o b e n z e n e i s an i n d u c e r of h e p a t i c mic rosomal cy tochrome P - 4 5 0 . 
The changes i n d rug m e t a b o l i s m which occu r a f t e r e x p o s u r e of r a t s to HCB 
i n d i c a t e t h a t HCB i s a "mixed i n d u c e r " , which i m p l i e s t h e i n d u c t i o n of 
b o t h p h e n o b a r b i t a l and 3 - m e t h y l c h o l a n t h r e n e I n d u c i b l e cy tochrome P-450 
i soenzymes ( S t o n a r d , 1974, 1976 , B l e k k e n h o r s t , 1978 , G o l d s t e i n , 1978 , 
Vize thum, 1980, Holme, 1982, F r a n k l i n , 1 9 8 3 ) . C a r p e n t e r ( 1 9 8 5 a , 1985b) 
d e s c r i b e s t h e same type of i n d u c t i o n by HCB f o r t he Tapanse q u a i l . Most 
a u t h o r s d e s c r i b e an i n c r e a s e i n t r a n s f o r m a t i o n of t y p i c a l ? -450c 
s u b s t r a t e s l i k e b e n z o ( a ) p y r e n e , e t h o x y r e s o r u f i n and e t h o x y c o u m a r i n to 
about h a l f t h e l e v e l t h a t can be r e a c h e d w i t h i n d u c t i o n by 
b e t a - n a p h t h o f l a v o n e o r 3 - m e t h y l c h o l a n t h r e n e , w h i l e c o n v e r s i o n of t y p i c a l 
P-450b s u b s t r a t e s l i k e a m i n o p y r i n e , p e n t o x y r e s o r u f i n (Rozman, 1 9 8 6 ) , and 
b i p h e n y l ( 4 - h y d r o x y t a t i o n ) i s i n c r e a s e d abou t a s much a s by p h e n o b a r b i t a l 
i n d u c t i o n . HCB s h a r e s t h i s t ype of i n d u c t i o n w i t h p o l y c h l o r i n a t e d 
b i p h e n y l s ( P a r k i n s o n , 1 9 8 3 ) . The i n d u c t i o n i s accompanied by a s i g n i f i c a n t 
i n c r e a s e i n l i v e r w e i g h t . R e c e n t l y , two s t u d i e s have been per formed i n 
which the t o t a l amount of P-450 i soenzymes h a s been e s t i m a t e d by means of 
raRNA i n d u c t i o n ( G o l d s t e i n , 1 9 8 7 ) , or immunochemical q u a n t i t a t i o n ( L i , 
1 9 8 7 ) . Both s t u d i e s conf i rmed the mixed n a t u r e of i n d u c t i o n . The r e s u l t s 
a r e p r e s e n t e d i n t a b l e 4 . O the r h e p a t i c d rug m e t a b o l i z i n g enzymes which 
a r e i nduced by HCB a r e t h e cy tochrome P-450 r e d u c t a s e (Holme, 1 9 8 2 ) , 
g l u c u r o n y l t r a n s f e r a s e ( G o l d s t e i n , 1978, Rozman, 1 9 8 6 ) , e p o x i d e h y d r o l a s e 
( C a r p e n t e r , 1985) and c y t o s o l i c g l u t a t h i o n e S - t r a n s f e r a s e ( w i t h CDNB a s 
s u b s t r a t e ) ( C a r p e n t e r , 1985 , D e b e t s , 1 9 8 1 b ) . 
I t h a s been e s t a b l i s h e d t h a t enzyme i n d u c t i o n by HCB i s no t caused by 
i m p u r i t i e s ( G o l d s t e i n , 1 9 7 8 ) . As f o r t h e m e t a b o l i t e s of HCB, t h e major 
m e t a b o l i t e p e n t a c h l o r o p h e n o l does no t i n d u c e P-450 ( G o l d s t e i n , 1977, San 
M a r t i n de V i a l e , 1980, L i , 1 9 8 7 ) . The c o n f u s i o n on t h i s m a t t e r i s due t o 
t he f a c t t h a t e a r l y s t u d i e s w i t h t h i s compound were per formed w i t h 
p e n t a c h l o r o p h e n o l , c o n t a i n i n g PCDD's and PCDF's a s i m p u r i t i e s ( G o l d s t e i n , 
1 9 7 7 ) . Lower c h l o r i n a t e d benzenes ( p e n t a , t e t r a and t r i c h l o r o b e n z e n e s ) 
i n d u c e cy tochrome P-450 to some e x t e n t ( G o l d s t e i n , 1 9 8 2 ) , bu t t h e amount 
of t h e s e compounds produced a s m e t a b o l i t e s of HCB i s i n s u f f i c i e n t to a c t 
a s an i n d u c e r in s i t u . T h i s i n e v i t a b l y l e a d s to t h e c o n c l u s i o n t h a t ' HCB 
i t s e l f i s r e s p o n s i b l e fo r t h e i n d u c t i o n d e s c r i b e d a b o v e . 
TABLE 4 . INDUCTION OF CYTOCHROME P-450 ISOENZYMES BY HEXACHLOROBENZENE 
INDUCER INDUCTION FACTOR ( i n d u c e d / c o n t r o l ) 
P - 4 5 0 a P-450b+e P - 4 5 0 c P - 4 5 0 d unknown t o t a l 
CORN OIL 
HEXACHLOROBENZENE 
PENTACHLOROBENZENE 
PENTACHLOROPHENOL 
1 
2 . 3 
1 .0 
1 .0 
1 
4 8 
13 
2 . 0 
1 
13 
1 .0 
1 .0 
1 
8 
1 .6 
1 . 2 
1 
0 . 0 4 
1 . 0 2 
1 . 1 7 
1 
2 . 8 
1 .6 
1 . 2 
ABSOLUTE VALUES (nmole/mg p r o t e i n ) 
0 . 0 5 0 .025 0 .015 0 .055 0 .54 0 .69 
Data taken from Li, Safe, Levin et al (1987) 
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THE BIOTRANSFORMATION OF HEXACHLOROBENZENE 
Hexachlorobenzene is very slowly metabolized. This is partly due to the 
fact that HCB is absorbed by the lymphatic system of the gastro-intestinal 
tract, thus avoiding the first pass liver circulation, and accumulates in 
adipose tissue (latropoulos, 197 5, Mehendale, 1975). Twenty years after 
the dramatic case of HCB poisoning in Turkey, traces of HCB were still 
detected in maternal milk (Peters, 1976). The first study on the 
biotransformation of HCB revealed no metabolites (Parke and Williams, 
1960). Since then, partly because of the HCB disaster in Turkey and partly 
because HCB became a worldwide pollution problem, the in vivo 
biotransformation of HCB has been widely studied. Koss (1978) showed that 
in a long-term exposure study in rats, 40 percent of the administered HCB 
is metabolized. 
The metabolites of HCB can be devided into three groups: 
-phenolic metabolites 
-sulfur-containing metabolites 
-lower chlorinated benzenes 
A large number of metabolites have been detected. They are presented in 
table 5. Recent reviews on the biotransformation of hexachlorobenzene have 
been published by Renner (1981, 1984a, 1985). 
The major metabolite of HCB is pentachlorophenol (PCP) . PCP has been 
detected in the liver, faeces and urine of rats exposed to HCB (Koss, 
TABLE 5. THE METABOLITES OF HEXACHLOROBENZENE 
BENZENES PHENOLES SULFUR CONTAINING METABOLITES 
pentachl 
1,2,3,4-
1,2,4,5-
1,3,5-tr 
orobenzene 
tetrachlorobenzene 
tecrachlorobenzene 
ichlorobenzene 
pentachlorophenol 
2,3,4,6-tetrachlorophenol 
2,3,5,6-tetrachlorophenol 
2,4,5- t r ichlorophenol 
2,4,6-trichlorophenol 
pentachlorothiophenol 
te t rachlorothlophenol 
pentachlorothioanisol 
te t rachlorothioani sol 
dichlorotetra(raethylthio)benzene 
hexa(methylthio)benzene 
tetrachloro-1,4-di(raethylthio)benzene 
1,4-dimereapto-tetrachlorobenzene 
4-methylthio-tetrachlorothiophenol 
N-acety1-S-(pentachlorophenyl)cysteine 
Adapted from Renner (1985) 
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1978). The second most important metabolite is tetrachlorohydroquinone. 
The other predominant metabolites are pentachlorothlophenol (PCThP) and 
pentachlorothioanisol. Both sulphur containing metabolites are 
interconvertable by the rat (Koss, 1979). The amount of sulphur containing 
metabolites as compared to the amount of pentachlorophenol excreted is 
1:2.8 after long-term exposure and 1:1.3 after short-term exposure (Koss, 
1976, 1978). The formation of lower chlorinated benzenes from HCB has been 
subject to discussion for some time. Renner (1984) suggested the formation 
of pentachlorobenzene to take place by a pathway he described as reductive 
desulphuration (figure 8). This implies the initial formation of a 
glutathione conjugate of HCB, which is subsequently converted stepwise 
into pentachlorothlophenol and pentachlorobenzene, respectively. Stewart 
(1986), however, reports the direct reduction of HCB to pentachlorobenzene 
by rat liver microsomes. The rate of this reduction, though, is extremely 
low. 
oi§£-
SCys 
CH2-CH-C0OH 
S NH-COCH 
CI 
HCB 
s5Cl ^5 CI "5 CI 
PCPThP 
glutathione cleavage of acetylation cleavage reductive 
conjugation glycine and glutamate ofC-Sbond desulphuration 
figure 8. Formation of pentachlorobenzene from hexachlorobenzene by the 
mechanism of reductive desulfuration, as proposed by Renner (1984). 
POSSIBLE REACTIVE 
HEXACHLOROBENZENE 
INTERMEDIATES IN THE BIOTRANSFORMATION OF 
As indicated, a relation is suspected between the biotransformation and 
porphyrinogenic action of hexachlorobenzene. A number of stable 
metabolites have been screened for their porphyrinogenic capacity and, at 
least in vivo, no metabolite has been found to be capable of inducing 
porphyria as strongly as HCB itself. A number of authors have suggested 
the involvement of a reactive intermediate in the inhibitory action toward 
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uroporphyrinogen decarboxylase. S i n c l a i r and Granick (1974) showed tha t a 
c e l l homogenate derived from c u l t u r e s of embryonal chick hepatocytes in 
which porphyria had been induced, can induce porphyria in another c u l t u r e , 
but only for a very l imi ted period of t ime. However, Cantoni (1987) 
r epor t s on an ex t r ac t ab l e and s t a b l e URO-D i n h i b i t o r from TCDD- and 
HCB-porphyric mice, and B i l l y (1987) r e p o r t s the same for r a t s . The 
i n h i b i t i o n of URO-D may be caused by covalent binding. Therefore, the 
mechanisms of ac t ion leading to formation of reac t ive in termedia tes and 
covalent binding which may occur during HCB biotransformat ion w i l l be 
d iscussed. 
Since P-450 plays an important ro le in the porphyric ac t ion of HCB, and 
the f i r s t hydroxylat ion product of HCB in vivo, pentachlorophenol , i s not 
porphyrinogenic, i t s tands to reason to assume a r eac t ive Intermediate 
produced during t h i s r e a c t i o n . Two types of in te rmedia tes a re conceivable , 
epoxides and r a d i c a l s . In add i t i on , phenols can be transformed in to 
quinones, which also have a lky la t i ng p r o p e r t i e s . These three types of 
r eac t ive in te rmedia tes are discussed s epa ra t e ly . 
1) EPOXIDES Reaction of the cytochrome P-450 generated oxene with a 
carbon-carbon double bond leads to the formation of an epoxide. The 
cytochrome P-450 mediated hydroxylat ion of benzene to phenol has been 
shown to involve an epoxide, as deduced by the nuclear induced hydrogen 
(NIH) sh i f t ( J e r i n a and l)aly, 1974). The benzo(a)pyrene 
7 ,8-d io l -9 ,10-epoxide ( f igure 2) covalent ly binds to DNA, causing 
mutations and carc inogeni ty (Bentley (1977). Monohalobenzenes undergo 
epoxidat ion leading to spec i f i c hydroxylat ion products (MacRonald, 1984). 
Epoxides can reac t with water to form d i o l s , e i t h e r chemically or enzyme 
ca ta lyzed . The enzyme involved i s epoxide hydrolase , a microsomal enzyme 
which s t e r e o s e l e c t i v e l y forms t r a n s - d i o l s (Oesch, 1979). 
The formation of a HCB-epoxide would be g r e a t l y hindered by the presence 
of the bulky ch lo r ine atoms. In the case of HCB, the NIH-shift would 
involve a p o s i t i v e l y charged ch lor ine ion as a leaving group. Other 
t h e o r e t i c a l pathways of phenol formation out of a HCB-epoxide involve the 
formation of chloroso compounds, which can s u b s t i t u t e with water to form 
pentachlorophenol . These mechanisms are discussed in more d e t a i l in 
chapter 8. 
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2) RADICALS AS A RESULT OF REDUCTIVE DECHLORINATION The mechanism of 
reductive dehalogenation by cytochrome P-450, as mentioned previously for 
carbon tetrachloride and halothane (figure 7), may play a role in the 
formation of pentachlorobenzene. 
In this case, a pentachlorophenyl radical will be formed after a one 
electron reduction by cytochrome P-450. This radical could either be 
reduced to pentachlorobenzene, or bind covalently to cellular 
macroraolecules (figure 9). Steward (1986) reports the microsomal formation 
of pentachlorobenzene from HCB by rat liver microsomes. This route would 
be enhanced under anaerobic conditions. 
CI 
9 . 
PCB 
Poss ib le route of 
-CI 
CI 
PCP 
BINDING TO 
LIPID, PROTEIN 
reduct ive dech lo r ina t ion of figure 
hexachlorobenzene, and generation of an intermediate pentachlorophenyl 
radical. 
3) QUINONES In the case of benzene, the u l t ima te r eac t ive species 
appeared to be the 1,4-benzoquinone, formed a f t e r oxidat ion of the benzene 
d i o l , the second hydroxy l a t i o n product of benzene by cytochrome P-450 
(Tunek, 1980). Since tetrachlorohydroquinone is detected as an in vivo 
metabol i te of HCB, t h i s type of r e ac t i ve compounds i s of i n t e r e s t . 
Quinones are toxic by two d i f f e r en t modes of ac t ion : covalent binding and 
redox cyc l ing . 
Covalent binding of quinones has for example been described for 
2-acetamido-p-benzoquinone, a me tabo l i t e of 3 ' -hydroxyace tan i l ide 
(Streeter and Baillie, 1985) and p-benzoquinone (Wallin 85). The proposed 
mechanism is a Michael addition to macromolecular nucleophilic groups, 
especially sulfhydryl groups. Glutathione Inhibits covalent binding by 
forming a conjugate, most likely by the same type of reaction. An example 
is given in figure 10 for bromobenzoquinone (Monks, 1985). 
Redox cycling as a mechanism of toxicity of quinones has been recognized 
for some time to be of major importance. A number of anticancer drugs, 
e.g. adriamycin (Smith, 1985) and toxic compounds exert their action in 
this way. Some enzymes are able to reduce quinones to their semiquinone 
radicals. For example, DT-diaphorase has a high affinity for quinones 
(Ernster, 1962), and the NADPH-cytochrome P-450 reductase has been shown 
to reduce the benzo(a)pyrene-3,6-quinone (Smith, 1985). The semiquinone 
radicals are able to be reoxidized, reducing molecular oxygen to 
superoxide anion radicals. This redox shutle results in a large 
comsumption of reduction equivalents, cellular oxidative stress, depletion 
of glutathione and cell death. (Kappus, 1985). 
SG 
3 Possible Monosubstituted GSH Conjugates 
figure 10. The metabolic route of bromobenzene leading to the reactive 
bromobenzoquinone, and the stable glutathione-bromohydroquinone as 
product. Adapted from Monks (1985) 
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OBJECTIVES OF THE INVESTIGATION 
Since the involvement of cytochrome P-450 in the development of HCB 
induced porphyria was established, a number of investigations have been 
carried out in order to determine which of the HCB metabolites was the 
actual porphyrinogenic agent. At the onset of the investigations presented 
In this thesis, no convincing evidence had appeared indicating the 
porphyrinogenic capacity of a particular metabolite. On the contrary, the 
major oxidative metabolite, PCP, had been shown to be non porphyrinogenic. 
This led to the hypothesis that a reactive intermediate was involved , 
generated during the hydroxylation of HCB to PCP (Debets, 1981). The 
general aim of the present study was to investigate the biotransformation 
of HCB, with special attention to the mechanism of generation of reactive 
intermediates. The approach chosen to elucidate this mechanism has been to 
study the reactions involved in vitro, since in vivo the reactivity of 
such compounds would greatly hinder their detection and isolation. 
The first objective of this study was to prove the involvement of 
cytochrome P-450 in the hydroxylation of HCB. This is described in chapter 
2. During the microsomal metabolism of HCB a small amount of metabolites 
was found to be covalently bound to protein. In chapter 3 the origin of 
this binding was studied. It appeared that PCP was further hydroxylated to 
tetrachlorohydroquinone, which in turn was oxidized to its benzoquinone. 
This tetrachlorobenzoquinone was postulated to be the actual covalently 
binding agent. The evidence for this mechanism of covalent binding to 
protein is described in chapters 4 and 5. Chapter 4 deals with the 
microsomal metabolism of pentachlorophenol, resulting in covalent binding 
to protein and DNA. In chapter 5 the driving force behind the oxidation of 
the tetrachlorohydroquinone to tetrachlorobenzoquinone is studied. In 
chapter 6, the determination of the cytochrome P-450 isoenzymes involved 
in the hydroxylation reactions of HCB and PCP is described. The last 
experimental chapter deals with the metabolism of HCB and PCP in a primary 
culture of chick embryo hepatocytes, in order to compare the microsomal 
data with a situation which more closely resembles the in vivo situation. 
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CHAPTER 2 
FORMATION OF PENTACHLOROPHENOL AS THE MAJOR PRODUCT OF 
MICROSOMAL OXIDATION OF HEXACHLOROBENZENE 
B. van Ommen \ P.J. van Bladeren ' , J.H.M. Temmink ' , and F. Miiller . 
1) Department of Toxicology and 2) Department of Biochemistry, Agricultural 
University 6703 BC Wageningen, the Netherlands. 
ABSTRACT 
On incubation of C -hexachlorobenzene with microsomes from livers of rats 
induced with hexachlorobenzene, the major product (80-90%) was pentachlorophenol. 
The only other detectable metabolite, tetrachlorohydroquinone (4-15%), was 
presumably formed from pentachlorophenol. A considerable amount of radioactivity 
(5-10% of the amount of extracted metabolites) was covalently bound to protein. 
Microsomes derived from male hexachlorobenzene-induced rats gave by far the 
highest conversion (approx. 1% of substrate). Microsomes from female hexachloro-
benzene-induced rats were 3 times less efficient. Microsomes from untreated and 3-
methyl-cholanthrene-treated animals gave less than 5% of the amount of penta-
chlorophenol formed by microsomes from hexachlorobenzene-induced male rats, while 
phenobarbital and aroclor 1254-induction resulted in formation of 51% and 34% 
respectively. 
INTRODUCTION 
The fungicide hexachlorobenzene (HCB) has been shown to be hepatocarcinogenic (1) 
and is known for its porphyrinogenic action in man and animal (2). The accumula-
tion of porphyrins is a result of inhibition of the enzyme uroporphyrinogen 
' Biochemical and Biophysical Research Communications 126 (1), 25-32 (1985) 
decarboxylase (3). Although it has been reported that HCB Itself has an inactiva-
ting effect upon this enzyme in its purified form (4), there is also substantial 
evidence that metabolism of HCB is a prerequisite for this inactivation. Selective 
inhibition of cytochrome P-450 in a primary liver cell culture prevents the 
accumulation of porphyrins after HCB-exposure (5), while in vivo induction of P-
450 by phenobarbital enhances the porphyrinogenic action of HCB (6-10). These 
experiments indicate the important role of cytochrome P-450 in the metabolism of 
HCB. Numerous studies have appeared on the in vivo metabolism of HCB, resulting in 
the identification of a large number of metabolites, e.g. chlorophenols, chloro-
benzenes and sulphur-conjugated chlorophenols and -benzenes (11-13). The only 
investigation on the microsomal metabolism of HCB reported thus far (11) was 
performed with microsomes of non-induced rats, and the amounts of metabolites 
found were too small for quantitation. In the present study the metabolism of 
C -labeled HCB by liver microsomes of rats pretreated with HCB and a number of 
other inducing agents was investigated and the amounts of metabolites were deter-
mined quantitatively. 
METHODS 
Chemicals: U- C -hexachlorobenzene (Amersham UK, sa. 106 mCi/mmol) was purified 
by HPLC, using the procedure described below for analysis of metabolites, to a 
radiochemical purity of 99.96% (0.03% contamination with pentachlorobenzene). 
Hexachlorobenzene (analytical grade, BDH chemicals, Poole UK) was purified by 
preparative HPLC (Chrompack Lichrosorb RP18 1.2x25 cm column, eluted isocratlcally 
with methanol) for use in microsomal incubations. NADPH was from Boehringer 
Manheim FRG. The HPLC marker metabolites were: tetrachlorohydroquinone (ICN 
Pharm., N.Y.); pentachlorophenol (Aldrich); chloranil (Merck); 2,3,4,5-tetra-
chlorophenol (Fluka); 1,2,3,4- (Merck), l,2,4,5-(Aldrich) and 1,2,3,5- (Merck) 
tetrachlorobenzene and pentachlorobenzene (Merck). 
Preparation of microsomes: 14 week old male or female Wistar rats were pretreated 
(2 rats per treatment) with HCB (14 days 0.1% in chow, prepared from a 1% solution 
in olive oil (6)), phenobarbital (7 days 0.1% in drinking water), 3-methylcholan-
threne (3 daily i.p. injections of 30 mg/kg body weight) and aroclor 1254 (one 
I.p. injection of 600 mg/kg body weight, sacrifice after 6 days). Livers were 
perfused with a 20 mM Tris-HCl 250 mM sucrose buffer, pH 7.4, homogenized with a 
teflon potter, and centrifuged for 20 minutes at 10.000 g. The supernatant was 
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centrifuged for 90 minutes at 105.000 g, and the pellet was washed in 150 raM KC1. 
The resulting pellet was resuspended in 100 mM potassium phosphate buffer, pH 7.4. 
iicrosomes were stored at -25°C until use. Cytochrome P-450 was determined 
according to Omura and Sato (14). Protein concentration was determined by the 
method of Lowry (15). 
Microsomal incubations: The standard incubation mixture contained 25uM C -HCB 
diluted to a s.a. of 20 mCi/mraol, 3mM MgClo, 0.1 M potassium phosphate buffer pH 
7.4 and 0.16 - 5 uM microsomal cytochrome P-450 in a final volume of 2 ml. 
Incubations were started by addition of ImM NADPH. After 30 minutes incubation at 
37°C the reaction was terminated by addition of trichloroacetic acid (3% final 
concentration). Metabolites were extracted with 2x3 ml of acetone/ethyl acetate 
1:2. This resulted in complete ( 99.9%) removal of non-covalently bound radioacti-
vity from the aqueous phase. The extracts were dried with Na2S0^ and after removal 
of the organic solvent in a stream of dry air, the residues were dissolved in 50 
ul of methanol. Controls consisted of incubations with boiled microsomes, without 
NADPH or with carbon monoxide. To find optimal conditions the concentrations of 
HCB, NADPH and the incubation time were varied. 
HPLCanalysis of metabolites: Separation of the metabolites of HCB was achieved on 
a Dupont Zorbax ODS column (0.46x25 cm). After injection of 50 ul incubation 
sample together with 5ul of a solution containing the marker metabolites, all 
radioactivity was eluted with a linear gradient of 65% 20 mM tris-acetate buffer, 
pH 8.0/35% methanol to 100% methanol in 10 min, followed by 20 min of 100% 
methanol, at a flow rate of 1 ml/min. The eluent was monitored at 254 nm and 0.3 -
1 ml fractions were collected in order to determine the amount of radioactivity, 
in 5 ml of Packard instagel. In some runs the tris-acetate buffer was replaced by 
1% acetic acid in water. 
Covalent binding to proteins: After the acetone/ethyl acetate extraction the 
aqueous (protein) samples were extracted with 10 ml of methanol (3 times), ethanol 
(2 times) and ethanol: chloroform: ether 2:2:1 (2 times). The resulting pellet was 
dissolved in 1 ml of soluene 350 (Packard) after which 10 ml of scintillation-
cocktail was added and the amount of radioactivity was determined. This method was 
adapted from that described by Koss (13). 
43 
RESULTS 
Metabolites of HCB: In order to determine and quantitate the possible metabolites 
of hexachlorobenzene we have developed an HPLC-procedure which separates HCB and 8 
potential metabolites (fig. la). Using this procedure it was found that the major 
product of the HCB-induced microsomal metabolism of HCB co-eluted with the penta-
chlorophenol marker, and consisted of approximately 90% of the radioactivity that 
eluted before the substrate. The only other detectable radioactive peak eluted 
together with tetra-chlorohydroquinone, and accounted for 4-15% of total metabo-
lites. In order to prove the identity of the pentachlorophenol- and tetrachloro-
hydroquinone-peaks, an HPLC run was performed in which the tris-acetate buffer, pH 
8, was exchanged for a 1% acetic acid solution in water (fig. lb). As a result the 
tetrachlorohydroquinone eluted just prior to the chloranil, and the pentachloro-
phenol marker appeared close to the tetrachlorobenzenes. As expected, figure la 
and b show that only pentachlorophenol (pKa= 4.6), tetrachlorophenol (pKa= 7.0) 
no-
a 
S?Q5 
UL 
10 15 20 25 0 10 15 20 25 
time (mm) 
Figure 1. HPLC-analysis of metabolites of hexachlorobenzene converted by 
microsomes of male hexachlorobenzene induced ra ts . 
a) Base run ( t r i s -ace ta te pH8-buffer as the aqueous component), b) acid run 
(1% ace t i c acid as the aqueous component). For exact cond i t ions and 
explanation of marker metabolites see methods section. 
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and tetrachlorohydroquinone were sensitive to changes in pH. The shifts in the 
radioactivity elution profile corresponded exactly with the shifts in the UV-
elution profile. Pentachlorobenzene was not generated, nor was it metabolized: the 
trace amount of radioactive contamination with pentachlorobenzene was found 
unaltered after every incubation. The conversion appeared to be an enzymatic 
(boiled microsomes gave no conversion) and cytochrome P-450 dependent reaction: 
incubations without NADPH resulted in no detectable metabolites, while only 10% of 
the maximal conversion was reached after saturating the microsomes with carbon 
monoxide (Table 1). Variation of the HCB- and NADPH-concentration showed that both 
substrates were present in saturating amounts. At low levels (0.16-0.63^1) the 
TABLE 1 . 
METABOLISM OF HEXACHLOROBENZENE BY MICROSOMES OF MALE HCB-INDUCED RATS 
a) boiled microsomes 
(microsomes + CO) 
b) variation of NADPH (mM) 
c) variation of HCB (pM) 
d) variation of P-450 (uM) 
e) variation of time (min) 
conversion ' 
0 
0.5 
1.0 
5 
10 
25 
0.16 
0.32 
0.64 
5 
10 
20 
0.07 
0.14 
0.04 
0.94 
1.08 
1.65 
2.19 
0.66 
0.31 
0.71 
1.63 
0.77 
1.58 
1.33 
2") % of metabolism ' 
%PCP 
13 
28 
0 
90 
91 
88 
86 
90 
84 
81 
71 
84 
84 
84 
%TCHQ 
0 
15 
0 
6 
6 
8 
8 
7 
9 
13 
15 
6 
8 
7 
covalent 
binding ' 
195 
307 
137 
264 
752 
1581 
478 
1000 
1478 
Unless otherwise stated, incubation conditions were: 25uM HCB, ImM NADPH, 
2.5 uM P^450, 30 min. 
1) Conversion is expressed as percentage of total radioactivity eluted from 
the column. 
2) Metabolites are expressed as percentage of total metabolites (i.e. total 
radioactivity eluted before the substrate). 
3) Covalent binding is expressed as p.p.m. of total added radioactivity. 
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conversion was linear with the concentration of P-450. Variation of the incubation 
time showed that maximal conversion was reached after 10 minutes (Table 1). The 
results indicate that within one series of incubations all values were comparable 
but that different series of incubations could result in slight variations in the 
rates of conversion, although the same ratios of conversion were measured. This 
was presumably due to a slight evaporation of HCB during solvent removal. 
Covalent binding to protein: The protein fraction of microsomes of male HCB-
induced rats contained 6.5 times more radioactivity than the same incubation with 
boiled microsomes (Table 1). Radioactivity in the protein fraction showed a 
linearity with the incuhation time, while incubations without NADPH or in the 
presence of carbon monoxide gave values similar to the incubation of boiled micro-
somes. This implies that, besides the extracted metabolites pentachlorophenol and 
tetrachlorohydroquinone, a substantial part of metabolized HCB (between 5.5 and 
10.8% of total extracted metabolites) was covalently bound to microsomal protein. 
Differential metabolism in microsomes of HCB-induced male and female rats 
Microsomes of HCB-induced female rats converted only 30% of the amount of HCB 
metabolized by microsomes of HCB-induced male rats (0.23% and 0.77% resp. of total 
TABLE 2. 
THE EFFECT OF INDUCING AGENTS ON THE MICROSOMAL METABOLISM OF HEXACHLORO-
BENZENE 
microsomes 
HCB male 
HCB female 
PB male 
3 MC male 
Aroclor male 
non induced 
non induced 
protein (mg/ml) 
male 
female 
1.60 
1.79 
1.81 
1.69 
1.20 
3.33 
3.57 
conversion ' 
0.77 
0.23 
0.38 
0.06 
0.28 
0.16 
0.07 
90 
93 
94 
32 
84 
19 
9 
% of 
PCP 
(100) 
(31) 
(51) 
(3) 
(34) 
(4) 
(1) 
2) 
metabolites ' 
TCHQ 
4 (100) 
2 (15) 
1 (17) 
0 (0) 
1 (12) 
25 (123) 
0 (0) 
25pM HCB was incubated at 37°C for 30 minutes. P-450 concentration was 2.5uM 
1) Conversion is expressed as percentage of total radioactivity, eluted from 
the column. 
2) Individual metabolites are expressed as percentages of total metabolites, 
the number in brackets denotes the amount of metabolite as percentage of 
the amount of metabolite formed by HCB microsomes. 
added HCB, Table 2). However, in both cases the same metabolites were produced. 
Non-induced male nor female rat liver microsomes were able to metabolize HCB to 
pentachlorophenol (Table 2). The difference between the amount of pentachloro-
phenol and the total amount of metabolites was due to a few very small unidenti-
fied peaks in the apolar region of the HPLC-eluate which were not detectable as 
metabolites from microsomes of any of the tested inducers. 
The effect of different inducing agents on the microsomal metabolism of HCB 
Besides HCB-microsomes, the microsomes of male rats induced with phenobarbital 
(PB), 3-methylcholanthrene (3MC) and aroclor 1254 were assayed for their ability 
to metabolize HCB. The results are shown in table 2; experiments with a doubled P-
A50 concentration gave comparable ratios for the conversions. After PB-induction 
the microsomal HCB-metabolism was 50% of that after HCB-induction per nmol P-450. 
3MC was not able to induce the HCB-converting P-450 ('s). Aroclor 1254, a mixed 
inducer, raised product formation to 1/3 of the HCB-induced microsomes. Both PB-
and aroclor microsomes produced pentachlorophenol as the predominant metabolite 
(84-94%), together with 1.5% tetrachlorohydroquinone. 
DISCUSSION 
In this report we demonstrate that hexachlorobenzene is metabolized by 
cytochrome P-450 and that pentachlorophenol is the only resulting meta-
bolite. The formation of tetrachlorohydroquinone can be attributed solely 
to the conversion of pentachlorophenol (16). Since pentachlorophenol itself 
is not porphyrinogenic (17), it seems likely that a reactive intermediate 
with a strong affinity for protein is generated by P-450 during the turn-
over of HCB and that this intermediate is responsible for the porphyrino-
genicity of HCB. The enhancement of covalent binding of radioactivity to 
protein during microsomal HCB-metabolism also points in this direction. 
Metabolism of labeled HCB both in primary liver cell culture (18) and in 
vivo (13) also results in covalently attached label to protein. 
Our results however, do not explain the greater susceptibility of female 
rats to the porphyrinogenic action of HCB. Female rats produce up to 300 
times more porphyrins than males (19). The finding that HCB-induced female 
rat liver microsomes metabolize HCB to a lesser extent than male rat liver 
microsomes is in agreement with the report of Franklin (19), who found the 
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same d i f fe rence for a number of o ther s u b s t r a t e s . R izza rd in i however, 
reports no difference in urinary excretion of pentachlorophenol between 
male and female rats after exposure to HCB (20). 
In recent years, considerable attention has been paid to the nature of the 
cytochrome P-450 isozymes induced by HCB (21-24). Our findings indicate 
that HCB is probably metabolized by (one of the) PB-induced forms, and not 
by a 3-MC induced isozyme, in accord with the results of Debets (6). 
To solve these questions, the mechanism of HCB-conversion and the possible 
generation of reactive intermediates is being investigated in a system 
reconstituted with purified HCB-induced cytochromes P-450. 
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CHAPTER 3 
THE MICROSOMAL METABOLISM OF HEXACHLOROBENZENE - ORIGIN OF THE 
COVALENT BINDING TO PROTEIN 
B. van Ommen*, A.E.P. Adang*, L. Brader*, M.A. Posthumus**, F. Miiller*** and P.J. 
van Bladeren*. 
Departments of Toxicology *, Organic Chemistry ** and Biochemistry ***, 
Agricultural University, De Dreyen 12, 6703 BC Wageningen, The Netherlands. 
ABSTRACT 
The microsomal metabolism of hexachlorobenzene is studied, with special attention 
to the covalent binding to protein. The metabolites formed are pentachlorophenol 
and tetrachlorohydroquinone. In addition, a considerable amount of covalent bin-
ding to protein is detected (250 pmoles pentachlorophenol, 17 pmoles tetrachloro-
hydroquinone and 11 pmoles covalent binding in an incubation containing 50 umoles 
of hexachlorobenzene). In order to establish the potential role of reductive de-
chlorination in the covalent binding, the anaerobic metabolism of hexachloro-
benzene was investigated. At low oxygen concentrations no pentachlorobenzene was 
detected, and only very small amounts of pentachlorophenol as well as covalent 
binding, indicating a relationship between covalent binding and the microsomal 
oxidation of hexachlorobenzene. Incubations with C-pentachlorophenol at low con-
centrations showed that a conversion dependent covalent binding occurs to the 
extent of 75 pmol binding per nmol pentachlorophenol. This is almost enough to 
account for the amount of label bound to protein observed in hexachlorobenzene 
incubations. This indicates that less than 10% of the covalent binding occurs 
during conversion of hexachlorobenzene to pentachlorophenol, and the remainder is 
X )
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produced during conversion of pentachlorophenol. The major product of microsomal 
oxidation of pentachlorophenol i-s tetrachlorohydroquinone, which is in redox-
equilibrium with the corresponding semiquinone and quinone (chloranil). The cova-
lent binding is inhibited by addition of ascorbic acid or glutathione to the 
hexachlorobenzene incubations. Ascorbic acid decreases the covalent binding with a 
simultaneous increase in formation of tetrachlorohydroquinone, probably due to a 
shift in the redox equilibrium to the reduced side. Glutathione does not act as a 
reducing agent, since the inhibition of covalent binding is not accompanied by an 
increase in tetrachlorohydroquinone formation. Instead glutathione reacts with 
chloranil, producing at least 3 stable products, probably in a Michael type reac-
tion. These results strongly indicate the involvement of chloranil or the semi-
quinone radical in the covalent binding during microsomal hexachlorobenzene meta-
bolism. 
INTRODUCTION 
Hexachlorobenzene (HCB) has been used worldwide as a fungicide and is formed as 
waste during the production of a number of chemicals. Although it is a hepato-
carcinogen (1) it is perhaps best known for its disturbance of the hepatic por-
phyrin synthesis (2). Evidence has accumulated that HCB has to be metabolized in 
order to become porphyrinogenic: induction of cytochrome P-450 by phenobarbital 
enhances the porphyrinogenic action (3-6), while selective inhibition of cyto-
chrome P-450 in a primary chick embryo liver cell culture decreases its action 
(7). We have previously investigated the microsomal metabolism of HCB, and shown 
that HCB is mainly converted to pentachlorophenol (PCP), while a small amount of 
tetrachlorohydroquinone (TCHQ) is also detected (8). TCHQ has been reported to be 
a metabolite of PCP (9). During the microsomal metabolism of HCB a substantial 
amount (+ 10%) of total metabolites becomes covalently bound to microsomal pro-
teins. Since the porphyrinogenic action of HCB is due to an inhibition of the 
liver enzyme uroporphyrinogen decarboxylase, it is tempting to assume that this 
inactivation is caused by a covalent modification as a result of HCB metabolism. 
These considerations led us to investigate in detail the origin of the covalent 
binding. 
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MATERIALS AND METHODS 
Chemicals: U-[ C]-Hexachlorobenzene (Amershara UK, 70 mCi/mmol) contained 0.12% 
pentachlorobenzene (PCB) and 0.04% tetrachlorobenzene as radiochemical impurities. 
U- C -pentachlorophenol (CEA, Gif-sur-Yvette, France, 35 mCi/mmol) contained 
2.2% tetrachlorophenol as radiochemical impurity, determined using the HPLC assays 
1 Q 
described below. 0 - H2O (99%) was from Amersham. The origin of all other 
chemicals has been described elsewhere (8). 
Microsomal incubations: Microsomes of male 12 week old Wistar rats induced with 
0.1% HCB for 14 days were prepared as described previously (8). The standard 
incubation mixture contained 25 pM C-HCB(3.5 pCi, in 50 pi acetone), 3 mM MgC^, 
0.1 M potassium phosphate-buffer pH 7.4 and 4 mg microsomal protein in a final 
volume of 2 ml. The reaction was started by addition of 1 mM NADPH. PCP-incuba-
tions contained 0.05-1 pM C-PCP (3.75-15 nCi in 50 pi acetone). After 10 minutes 
incubation at 37°C, the reaction was terminated with trichloroacetic acid (final 
cone. 3%). Total ( >99.9%) soluble radioactivity was extracted with ether ( 2 x 3 
ml). The extracts were dried with Na2S0/ and the ether was evaporated in a stream 
of nitrogen. Residues were dissolved in 50 pi of methanol for HPLC analysis. For 
anaerobic incubations, the incubation mixture was flushed with argon and degassed 
four times. HCB and NADPH were added by syringe through the seal, to start the 
reaction. Some anaerobic incubations also contained glucose oxidase (50 units) and 
glucose (10 mM). The oxygen concentration was measured in the gas-phase of tubes, 
treated similarly, but with non-radioactive HCB. 100 pi of the gas-phase was 
injected onto a GLC equipped with a catharoraeter (Pye Unlearn CDC chromatograph, 
molecular sieve 5A 80-100 mesh column 5ft x 4 mm ID; carrier gas argon. 
To be certain of equilibrium between gas- and liquid-phase the tubes were 
vigourously shaken before measurement. This method showed a range in oxygen con-
centration between 280-1000 ppm, while addition of glucose/glucose oxidase resul-
ted in an oxygen concentration of 100-500 ppm. 
HPLC-analysis of metabolites: Separation of HCB, TCHQ, chloranil (CAN, tetra-
chloro-p-benzoquinone), PCP and PCB was achieved by injection of the sample in 50 
pi of methanol (see above) plus 10 pi of methanol containing markers, on a Perkin 
Elmer series 4 HPLC equipped with a Chrompack lichrosorb 150 x 4.6 mm 5RP18 
column, eluted with a gradient of 60% methanol in a 0.1% acetic acid solution in 
water to 100% methanol (1.67% per minute for 15 min. followed by 1.5% per min for 
10 rain, and kept at 100% for 5 minutes). Flow rate was 1.0 ml/rain, and detection 
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was at 254 nm. 1 ml fractions were collected and screened for radioactivity (5 ml 
atomlight scintillation fluid (NEN) in a Packard tricarb counter). 
Covalent binding to protein: After ether extraction the aqueous (protein) samples 
were extracted with 3 x 10 ml methanol, 3 x 10 ml ethanol and 3 x 10 ml ether. 
After drying the protein pellets were dissolved in 1 ml Packard soluene 350 and 15 
ml scintillation fluid and the amount of radioactivity was determined. 
18 
GC-MS-determination of O-lncorporation in PCP and TCHQ: Unlabeled HCB was incu-
bated as described above for the radioactive compound, but in water containing 25% 
18 
0 -IkO. The ether extract was methylated with diazomethane and PCP-methyl-
ether and TCHQ-dimethylether were isolated by HPLC (isocratic elution in 100% 
acetonitril, 0.5 ml per minute on a Chrompack hypersil 290 x 4.6 mm 5 RP18 column, 
k' 2.0 and 1.7, respectively). After evaporation of the acetonitril the samples 
were dissolved in 5 ul of ether and injected into a GC-MS (VG MM7070). Samples 
were injected on a 3% 0V-17/Chromosorb WHP column (2mm ID x 1.5m) using a tempera-
ture gradient of 160 °C to 200 °C at 6 °C per minute. Selected ion recording was 
performed for peaks at m/z 277.86 and 279.86 (molecular ion peaks of PCP-methyl-
ether, further termed M+ and M++2) and at m/z 258.89 and 260.89 (M+ minus CH3 
peaks of TCHQ-dimethylether). The ratios between the integrated M and M +2 
signals were calculated and compared with the corresponding values found for the 
reference compounds. Both PCP- and TCHQ-methylether derived from incubations in 
unlabeled water and the synthetic compounds were measured as reference. 
RESULTS 
Metabolism of HCB: As found previously (8), the only products of the microsomal 
oxidation of HCB are PCP (90% of total metabolites) and TCHQ (5-10% of metabo-
lites), together with a small amount of material covalently bound to proteins. Of 
TCHQ, both the 1,2- and 1,4-isomers were detected, of which the 1,4-diol was the 
major fraction. The apparent K of the formation of PCP and TCHQ were both deter-
mined to be 34 pM with a V
 x of 24 pmol PCP. mg protein . min and 1.9 pmol 
TCHQ/mg protein . min (fig. 1). The formation of TCHQ is linear with time 
during the 10 minutes incubation time, while the PCP-formation shows a slight 
deviation from linearity after 5 minutes. 
Substitution of NADPH with NADH results in zero conversion (table 1), while simul-
taneous addition of both cofactors results in the same rate of metabolism as 
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Figure 1. Lineweaver-Burke p l o t s of the format ion of PCP and TCHQ in the micro-
somal ox ida t ion of HCB. 25 urn C -HCB was incubated for 10 minutes i n a suspen-
s ion of microsomes der ived from male HCB-induced r a t s (2 mg p r o t e i n per ml), in 
the presence of 1 mM NADPH. Products were separa ted from HCB by HPLC and q u a n t i -
t a t ed by measurement of r a d i o a c t i v i t y . 
TABIfi 1. 
THE MICROSOMAL METABOLISM OF HCB 
a) incubations total conversion ' 
(pmol) 
1 mM NADPH 260 
1 mM NADH 35 
1 mM NADPH + 
1 nM NADH 265 
low oxygen 
concentration 15-65 
PCP 
(pmol) 
220 
0 
225 
13-58 
PCB 
(pmol) 
0 
0 
0 
0 
TCHQ 
(pmol) 
14 
4 
20 
0 
covalent 
(pmol 
15.2 
0 
7.3 
0-1 
25 uM C-HCB was incuba ted a t a p r o t e i n concen t ra t ion of 2 mg/ml. Microsomes were 
derived from male HCB induced r a t s . Incubat ions were performed in a volume of 2 ml 
a t 37°C. I n t h e low oxygen c o n c e n t r a t i o n i n c u b a t i o n s oxygen was removed by 
repeated degassing and purging w i t h argon i n a sealed incuba t ion tube. The upper 
and lower l i m i t va lues of conversion a t low oxygen p ressure cond i t i ons a r e shown. 
Values in between show no PCB or covalent binding. 
The v a r i a t i o n in metabolism under low oxygen cond i t ions i s presumably due to the 
v a r i a t i o n i n oxygen concen t r a t i on (see method sec t ion) . 
a
' Tota l conversion denotes the t o t a l amount of e x t r a c t a b l e me tabo l i t e s produced 
and i s c a l c u l a t e d from the t o t a l amount of r a d i o a c t i v i t y e l u t i n g from the HPLC 
before the s u b s t r a t e . 
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compared to the incubations with NADPH alone. 
Under anaerobic or very low oxygen conditions, resulting in a PCP-formation of 4-
26% as compared to aerobic conditions, the formation of PCP, PCB and covalent 
binding was measured. No PCB-formation was detected. Only at 26% PCP-formation a 
small amount of covalent binding was detected. (12% as compared to aerobic incuba-
tions, table 1). The variation in PCP-formation is probably due to the variation 
in oxygen concentration (100-1000 ppm in the gas phase, see method section). 
18 
As shown in table 2, there is no evidence for incorporation of oxygen from 0-
18 H2O in to PCP or TCHQ. 0 - inco rpo ra t i on would r e s u l t in a 2 Dalton increase of the 
molecular weight, resulting in a shift in the ratios of the peaks. Both for PCP 
1 8 
and TCHQ these ratios are unchanged after microsomal incubation of HCB in 0-
1^0, as compared to an incubation in O-H9O or the synthetic reference. The 
t h e o r e t i c a l va lues for the peak r a t i o s i f oxygen i s derived completely from E^O 
are also stated in table 2. 
TABLE 2. 
ORIGIN OF THE OXYGEN IN PCP AND TCHQ 
sample PCP TCHQ 
(M++2/M+ x 100) (M+-13/M+-15 x 100) 
a) 160-H20 156.3 + 2.7 (n=9) 127.6 + 4.7 (n=10) 
b) 25% 180-H20 158.3 + 1.6 (n=7) 126.9 + 3.6 (n=3) 
synthetic reference 157.0+1.0 (n=4) 126.5+0.9 (n=10) 
expected value, if 
oxygen is derived from H^O1) 189.6 160.4 (1 x *°0) 
193.4 (2 x 1 8 0 ) 
Unlabeled HCB incuba t ions were performed under normal cond i t i ons (a) and in a 
system conta in ing 25% 0- labe led H20. PCP and TCHQ were pu r i f i ed by e x t r a c t i o n 
and HPLC of t h e i r methyl e t h e r s and analysed by GC-MS ( s e l e c t i v e ion record ing) . 
The ex ten t of i nco rpo ra t i on of 0 was determined by comparing the r a t i o ' s for 
peaks a t m/z=277.9 and 279.9 for PCP-methylether (M+ and M++2) and a t m/z=258.9 
and 260.9 (M+-15 and M+-13) for TCHQ-dimethyl e the r . 
' The expected va lue i s ca l cu la t ed as fo l lows: in the case of 25% 0 - l a b e l i n g , 
25% of each m a s s peak w i l l show a 2 m a s s - u n i t s h i f t , r e s u l t i n g i n a 25% 
decrease of each i n d i v i d u a l o r i g i n a l mass peak and a d d i t i o n of t h i s va lue t o 
the peaks two mass u n i t s h igher . 
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Covalent binding by Pentachlorophenol: At normal incubation conditions the amount 
of covalent binding of radioactivity to protein resulting from metabolism of HCB 
is 10.6 + 2.3 pmol/4 mg protein (n=8). In order to establish whether this covalent 
binding originates from an intermediate generated during the formation of PCP from 
HCB, or from binding of PCP or a conversion product of PCP, we have incubated C-
PCP under the same conditions as C-HCB but at PCP-concentrations which are 
comparable to the amount of PCP formed during HCB-metabolisra (0.250 + 0.035 nmol/4 
mg protein/10 min. in a 2 ml incubation, n=8). The results are shown in figure 2. 
I t appears that there i s an almost l inear relationship between the amount of 
covalent binding to protein and the PCP-concentration, with an i n i t i a l slope of 75 
pmol binding per nmol PCP. Figure 2 represents the covalent binding due to conver-
sion of PCP, since the values are corrected for the binding of PCP i tse l f , which 
amounted to 18 pmol binding per nmol PCP (derived from incubations with boiled 
microsomes and incubations without NADPH). 
Inhibition of covalent binding: In the C-HCB-incubations, ascorbic acid appeared 
to be able to completely inhibit the covalent binding at a concentration of 1 mM 
(fig. 3). x\t concentrations which show no decrease in total conversion, there i s a 
covalent binding to 
protein (pmol) 
12 On 
100-
80-
60-
40-
20-
0-
0.2 0.4 06 0.8 1.0 
[PCPKuM) 
Figure 2. Covalent binding to protein as a result of metabolism of PCP in micro-
somal incubations at very low PCP-concentrations. The values are corrected for 
binding of PCP i tself . Covalent binding was measured by determining the amount of 
radioactivity in protein fractions of microsomal incubat ions a f t e r extensive 
washing with organic solvents. 
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concentration-dependent decrease of covalent labeling. The loss of covalent 
binding i s accompanied by an increase in TCHQ-formation: The concentration of TCHQ 
more than doubles after addition of 1 mM ascorbic acid to the incubation mixture. 
The amount of TCHQ which is produced due to addition of ascorbic acid is 60% of 
the amount of covalent binding wich disappears. In some experiments, part of the 
TCHQ is measured as chloran.il (CAN, tetrachloroquinone), due to partial oxidation 
of TCHQ during solvent removal. Glutathione also inhibits covalent binding (fig. 
3) . As compared to ascorbic acid, glutathione shows a stronger inhibit ion: even a t 
0.01 mM an effect is observed. Up to 10 mM, the total conversion is not affected. 
In the case of glutathione however, no increase in TCHQ is observed. Similar 
results are also obtained with cysteine: inhibition of covalent binding , but no 
increase in TCHQ. 
To find an explanation for these phenomena, the reaction of glutathione with CAN 
was studied. Addition of glutathione to a solution of CAN in methanol at equimolar 
concentrations does not give rise to the formation of TCHQ, but results in the 
formation of at least three stable compounds, termed 1, 2 and 3, of which 3 is the 
% of control 
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50 
0J 
0 001 0.03 0.1 0.2 
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50 
0J 
o= TCHQ-formation 
• = total conversion 
• = covalent binding 
0 0.01 0.03 0.1 03 1 
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Figure 3. The ef fec t of ascorbic acid (a) and g lu ta th ione (b) on the covalent 
binding, to ta l conversion and TCHQ-formation in the microsomal metabolism of HCB. 
Total conversion (the tota l amount of soluble metabolites produced) and TCHQ-
formation were determined by HPLC of extracted substrate and products. Covalent 
binding was measured by counting the radioactivity of protein samples after exten-
sive washing with organic solvents. All resul ts are expressed as the percentage of 
act ivi ty with respect to a control incubation without ascorbic acid or gluta-
thione . 
major compound (figure 4). These compounds are different from TCHQ, CAN and gluta-
thione in their absorption spectra and HPLC behaviour. All products are water 
soluble. Upon reduction with ascorbic acid, fractions 1, 2 and 3 show a single 
absorption peak at 320, 330 and 335 nm, respectively. (TCHQ and CAN show single 
peaks at 310 and 286 nm, respectively.) Glutathione apparently does not act as a 
reducing agent towards the benzoquinone, but forms adducts. 
A A 
10-i AA(254nm) 
600 700 
Mnm) 
Figure 4. HPLC-analysis and absorption spectra of the 3 products of the reaction 
of glutathione with chloranil. HPLC separation was achieved on a reversed phase C-
18 column, eluted isocratically with 50% methanol and 50% HoO containing 0.4% 
acetic acid. Spectra were recorded in the same solution. 
DISCUSSION 
HCB i s a very poor s u b s t r a t e for the cytochrome P^450 r e a c t i o n . The low v m a x _ v a l u e 
corresponds wi th the i n vivo da ta on the slow b io t ransformat ion of HCB (10 ) . The 
HCB-concentration i n the s tandard incubat ions (25 pM) i s lower than the apparent 
KJJJ (34 pM). This i s due to the very poor s o l u b i l i t y of HCB. The near absence of 
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metabo l i t e s and covalent binding in the anaerobic incuba t ions i n d i c a t e t h a t a 
r educ t ive d e c h l o r i n a t i o n , as suggested by Renner (11) i s u n l i k e l y . This impl ies 
t h a t the covalent binding probably cannot be a r e s u l t of the formation of a 
pentachlorophenyl r a d i c a l , analogous to the r a d i c a l s de tec ted under anaerobic 
cond i t ions i n the microsomal metabolism of carbon t e t r a c h l o r i d e and ha lo thane (12, 
13) . 
Our r e s u l t s i n d i c a t e t h a t the covalent binding which occurs during the microsomal 
metabolism of HCB does not o r i g i n a t e from an in termedia te which i s generated 
during the turnover of HCB to PCP by cytochrome P-450, but mainly r e s u l t s from the 
conversion of PCP. The amount of PCP which i s produced dur ing HCB-conversion i n 
our incuba t ion system a f t e r 10 minutes i s 250 pmol, while the amount of covalent 
binding to microsomal p r o t e i n i s 10.6 pmol. The C-PCP incuba t ions show t h a t 114 
CI OH OH 
CI cr\?*^a CK\JS^CI 
Cl 
PCP 
OH 
TCHQ 
10-
atxa 
OH 
• 1 -
ovalent bindir 
^=^ 
q 
cu 
CK 
0 
0 
0 
CAN 
-a 
- C l 
to protein 
Figure 5. Proposed route of microsomal metabolism of HCB and mechanism of covalent 
binding as a r e s u l t of metabolism. 
pmol PCP i s necessary for 10.6 pmol covalent b inding . Although the conversion of 
HCB to PCP i s not completely l i n e a r dur ing the 10 minutes incubat ion t ime, the 
average amount of PCP a v a i l a b l e for convers ion and binding during the incuba t ion 
time w i l l not l a r g e l y exceed ha l f of the amount which i s formed a f t e r 10 minutes , 
e . g . 125 pmol PCP. This i s 1.1 times the amount of PCP which produces the amount 
of covalent binding generated dur ing HCB-turnover. 
The major me tabo l i t e of PCP during metabolism by microsomes of HCB induced male 
1 Q 
r a t s i s TCHQ. The r e s u l t s of the microsomal incubat ion of HCB i n 0 - l abe led H20 
show t h a t both oxygen atoms of TCHQ a r e der ived from molecular oxygen. This r u l e s 
out the p o s s i b i l i t y t h a t TCHQ i s ( p a r t l y ) formed by ^ O - s u b s t i t u t i o n of PCP or an 
in t e rmed ia te during the PCP-:formation, and i n d i c a t e s a s equen t i a l hydroxyla t ion of 
HCB to PCP and of PCP to TCHQ by cytochrome P-450. TCHQ can undergo a two s t ep -
two e l e c t r o n o x i d a t i o n to the benzoquinone-form (CAN), w i t h a semiquinone r a d i c a l 
as the one e l e c t r o n ox ida t ion in te rmedia te ( f i g . 5 ) . The ex i s t ence of t h i s semi-
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qulnone has been demonstrated by ESR and i t s lifetime was estimated to be 5 
seconds (14). Either the tetrachloro-benzo-semiquinone radical might be r e -
sponsible for the majority of the covalent binding which i s measured after HCB 
metabolism (fig. 5) or chloranil i t se l f , which might undergo a Michael type addi-
t ion. The finding that , together with the loss of covalent binding as a result of 
the presence of ascorbic acid, the TCHQ-concentration is raised with a comparable 
amount, seems to indicate the involvement of CAN or the benzoquinone radical in 
the covalent binding. 
The protective action of ascorbic acid is probably due to a shift in the redox 
equilibrium to the reduced form (TCHQ), thus lowering the concentration of the 
semiquinone and CAN and causing a loss of covalent binding. The redoxpotentials 
(EQ) of the chloranil-TCHQ and the dehydroascorbic acid-ascorbic acid equilibria 
are 0.71 V and 0.06 V, respectively (15), showing that 1 mM ascorbic acid i s well 
capable of lowering the CAN concentration to zero levels . This also explains the 
r ise of TCHQ concentration when the covalent binding is inhibited by ascorbic 
acid. The protective role of ascorbic acid against HCB-induced porphyria in chick 
embryo liver ce l l culture has been reported ear l ie r (3) . 
Glutathione and cysteine are known to react easily with benzoquinones. The reac-
tion with 2,6-dichloro-p-benzoquinone for instance is used in the determination of 
cysteine (16). In general, SH-groups react with the quinone in a Michael type 
reaction followed by loss of HC1. From a reaction at equimolar amounts of gluta-
thione and CAN, 3 products are formed, but no TCHQ was observed. In this way CAN 
might also react with protein-SH-groups. Glutathione and cysteine will act as 
inhibitors in this process. This explains the fact that, in contrast to ascorbic 
acid, no increase in TCHQ is measured at concentrations of glutathione and 
cysteine which completely inhibit covalent binding. 
Diethylmaleate, a GSH-depleting agent, has been reported to enhance the porphy-
rinogen^ action of HCB in vivo (4 ,5) . The antiporphyrinogenic act ivi ty of ascor-
bic acid in an in v i t ro culture system and the observation that ascorbic acid and 
glutathione inhibit the covalent binding without inhibiting the cytochrome P-450 
ac t iv i ty suggest the involvement of covalent binding in the porphyrinogenic action 
of HCB. This covalent binding is mainly due to pentachlorophenol metabolism. 
On the other hand, pentachlorophenol has been shown to be unable to cause porphy-
r ia or induce cytochrome P-450 isoenzymes in ra ts (17, 18, 19). We are presently 
investigating whether the lack of inducing capacity of PCP i s responsible for i t s 
slow metabolism in vivo and lack of porphyrinogenic act iv i ty . 
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CHAPTER 4 
THE MICROSOMAL METABOLISM OF PENTACHLOROPHENOL AND ITS 
COVALENT BINDING TO PROTEIN AND DNA 
Ben van Ommen*, Anton Adang, Franz Miiller and Peter J. van Bladeren 
Department of Toxicology and Department of Biochemistry , Agricultural University, 
De Dreyen 12, 6703 BC Wageningen, The Netherlands 
SUMMARY 
The microsomal metabolism of pentachlorophenol (PCP) was investigated, with 
special attention to the conversion dependent covalent binding to protein and DNA. 
The two metabolites detected were tetrachloro-1,2- and -1,4-hydroquinone. 
Microsomes from isosafrole (ISF) induced rats were by far the most effective in 
catalyzing the reaction: the rate of conversion was increased 7-fold over control 
microsomes. All other inducers tested (hexachlorobenzene (HCB), phenobarbital (PB) 
and 3-methylcholanthrene) (3MC) gave 2-3 fold increases over control. There are 
indications that the 1,2- and 1,4-isomers are produced in different ratio's by 
various cytochrome P-450 isoenzymes: (a) Microsomes from PB and HCB treated rats 
produced the tetrachloro-1,4- and tetrachloro-1,2-hydroquinone in a ratio of about 
2, while microsomes from rats induced with 3MC and ISF showed a ratio of about 
1.3. (b) When pentachlorophenol was incubated with microsomes from rats treated 
with HCB a mixed type inducer of P-450, the ratio between formation of the 1,4-
and 1,2-isomers decreased with increasing concentration of PCP suggesting the 
involvement of at least two P-450 isoenzymes with different Km-values. The overall 
apparent Km-value for HCB microsomes was 13 pM both for the formation of the 
1) Chemico-Biologlcal Interactions 60(1), 1-11 (1986) 
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soluble metabolites and the covalent binding to microsomal protein, suggesting 
both stem from the same reaction. The covalent binding could be inhibited by 
ascorbic acid, and this inhibition was accompanied by an increase in formation of 
tetrachlorohydroquinones (TCHQ). Although a large variation was observed in rates 
of conversion between microsomes treated with different (or no) inducers, the rate 
of covalent binding to microsomal protein was remarkably constant. A conversion-
dependent covalent binding to DNA was observed in incubations with added DNA which 
was 0.2 times the amount of binding to protein (37 pmol/mg DNA). 
INTRODUCTION 
Pentachlorophenol (PCP) is used worldwide as a wood preservative and, due to its 
relatively slow biodegradation, forms a serious environmental problem. The best 
known toxic actions of PCP are its ability to uncouple the oxidative phosphoryla-
tion (1) and its inhibitory effect on cytochrome P-450 (2) and sulphotransferases 
(3). A carcinogenic effect cannot be excluded: the interpretations of long term 
carcinogenicity studies are controversial on this matter (for an overview: ref.4), 
while both in vivo (5) and in vitro (6) studies have demonstrated the DNA-damaging 
properties of PCP or PCP metabolites. 
The metabolism of PCP has been studied in vivo and in vitro (7). In both cases, 
the primary oxidative metabolites were the tetrachloro-1,2- and -1,4-hydro-
quinones. In vivo, PCP and its metabolites are partly excreted as their glucu-
ronides (7). The formation of diols was enhanced after treatment of rats with 
inducers of cytochrome P-450 both in vivo and in vitro (7,8). 
Our interest in PCP originates from the fact that PCP is the primary oxidative 
metabolite of hexachlorobenzene. During the microsomal metabolism of hexachloro-
benzene a substantial amount of covalent binding to protein was detected (9). 
Further investigation showed that this covalent binding did not occur during the 
first hydroxylation step, but rather after PCP was metabolized to the 1,2- and 
1,4-diols. The diols can be oxidized to the quinone form, which binds covalently 
to protein (10). These results led us to investigate in detail the microsomal 
metabolism of PCP, with special attention to the covalent binding to protein and 
DNA. 
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METHODS 
CHEMICALS. U-C1 C)-pentachlorophenol was purchased from CEA (Gif-sur-Yvette, 
France) and had a specific activity of 37.5 mCi/mmol. Depending on the batch, 0.5-
1.8% tetrachlorophenol was present as a radiochemical impurity, as determined by 
the HPLC method described below. PCP was from Aldrich, tetrachloro-1,4-hydroqui-
none (1,4-TCHQ) from ICN pharm. N.Y., tetrachloro-1,4-benzoquinone (1,4-TCBQ) from 
Merck, 1,2-TCBQ and alpha-naphthoflavone from Janssen, Belgium, tetrachlorophenol 
and isosafrole from Fluka, NADPH from Boehringer Mannheim and 3-methylcholanthrene 
and Proteinase K (17 u/mg) from Sigma. 1,2-TCHQ was prepared by reduction of 1,2-
TCBQ with ascorbic acid in methanol. The methylethers of PCP, Tetrachlorophenol, 
1,2- and 1,4-TCHQ were prepared by reaction with diazomethane in diethylether 
(prepared from Diazald, Janssen). 
ANIMALS AND TREATMENTS. 11-12 Week old male or female Wistar rats were treated 
with hexachlorobenzene (14 days 0.1% in chow), phenobarbital (7 days 0.1% in 
drinking water), 3-methylcholanthrene (3 daily i.p. injections of 30 mg/kg body 
weight) or isosafrole (4 daily i.p. injections of 150 mg/kg bodyweight). The 
preparation of microsomes has been described elsewhere (9). 
MICROSOMAL INCUBATIONS. Standard microsomal incubation conditions were: 1 C-PCP 
(spec. act. 0.57 mCi/mmol, 100 uM, added in 50 ul of acetone), microsomes of HCB-
induced rats (2 mg protein), 0.1 M potassium phosphate buffer pH 7.4 and 3mM 
MgClo, in a final volume of 2 ml. The reaction was started by addition of NADPH to 
a final concentration of 1 mM. After 5 or 10 minutes incubation at 37°C the 
reaction was stopped with HC1 (final concentration 0.6N). Ascorbic acid, to a 
final concentration of 10 mM, was added to prevent oxidation of hydroquinones to 
quinones after the enzymatic reaction was stopped. Totale soluble radioactivity 
( 99.6%) was extracted with 3x3ml acetone/ethyl acetate (1:2). The extracts were 
dried with NaoSO^ and methylethers were prepared by addition of a solution of 
diazomethane in ether. After removal of the solvent in a stream of nitrogen, the 
samples were dissolved in 50 ul of methanol for HPLC-separation. 
HPLC-ANALYSIS OF METABOLITES. Separation of the methylated PCP and metabolites was 
achieved by injection of 50 ul of methanol containing the extracted metabolites 
plus 10 pi marker solution, on a Perkin Elmer series 4 HPLC, equipped with a 
Chrompack Lichrosorb 150x4.6 mm 5RP18 column, eluted isocratically with 82% metha-
nol and 18% Ho0 (see fig. 1). In order to check whether methylation was complete 
using the above conditions, the phenolic metabolites were also separated. The same 
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system was used, but the metabolites were eluted using a gradient of 50 to 85% 
methanol in a 1% aqueous acetic acid solution in 15 minutes, followed by a gra-
dient of 85 to 100% methanol in 10 minutes. The k'-values were: 1,2-TCBQ 2.4, 1,4-
TCHQ 3.2, 1,4-TCBQ 5.0, 1,2-TCHQ 7.6, PCP 8.2, 1,4-TCHQ-dme 13.7, tetrachlorophe-
nol-me 14.2, 1,2-TCHQ-dme 15.0 and PCP-me 17.4. This method revealed a maximum of 
1.2% of radioactivity to be non-methylated, of which at least 95% was PCP. The 
eluent was monitored at 254 nm and 0.6 ml fractions were collected for measurement 
of radioactivity in 3.5 ml Atomlight (NEN) in a Packard Tricarb scintillation 
counter. 
COVALENT BINDING TO PROTEIN. After extraction of the soluble metabolites the 
precipitated proteins in the aqueous phase were washed with 3x10 ml of methanol, 
3x10 ml of ethanol, 2x10 ml of acetone and 10 ml of diethylether. After drying 
the protein, pellets were dissolved in 1 ml soluene 350 (Packard). 15 ml scintil-
lation liquid was added and the amount of radioactivity was determined. As a 
control on this method a number of incubations were treated as follows: the 
reaction was stopped by addition of sodium dodecyl sulphate (SDS) to a final 
concentration of 5% in order to prevent precipitation of the proteins in the 
presence of organic solvents. The aqueous phase was then extracted with 5x5 ml 
ethyl acetate, after which the aqueous (protein) phase was screened for radioacti-
vity, while the ethyl acetate extract was prepared for HPLC-analysis as described 
above. Both methods showed the same amounts of covalent binding and soluble meta-
bolites for similar incubations. 
COVALENT BINDING TO DNA. To microsomal incubations of 2 mg of microsomal protein 
from HCB induced rats in 2 ml and containing 100 uM C PCP with a Spec. Act. of 5 
mCl/mmol, 1 mg of calf thymus DNA was added. After 5 min. incubation, the reaction 
was stopped by addition of 2 ml of phenol (water saturated). The water phase was 
extracted with equal volumes of phenol, phenol:chloroform 1:1 and chloroform, 
respectively. To the aqueous phase was added 0.25 mg Proteinase K in 0.5 ml of 
water, and this mixture was incubated for 15 hr at 37°C, after which the same 
extraction procedure was followed once again to remove residual protein and amino 
acids. Addition of 5 volumes of ethanol precipitated the DNA overnight at -20°C. 
After centrifugation the DNA was resuspended in Tris-acetate pH 7.4 (20 mM, 1 ml). 
The purity and recovery of the DNA were determined spectrophotometrically (11) and 
the amount of covalently bound radioactivity was determined after addition of 10 
ml scintillation liquid (atomlight). DNA recovery was 38-58%, while the ratio in 
absorbance between 260 nm (DNA-absorption) and 280 nm (protein absorption) was the 
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same as measured for pure DNA (2.09 and 1.95 respectively). Formation of soluble 
metabolites in DNA incubations was determined in duplicate incubations which were 
treated as described under microsomal incubations. 
RESULTS 
IDENTIFICATION OF METABOLITES. Rat liver microsomes converted pentachlorophenol 
(PCP) into tetrachloro-1,4- and -1,2-hydroquinone. HPLC-separation of the methy-
lated conversion products showed only radioactivity coeluting with added 1,4- and 
1,2-THCQ-dimethylethers (figure 1). No other conversion products could be detec-
ted. No conversion occurred in incubations without NADPH. Using microsomes of 
hexachlorobenzene-induced male rats, the characteristics of the reaction were 
studied. With all protein concentrations used the rate of conversion was linear 
with time for 10 minutes. Doubling the protein concentration from 0.5 to 1 mg/ml 
PCPme 
2.0 
^ 15-
.2 1.0-
; 0.5-
Qsc.acid 
ITTM I I I I I I I I I I W4 
25 30 
fraction 
Figure 1. HPLC-analysis of methylated PCP metabolites. 2 mg of microsomal protein 
from HCB induced ra ts was incubated with 100 uM C-PCP for 5 minutes as described 
in Methods. Metabol i tes were ex t r ac t ed , methylated and submitted to HPLC 
separation. Non radioactive methylated metabolites were added for identification. 
The upper trace shows the UV absorption of the eluate, while the lower trace shows 
the amount of radioactivity, expressed as percentage of to ta l eluted radioact ivi-
ty, of the corresponding fractions. (d)me denotes (di)methylether. 
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Figure 2. Lineweaver-Burk plot of the formation of soluble metabolites and cova-
lent binding in the microsomal conversion of PCP. 2 mg/ml microsomal protein from 
HCB induced rats was incubated for 10 minutes. For exact conditions, see Methods. 
had no effect on the r a t e , while 2 mg/ml showed a 30% decrease in rate as compared 
to 1 mg/ml. As shown in figure 2, the relat ion between conversion and PCP-concen-
trat ion can be described by Michaelis-Menten kinet ics , resulting in an apparent Km 
of 13 pM. I t appeared that the ra t io between the 1,4-TCHQ and the 1,2-TCHQ de-
creased with increasing PCP-concentration (figure 3): PCP-concentrations between 
0.4 and 10 uM resulted in a 1,4/1,2-ratio of approximately 6, while further 
raising the concentration up to 200 uM showed a decrease in this ra t io to 1.5. 
EFFECT OF INDUCING AGENTS. In addition to microsomes from ra t s treated with HCB, 
microsomes from male and female ra ts induced with phenobarbital, 3-methylcholan-
threne and isosafrole were also tested for their ab i l i ty to convert PCP and 
compared to microsomes from untreated r a t s . The resul ts are presented in table 1. 
I t appeared that for both sexes isosafrole induction resulted in the highest ra te 
of conversion (6-7 fold higher rates as compared to non-induced microsomes). HCB-
induction showed a 3-4 fold increase. Both phenobarbital and 3-methylcholanthrene 
resulted in a 2.3 fold increase for male r a t s , while microsomes derived from 
female ra ts treated with 3-MC showed a 3-fold induction. PB-treatment of female 
0 
ratio 1.4-DIOL 
1.2-DIOL 
0.4 1 10 30 100 200 
[PCPKuM) 
Figure 3 . Rat io ' s of formation of the 1,4- and 1,2-TCHQ as a function of the 
concentration of PCP in a microsomal incubation system. 1 mg/ml microsomal pro-
tein from HCB induced ra t s was incubated for 5 minutes. 
% of control in the 
absence of ascorbic acid 
1«h 
0.1 Q3 1 3 
[ascorbic acid](mM) 
Figure 4. Effect of ascorbic acid on the covalent binding (-Q-), to ta l conversion 
(-0-) and TCHQ formation (-•-) in the microsomal metabolism of PCP at standard 
conditions. Total conversion denotes the t o t a l amount of soluble metabol i tes 
produced. All resul ts are expressed as the percentage of act ivi ty with respect to 
a control incubation without ascorbic acid. 
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TABLE 1 
THE MICROSOMAL METABOLISM OF PENTACHLOROPHENOL EFFECT OF INDUCING AGENTS AND THE 
EFFECT OF INHIBITION OF THE COVALENT BINDING 
Inducer Sex Rated % 1,4- % 1,2-
TCHQb TCHQb 
Ratio 
1,4/1,2-TCHQ 
Rate of 
covalent 
binding0 
None 
HCB 
PB 
3MC 
ISF 
m 
f 
m 
f 
m 
f 
m 
f 
m 
f 
113 
120 
378 
469 
265 
146 
263 
365 
798 
720 
(212) 
(232) 
(540) 
(555) 
(340) 
(265) 
(361) 
(550) 
(808) 
(648) 
52 
24 
73 
68 
52 
69 
53 
51 
55 
53 
(52) 
(35) 
(77) 
(59) 
(63) 
(58) 
(50) 
(51) 
(55) 
(53) 
11 
17 
31 
26 
27 
46 
45 
44 
42 
38 
(11) 
(30) 
(23) 
(31) 
(21) 
(29) 
(35) 
(44) 
(44) 
(38) 
4.9 
1.6 
2.5 
2.6 
2.0 
1.6 
1.2 
1.2 
1.3 
1.4 
(4.9) 
(1.1) 
(4.3) 
(1.9) 
(3.1) 
(2.0) 
(1.4) 
(1.2) 
(1.2) 
(1.4) 
72 
74 
63 
75 
76 
104 
75 
16 
66 
71 
The incubations were performed at 37 for 5 min, with the following 
concentrations: 100 uM PCP, 1 mM NADPH, 3 mM MgClo, 0.1 M potassium phosphate 
buffer (pH 7.4) and 2 mg microsomal protein in a 2 ml volume. All values are the 
average of duplicate incubations of a representative experiment. The figures in 
parenthesis represent the values derived from experiments in which teh covalent 
bindng was completely inhibited by the addition of 10 mM ascorbic acid. 
a. The rate is expressed as pmol total soluble metabolite formed per mg 
protein/min. Total metabolite formation is expressed as the total amount of 
radioactivity which eluted from the HPLC-column before the substrate, divided 
by the total eluted radioacitivity. 
b. 1,4-TCHQ and 1,2-TCHQ are expressed as percentage of total metabolites. 
The rate of covalent binding (in pmol.min .mg ) is calculated from the 
difference in covalent binding in incubations without and with ascorbic acid. 
Binding in the presence of ascorbic acid was the same as in incubations without 
NADPH. 
rats had almost no effect on the rate of conversion. The ratio between formation 
of the 1,4-TCHQ and 1,2-TCHQ was dependent on the inducer used (table 1). Induc-
tion with isosafrole or 3-MC resulted in a 1,4/1,2-ratio of 1.2-1.4, PB-treatment 
gave a ratio of 1.6-2.0 and HCB-induction showed a 2.5 ratio. These results were 
similar for both sexes. 
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COVALENT BINDING TO PROTEIN. A substantial amount of covalent binding to protein 
was detected. This binding was dependent on metabolism of PCP. Incubations without 
NADPH resulted in a very small amount of binding, (1-2.5% of the amount of C-
PCP added, dependent on the batch of isotope used), which was independent of the 
incubation time or the amount of protein. The covalent nature of the binding was 
confirmed by the finding that two essentially different methods of analysis resul-
ted in the same values for incubations both with and without NADPH. As determined 
for HCB-microsomes, the binding was dependent on the concentration of PCP. The 
apparent Km-value for covalent binding of 13 uM was very similar to the apparent 
Km-value found for the formation of the soluble metabolites (fig. 2). 
Ascorbic acid was able to completely inhibit the metabolism-dependent covalent 
binding to microsomal protein. At 5 uM PCP the inhibition of covalent binding was 
complete at 1 mM ascorbic acid (fig. 4), while at 100 uM PCP complete inhibition 
was achieved at 10 mM ascorbic acid (table 1). At both concentrations the inhibi-
tion of covalent binding was accompanied by an increase in formation of 1,4- and 
1,2-TCHQ. The sum of covalent binding and formation of soluble metabolites re-
mained the same on increasing the concentration of ascorbic acid. Although the 
covalent binding was clearly related to conversion and PCP-concentration, the 
amount of binding did not differ greatly between the incubations with microsomes 
obtained from rats treated with different inducers (table 1). The rate of binding 
amounted to approximately 70 pmol/mg/min for all types of microsomes used, inclu-
ding microsomes from non-induced rats. In most cases, the increase in rate of 
formation of soluble metabolites as a result of adding 10 mM ascorbic acid to the 
incubation matched the decrease in covalent binding. 
The ratio between the 1,4-TCHQ and 1,2-TCHQ did not change when the covalent 
binding was inhibited in incubations with isosafrole and 3-MC-microsomes (table 
1). However, in the case of HCB- and PB-microsomes, this ratio (with the exception 
of female HCB-microsomes) was raised 30-60% after inhibition of covalent binding. 
COVALENT BINDING TO DNA. The amount of binding to DNA was much smaller than the 
amount of binding to protein. Incubations (2 nig of protein from HCB induced rats, 
5 min. incubation to which 1 mg DNA was added) showed a covalent binding of 12+3 
pmol/mg DNA/min (n=3). The average amount of binding to microsomal protein under 
these conditions was 63 pmol/mg protein/min. The addition of DNA had no effect on 
the formation of soluble metabolites. The DNA-binding was corrected for the amount 
of label recovered in incubations with DNA but without NADPH, which showed an 
average binding of 73 pmol/mg DNA in a 5 minutes incubation. 
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DISCUSSION 
The aim of this study was to characterize and quantitate the microsomal metabolism 
of pentachlorophenol, with special attention to its ability to produce a metabo-
lism-dependent covalent binding to protein and DNA. Protein binding was detected 
previously in a study of the nature of the covalent binding of hexachlorobenzene 
(10), of which PCP is the primary product (9). 
The tetrachloro-1,4- and -1,2-hydroquinones, which we detected as the only micro-
somal oxidation products, were described previously to be the in vivo and in vitro 
conversion products of PCP (7). In contrast to other findings (12), no inhibitory 
effect of PCP on its own metabolism was found up to a concentration of 200 pM. An 
apparent Km-value of 13 uM was found both for the formation of the hydroquinones 
and the covalent binding, suggesting that both stem from the same reaction. There 
are strong indications for the fact that the benzoquinone or the semiquinone form 
of 1,4- and 1,2-TCHQ is responsible for the covalent binding properties. Gluta-
thione has been shown to inhibit binding to protein by forming conjugates with the 
benzoquinones (10), while ascorbic acid reduces the benzo- and semiquinone to the 
hydroquinone form, thus preventing covalent binding. 
The results of the experiments with microsomes derived from rats treated with 
different inducers indicate that PCP is best converted by cytochrome P-450d, the 
isosafrole induced isoenzyme (13). HCB-microsomes contain (in decreasing quantity) 
cytochrome P-450b, d, c and a (14). The difference in 1,4/I,2-TCHQ-ratio between 
on the one hand ISF and 3MC and on the other hand PB and HCB-microsomes suggests 
the involvement of two separate isoenzymes. The shift in this ratio with increa-
sing PCP-concentrations in incubations with HCB microsomes can also be explained 
by the involvement of two isoenzymes with different Km-values and giving different 
1,4/1,2-ratios. This may be the result of differences in regioselective binding of 
PCP to the different isoenzymes. Since microsomal incubations will not give 
definite answers to these questions, we intend to investigate this matter with 
purified P-450 isoenzymes. 
The finding that in the case of experiments with PB or HCB microsomes, the ratio 
between 1,4- and 1,2-TCHQ raises after inhibition of the covalent binding, indi-
cates a disproportional binding of the 1,2-TCHQ to protein under these conditions. 
With 3-MC or ISF microsomes, the ratio does not change, implying that both isomers 
bind with the same affinity. 
Regardless of the origin of the microsomes used and the rates of conversion, the 
72 
amount of covalent binding found is almost constant. From the experiments in the 
presence of ascorbic acid it is clear that in all cases covalent binding is the 
result of tetrachlorobenzoquinone or semiquinone formation. Perhaps the oxidation 
of the hydroquinones to the benzoquinone form is the rate limiting step in the 
process of covalent binding. The amount of covalent binding in HCB microsomes from 
HCB induced rats with respect to the amount of TCHQ is about 13%. Studies in chick 
embryo hepatocyte cultures showed this amount to be only about 2.5% (15). This 
might be explained by the fact that intracellular conditions prevent oxidation of 
TCHQ to TCBQ. 
The conversion dependent covalent binding to DNA is in agreement with the reported 
finding that TCHQ is able to bind to DNA (6). The amount of binding reported in 
the study mentioned is much smaller (53 pmol/mg DNA after 1 hour incubation with 
50 mM TCHQ). This can also be explained by the necessity of oxidation to TCBQ, 
which in microsomes can occur enzymatically, for instance by activated oxygen 
species generated by cytochrome P-450 (16). Care should be taken in extrapolation 
of the in vitro covalent binding to the in vivo situation, since both reduction 
and conjugation mechanisms, which are present in living cells, are able to prevent 
this process. 
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CHAPTER 5 
THE OXIDATION OF TETRACHLORO 1,4-HYDROQUINONE BY MICROSOMES 
AND PURIFIED CYTOCHROME P-450. IMPLICATIONS FOR COVALENT BINDING 
TO PROTEIN 
Ben van Ommen, Jan Willem Voncken, Franz Huller* and Peter J. van Bladeren 
Departments of Toxicology and *Biocheraistry, Agricultural University, De 
Dreyen 12, 6703 BC Wageningen, The Netherlands 
ABSTRACT 
The enzymatic oxidation of tetrachloro-l,4-hydroquinone (TCHQ), resulting 
in covalent binding to protein of tetrachloro-l,4-benzoquinone (TCBQ), was 
investigated, with special attention to the involvement of cytochrome 
P-450 and reactive oxygen species. TCBQ itself reacted very rapidly and 
extensively with protein (58% of the 10 nmoles added to 2 mg of protein, 
in a 5 minutes incubation). In microsomal incubations TCHQ oxidation was 
shown to be dependent on NADPH and partially dependent on cytochrome P-450 
(30% inhibition by carbon monoxide) and oxygen (61% inhibition in 
anaerobic incubations). Ascorbic acid and glutathione prevented covalent 
binding of TCBQ to protein, both when added directly and when formed from 
TCHQ by microsomes. In a reconstituted system, purified cytochrome P-450b 
was able to oxidize TCHQ. Addition of superoxide dismutase to this system 
completely inhibited the oxidation. In microsomal incubations, superoxide 
dismutase prevented 61% of the covalent binding, the same amount as found 
in anaerobic incubations. However, covalent binding as a result of 
microsomal hydroxylation of pentachlorophenol to TCHQ and subsequent 
oxidation of TCHQ to TCBQ was not influenced by the addition of superoxide 
dismutase. This might indicate that the oxidation of TCHQ now takes place 
at the active site of cytochrome P-450, presumably still as a result of 
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superoxide anion production by cytochrome P-450. As a consequence, 
metabolically formed hydroquinones might more easily be converted to 
quinones, with possible toxic implications, than hydroquinones added from 
the outside. 
INTRODUCTION 
Toxic effects of quinones usually are the result of one of the two 
following mechanisms: i) covalent binding to cellular macromolecules (1), 
and ii) a redox shuttle between the quinone and semiquinone form, 
resulting in the generation of reactive oxygen species during reoxidation, 
imposing a condition of cellular oxidative stress (redox cycling) (2). 
Exploiting their ability to redox cycle, several quinones are used 
therapeutically, e.g. mitomycins in cancer chemotherapy (3). 
A number of quinones have been described to be metabolically formed. 
Oxidation of aromatic diols, e.g. catechols like dopamine and adrenaline 
(4), and phenols such as 1-naphtol results in quinone formation (5). In 
some cases, metabolically formed quinones have been implicated in the 
toxic effects of the parent compound: benzene undergoes two hydroxylations 
by cytochrome P-450, and the resulting 1,4-hydroquinone and catechol are 
oxidized to their quinone forms (6). These quinones may play a role in 
benzene induced leukemia (7). A similar route has been described for the 
formation of 2-broraobenzoquinone from bromobenzene (8). The glutathione 
conjugate of this quinone is thought to be responsible for the nephrotoxic 
effects of bromobenzene, bromophenol and 2-bromohydroquinone (9). 
Recently, quinone metabolites have been implicated in the toxic effects of 
hexachlorobenzene. 
Hexachlorobenzene (HCB) is known for its porphyrinogenic action (10). The 
HCB induced porphyria is thought to be associated with metabolic 
activation (11, 12). HCB has also been shown to be carcinogenic in a 
number of species (13, 14, 15) and for both of its primary oxidative 
metabolites, pentachlorophenol (PCP) and tetrachloro-1,4-hydroquinone 
(1,4-TCHQ), DNA damaging properties have been recorded (16, 19). 
Studies on the microsomal metabolism of HCB revealed covalent binding to 
protein and DNA to occur after hydroxylation of both HCB and PCP (17, 18, 
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19). Both compounds yield tetrachloro-1,4- and -1,2-hydroquinone as 
products. These oxidations may be catalyzed by several forms of cytochrome 
P-450, and of these cytochrome P-450p, a rat liver microsomal isoenzyme 
induced by macrolide antibiotics like triacetyloleandomycin and 
glucocorticoids like dexamethasone (20), has been shown to exhibit by far 
the highest rate for both hydroxylations. 
It is assumed that tetrachloro-1,4-hydroquinone is oxidized to the 
ultimate covalent binding compound tetrachloro-1,4-benzoquinone 
(chloranil) in microsomal incubations. Ascorbic acid inhibits the binding 
by preventing the oxidation of the hydroquinones, and glutathione inhibits 
the binding by formation of conjugates with the benzoquinone (18). Similar 
mechanisms for protection against binding have been described for phenol 
(6, 21) and bromobenzene (8). 
The nature of the hydroquinone oxidizing agent and the possible enzymes 
involved is not always clear. E.g. for raethyldopa (4), cytochrome P-450 
has been shown to be involved, and in some cases the role of reactive 
oxygen species like the superoxide anion radical plays a role (4, 8). For 
2-bromohydroquinone, NADPH promoted binding (8), while for p-hydroquinone 
NADPH decreased the amount of binding (21). 
The aim of the present study was to investigate the role of cytochrome 
P-450 and possible other enzymes in the oxidation of 
tetrachloro-1,4-hydroquinone, the involvement of oxygen in this process 
and the possible protective mechanisms against this oxidation. 
MATERIALS AND METHODS 
chemicals. Pentachlorophenol was from Aldrich, 
tetrachloro-1,4-hydroquinone from ICN pharm., NY, 
tetrachloro-1,4-benzoquinone was from Merck, NADPH from Boehringer, 
superoxide dismutase from Sigma (type I, 2800 units per mg), catalase 
(10,000 units per mg) from Merck, dilauroylphosphatidylcholine from Sigma. 
All other chemicals were at least of analytical grade. The synthesis of 
the TCBQ-glutathione conjugates has been described previously (18). 
radiochemicals. U-( C)-PCP (37.5 mCi/mmol) was from CEA, Gif sur Yvette, 
France. U-( C)-1,4-TCHQ was prepared by large scale incubations of 
C-PCP with microsomes from isosafrole induced male rats, for 20 minutes 
at 37°C. The conditions were: 2mg/ml microsomal protein, 1 mM NADPH, with 
an extra 1 mM addition after 10 minutes, 150 nmole C-PCP, s.a. 37.5 
mCi/mmole, in 0.75 ml of acetone, 0.1 M potassium phosphate buffer, pH7.4, 
3 mM MgCl2 and 2 mM ascorbic acid. The total volume was 24 ml. The 
reaction was stopped with 0.2 ml of HC1 (6N) and ascorbic acid was added 
to a final concentration of 10 mM. 1,4-TCHQ was purified from the extract 
by preparative HPLC using a gradient of 57% to 100% methanol against 
water containing 1% acetic acid in 8 minutes, followed by 5 minutes at 
100% methanol. (k* (1,4-TCHQ) = 4.5, k'(1,2-TCHQ)=7.2, k'(PCP)=9). The 
conversion of PCP to 1,4-TCHQ was approximately 15%, and 1,2-TCHQ 
formation was about 2%. During storage 1,4-TCBQ could be formed up to 15%. 
When necessary, TCBQ was completely removed directly before the 
incubations by the addition of 1 mM ascorbic acid to the TCHQ solution, 
extraction of TCHQ with diethylether, evaporation of the ether and 
dis 
14, 
solving the TCHQ in acetone. C-1,4-TCBQ was prepared from 
C-l,4-TCHQ by quantitative oxidation with an excess of 
dichlorodicyanoquinone (DDQ) in water/methanol 50/50. 1,4-TCBQ was then 
purified by HPLC as described below for 1,4-TCHQ and 1,4-TCBQ incubations. 
purification of enzymes. Cytochrome P-450b was purified from liver 
microsomes of phenobarbital treated male Wistar rats according to (22), 
resulting in an electrophoretically pure isoenzyme with a specific 
concentration of 20.2 nmoles per mg protein. The NADPH-dependent 
cytochrome P-450 reductase was purified from liver microsomes of 
phenobarbital treated New Zealand white rabbits, using DEAE-cellulose and 
2'5'ADP-Sepharose affinity chromatography (23). Detergent was removed from 
both enzymes by using a hydroxylapatlte column (Biogel HTP, Biorad 
Laboratories). 
microsomal incubations The microsomal incubations were performed with 2 mg 
of microsomal protein derived from 12 week old dexamethasone treated male 
Wistar rats (4 daily i.p. injections of 300 mg dexamethasone per kg body 
weight). Microsomes were prepared as described previously (17). Unless 
otherwise stated, the standard conditions for microsomal incubations were: 
a 2 ml volume, 5 minutes incubation at 37°C, 0.1 M potassium phosphate 
buffer, pH 7.4, 3 mM M g C ^ and 1 mM NADPH. The reaction was terminated by 
the addition of 0.2 ml 6N HC1, after which 3 extractions with 3 ml ethyl 
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acetate / acetone 2:1 were performed. PCP-incubations: PCP was added in 50 
pi of acetone, to a final concentration of 100 pM (specific activity:1.14 
mCi/mmole). TCHQ-incubations: TCHQ was added in 50 pi of acetone, to a 
final concentration of 2.5 pM. The specific activity was 2 mCi/mmole. 
TCBQ-incubations: the same as for TCHQ, specific activity was 0.9 
mCi/mmole. After drying the extracts with Na2S0^, the solvents were 
evaporated in a stream of nitrogen, and the residues were dissolved in 50 
pi of methanol for HPLC analysis. Anaerobic incubations were performed as 
described previously (18). 
HPLC analysis. The extracts of the incubations were analysed by HPLC using 
a Perkin Elmer series 4 HPLC equipped with a Chrompack lichrosorb 150x4.6 
mm 5RP18 column. 1,4-TCHQ and 1,4-TCBQ were analysed isocratically at 55% 
methanol and 45% water containing 1% acetic acid. (k'(DDQ)=2.0, 
k'(1,4-TCHQ)=5.0, k'(l,4-TCBQ)=7.0) Detection was by UV (254nm), fractions 
of 0.6 ml were collected of which, after addition of 4 ml of scintillation 
liquid (Atomlight, NEN-Dupont), the amount of radioactivity was determined 
in a Packard tricarb 300 scintillation spectrometer. 
measurement of covalent binding. After removal of the organic phase after 
the last extraction, the precipitated protein was separated from the 
aqueous phase by centrifugation, and washed extensively with organic 
solvents. For PCP incubations, the protein pellet was washed with 3x10 ml 
of methanol, 3x10 ml of ethanol, 2x10 ml of acetone and 10 ml of 
diethylether. For incubations with 1,4-TCHQ and 1,4-TCBQ, it appeared to 
be sufficient to wash with 10 ml of methanol, 10 ml of ethanol, 10 ml of 
acetone and 10 ml of diethylether. After evaporation of the remaining 
diethylether, 1 ml of Soluene 350 (Packard) was added in order to dissolve 
the protein, and the sample was screened for radioactivity in 15 ml of 
scintillation liquid (Atomlight). 
incubations with purified enzymes. Reconstitution experiments with 
purified cytochrome P-450b and NADPH dependent cytochrome P-450 reductase 
were performed using the same conditions as described for the microsomal 
experiments, except for the replacement of the microsomes with a mixture 
of the enzymes, (1 nmole of P-450 and 3 nmoles of reductase), which were 
preincubated in a small (0.25 ml) volume, together with 40 pg of 
dilauroylphosphatidylcholine, for 3 minutes at 37°C. BSA (2 mg) was added 
as a target for covalent binding to protein. 
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oxygen consumption measurements. The microsomal oxygen consumption 
measurements were performed with a Clark type oxygen electrode equipped 
with a LKB spectroplus spectrometer, using the same conditions as in the 
microsomal incubations, except for the amount of acetone added (5 pi 
instead of 50 ul) , and the amount of microsomal protein (0.5 mg of 
microsomal protein from dexamethasone induced male rats, instead of 2 mg), 
in order to decrease the rate of oxygen consumption to a measurable level. 
RESULTS 
1) The covalent binding to protein of tetrachloro-l,4-benzoquinone 
TCBQ reacted very rapidly with microsomal protein. After a 5 minute 
incubation 58% of the added TCBQ was bound covalently (290 pmole/minute/mg 
protein)(figure 1). 13% of the label could not be extracted, while of the 
extracted label, 75% was in the hydroquinone form. The reaction appeared 
to be non enzymatic, because incubations of 5 nmoles of TCBQ with 2 mg of 
BSA resulted in approximately the same amount of binding (52%). NADPH and 
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figure 1 
Covalent binding of tetrachloro-1,4-benzoquinone to microsomal protein. 
5 nmoles of 1,4-TCBQ were incubated for 5 minutes at 37 C with 2 mg of 
microsomal protein in a 2 ml volume, as described in the method 
section. The concentration of NADPH, NADH was 1 mM, ascorbic acid 3 mM 
and glutathione 1.5 mM. n=2. 
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figure 2 
Covalent binding of tetrachloro-1,4-hydroquinone to microsomal protein. 
Standard 5 minute incubations consisted of 2 mg of microsomal protein 
from dexamethasone induced male rats, 5 nmoles 1,4-TCHQ and 1 mM NADPH, 
in a 2 ml volume of a buffered solution as described in the method 
section. Additions were: 25 uM hexachlorobenzene, 3 mM ascorbic acid 
and 1.5 mM glutathione. n=2. 
NADH acted as reducing agents towards TCBQ. After incubation of TCBQ with 
1 mM NADPH or NADH, HPLC analysis of the extracted label revealed 78% to 
be in the hydroquinone form for NADPH and 75% for NADH. However, in 
microsomal incubations the covalent binding to protein was hardly 
influenced by these additions (53% and 44% of total added radioactivity, 
for NADPH and NADH respectively (figure 1).) Ascorbic acid, on the other 
hand, was a more effective protecting agent against covalent binding of 
TCBQ. Addition of 3 mM to the incubation mixture resulted in a decrease to 
12% binding. 98% of the extracted label was TCHQ. Glutathione (1.5 mM) 
also inhibited covalent binding. In this case however, nearly all 
radioactivity (89%) remained in the aqueous phase after extraction, 
indicating the formation of a water soluble conjugate. HPLC analysis of 
the aqueous phase suggested formation of a highly conjugated molecule (at 
least 3 molecules of glutathione per TCBQ), since the elution time of the 
major radioactive fraction was shorter than that of the mono- and 
disubstituted TCBQ, of which the identity was established previously (18). 
2) The oxidation of tetrachloro-1,4-hydroquinone, and the involvement of 
reactive oxygen species in this reaction 
The covalent binding to protein as a result of metabolic activation of 
TCHQ was studied with C-TCHQ in microsomes and in a reconstituted system 
consisting of purified rat liver cytochrome P-450b and NADPH-cytochrorae 
P-450 reductase, as well as with C-PCP in microsomes, in order to 
investigate the binding of TCHQ generated at the active site of cytochrome 
P-450. 
The microsomal studies with C-1.4-TCHQ indicated that TCHQ itself did 
not bind to protein. Incubations without NADPH showed a binding of 5% 
(figure 2), while addition of NADPH to the incubation increased the 
binding to 44% of the added 5 nmoles of TCHQ. The concentration dependency 
of the covalent binding is shown in figure 3. Up to 10 nmoles (5 uM) , a 
linear relationship existed between binding and concentration. All 
incubations therefore were performed with 5 nmoles of TCHQ. 
Glutathione and ascorbic acid inhibited the covalent binding in the same 
manner as with the incubations with TCBQ: for glutathione, total 
inhibition of binding with the major part of the label (96%) remaining in 
the aqueous phase after extraction, and for ascorbic acid total inhibition 
of the binding with all of the extracted label in the reduced 
(hydroquinone) form (figure 2). 
figure 3 
Dependency of the covalent binding to microsomal protein on the 
concentration of tetrachloro-1,4-hydroquinone, in a microsomal' 
incubation. 2 mg of protein was incubated in the presence of 1 mM 
NADPH. The binding is corrected for the binding in the absence of 
NADPH, which amounted to approximately 9% of total binding. n=2. 
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TABLE 1. COVALENT BINDING TO PROTEIN OF TETRACHLORO-1,4-HYDROQUINONE 
CATALYZED BY PURIFIED CYTOCHROME P-450b 
experiment 1 
COVALENT BINDING - pmole 
BSA 201 + 25 (4.0) 
BSA + NADPH 168 + 12 (3.4) 
BSA + NADPH + REDUCTASE 160 ± 5 (3.2) 
BSA + NADPH + REDUCTASE + CYTOCHROME P-450b 525 ± 15 (10.6) 
BSA + NADPH + REDUCTASE + CYTOCHROME P-450b + CO 129 + 3 (2.6) 
experiment 2 
COVALENT BINDING - pmole 
BSA + NADPH + REDUCTASE + SOD 401 + 6 (8.0) 
BSA + NADPH + REDUCTASE + CYTOCHROME P-450 + SOD 423 + 23 (8.6) 
Numbers in brackets: % of total added radioactivity bound to protein 
exp.l: 2 mg BSA, 1 mM NADPH, 1 nmole P-450b, 3 nmole reductase 
exp.2: The same as in exp. 1, except for BSA: lmg, SOD lmg 
In order to estimate the role of cytochrome P-450 in the oxidation of TCHQ 
to TCBQ, the microsomes were saturated with carbon monoxide. This resulted 
in a 30% decrease of covalent binding as compared to the standard (+NADPH) 
incubations. Anaerobic incubations showed a 61% decrease of binding 
(figure 2). Addition of 25 uM hexachlorobenzene resulted in a 19% increase 
of the covalent binding. 
TABLE 2. THE EFFECT OF HCB AND METABOLITES ON THE MICROSOMAL OXYGEN 
CONSUMPTION. 
COMPOUND OXYGEN CONSUMPTION 
(% decrease of [0-] per minute) 
none (acetone) 2.34 + 0.10 
HCB (25 pM) 2.80 + 0.28 
PCP (100 uM 0.98 + 0.09 
1,4-TCHQ (10 uM) 4.63 + 0.84 
0.5 mg of microsomal protein of dexamethasone induced rats was 
incubated at 37 C, in the presence of 1 mM NADPH. For exact conditions, 
see method section. 
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figure 4 
Effect of addition of superoxide dismutase (SOD, 1 tag, 2800 units) and 
catalase (CAT, 1 mg, 10,000 units) on the covalent binding to 
microsomal protein of tetrachloro-1,4-hydroquinone (a) and 
pentachlorophenol (b). The 1,4-TCHQ incubations were performed as 
stated in figure 3, the PCP incubations were performed similarly, with 
a PCP concentration of 100 uM. For PCP, the covalent binding is 
corrected for binding in the absence of NADPH. (Without NADPH no 
formation of 1,4-TCHQ was observed.) n=2. 
Incubations with purified cytochrome P-450b (the major isoenzyme after 
induction of rats with phenobarbital) and NADPH-cytochrome P-450 reductase 
in the presence of dilauroylphosphatidylcholine (1 nmole, 3 nmoles and 40 
ug, respectively) showed the ability of cytochrome P-450 to oxidize TCHQ 
(table 1, exp.l). Furthermore, carbon monoxide was able to inhibit this 
P-450 activity completely. 
In order to determine the role of activated oxygen species in the 
oxidation of TCHQ, a number of incubations were performed to which 2800 
units of superoxide dismutase (SOD) and 10,000 units of catalase (CAT) 
were added. In microsomal experiments with C-TCHQ, 1 mg of SOD decreased 
the covalent binding by 50%, while a further addition of 1 mg of catalase 
had only a minor extra effect (from 50% to 52%, see figure 4a). In the 
reconstituted system the binding was almost completely inhibited by the 
addition of 1 mg of SOD. (table 1, exp. 2). The increase in blanc binding 
as compared to experiment 1 is probably due to a greater susceptability of 
SOD than BSA to covalent binding. Incubations with C-PCP showed no 
% decrease of 
[02]per minute 
125 2.5 5 10 
[TCHQKuM) 
figure 5 
Dependency of the microsomal oxygen consumption on the concentration of 
tetrachloro-1,4-hydroquinone. Microsomal incubations were performed as 
described for the covalent binding studies (figure 3), except for the 
amount of protein (0.5 mg) and the amount of acetone (5pl), in a Clark 
type oxygen electrode cell. n=2. 
decrease in covalent binding due to the addition of SOD or SOD together 
with catalase (figure 4b). Instead, a small increase was measured, again 
most probably due to a high affinity of these proteins for covalent 
binding. 
3) Microsomal oxygen consumption. In order to estimate the amount of 
reactive oxygen species generated during the microsomal incubations, a 
number of (non- radioactive) incubations were performed in a closed cell, 
fitted with a Clark type oxygen electrode. The blanc level of oxygen 
consumption, due to the addition of acetone, was a decrease of 2.34% per 
minute. Addition of PCP and 1,4-TCBQ decreased this amount (table 2), 
while HCB showed a small increase. The largest increase was due to 
addition of 1,4-TCHQ to the microsomal incubations (4.63% per minute). The 
oxygen consumption as a result of 1,4-TCHQ is of an enzymatic nature and 
NADPH dependent (table 3). Substitution of NADPH for NADH resulted in loss 
of activity. The dependency of oxygen consumption on the concentration of 
1,4-TCHQ is shown in figure 5. 
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TABLE 3. THE EFFECT OF TETRACHLORO-1,4-HYDROQUINONE ON THE MICROSOMAL 
OXYGEN CONSUMPTION 
SAMPLE OXYGEN CONSUMPTION 
(% decrease of [0„] per minute) 
TCHQ 0 
TCHQ + NADPH 0 
TCHQ + micr 0 
TCHQ + micr + NADPH 5.15 
TCHQ + micr + NADH 0 
TCHQ + micr + NADPH + NADH 4.60 
The concentrations used were:10 uM 1,4-TCHQ, 1 mM NADPH, 0.5 mg of 
microsomal protein from dexametha^one treated male rats. The 
incubations were performed at 37 C. 
DISCUSSION 
The role of cytochrome P-450 in oxidation of tetrachlorohydroquinone 
Cytochrome P-450 i s capable of oxidizing TCHQ. With pur i f ied r a t l i v e r 
cytochrome P-450b, NADPH-dependent covalent binding occurred to the extent 
of 365 pmole/min/nmole P-450, and t h i s binding was completely inh ib i t ed by 
carbon monoxide. On the other hand, i n h i b i t i o n of microsomal cytochrome 
P-450 by carbon monoxide r e su l t ed in only a p a r t i a l loss of covalent 
binding. The microsomal incubat ions thus c l e a r l y suggest tha t P-450 i s not 
the only enzyme involved in t h i s r e a c t i o n . Moreover, in the t o t a l absence 
of molecular oxygen, covalent binding did s t i l l take place (23% as 
compared to [+NADPH/+02] i ncuba t ions ) . This ind ica te s t ha t in add i t ion to 
cytochrome P-450, a t l e a s t two other types of enzymes a re involved: i ) 
non-P450 enzymes which use oxygen and NADPH for the oxida t ion of TCHQ 
( respons ib le for the d i f ference between the remaining a c t i v i t y a f t e r 
CO-inhibit ion and the remaining a c t i v i t y in incubat ions without oxygen) 
and i i ) enzymes which need NADPH but do not need oxygen ( respons ib le for 
the a c t i v i t y which remains in incubat ions without oxygen). 
The role of activated oxygen species in the oxidation of TCHQ 
A number of hydroquinones a re dependent on ac t iva ted oxygen species in 
t h e i r oxidat ion to quinones. On the o ther hand, c e r t a i n quinones are 
formed by oxida t ion of hydroquinones by molecular oxygen. Lau e t a l (8 ) 
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described the p a r t i a l i n h i b i t i o n of covalent binding of 4-bromocatechol by 
superoxide dismutase. Activated oxygen species a re involved in the 
oxidat ion of dopa and dopamine (4 , 24) . However, in the case of 
2-acetamido-p-hydrbquinone, n e i t h e r SOD nor ca t a l a se caused a s i g n i f i c a n t 
decrease in 2-acetamido-p-benzoquinone formation (25) . Although both 
molecular oxygen and superoxide anion have been shown to be involved in 
the p-hydroquinone oxidat ion (26) , p-hydroqulnone oxidized spontaneously 
in aqueous so lu t i on , and add i t ion of superoxide dismutase increased t h i s 
oxida t ion f ivefold (27) . The binding in microsomal incubat ions of 
hydroquinone and catechol i s not s t imulated by the presence of NADPH (21 ) . 
The one e l e c t r o n reduct ion of molecular oxygen has a much lower redox 
p o t e n t i a l then the one e l ec t ron reduct ion of superoxide anion (28) . 
Apparently, the redox p o t e n t i a l s of the hydroquinone/semiquinone and 
semiquinone/benzoquinone e q u i l i b r i a a re of major importance in the 
ox ida t ion . These values s t rongly depend on the environment. Under ap ro t i c 
cond i t ions , the El /2 value of TCBQ i s 0.6 V higher than tha t of 
benzoquinone (29) , while in a lcoho l ic so lu t ion the redox p o t e n t i a l s a re 
s imi la r (30) . 
The oxidat ion of TCHQ by pur i f ied cytochrome P-450 appeared to be 
completely mediated by superoxide anion r a d i c a l s , s ince no d i f ference was 
observed between blanc incubat ions and incubat ions which, ecxept for the 
add i t ion of superoxide dismutase, have shown to be able to s t imula te 
covalent b inding. Cytochrome P-450 i s known for i t s a b i l i t y to generate 
r eac t ive oxygen spec ies l i k e superoxide anion r a d i c a l s , hydroxyl r a d i c a l s 
and hydrogen peroxide (31 ) . The involvement of these r eac t ive oxygen 
species is a lso apparent from the finding t ha t add i t ion of 
hexachlorobenzene to a microsomal incubat ion of TCHQ increased the 
covalent binding wi th 19%, a value remarkably s imi la r to the 20% increase 
in microsomal oxygen consumption a f t e r add i t ion of the same concent ra t ion 
of HCB. Covalent binding as a r e s u l t of the incubat ion of C-PCP a l so was 
s t imulated by 23% by the addi t ion of HCB. 
In the microsomal incubat ions add i t i on of superoxide dismutase and 
ca t a l a se inh ib i t ed the covalent binding almost to the extent of the 
incubat ions without oxygen (52% and 61% r e s p e c t i v e l y ) , which implies t ha t 
a l l oxygen consuming reac t ions leading to covalent binding are mediated 
through reac t ive oxygen spec i e s . Besides cytochrome P-450, a number of 
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other enzymes produce these compounds. It is known, for example that the 
flavin containing NADPH-cytochrome P-450 reductase can produce superoxide 
anion radicals (32). However, incubations of TCHQ with this enzyme in its 
purified form did not give rise to covalent binding. 
The large amount of oxygen consumption in the presence of 1,4-TCHQ and 
NADPH is most likely due to uncoupling of cytochrome P-450. The reaction 
is dependent on both microsomes and NADPH and independent of NADH. This 
indicates that chemical oxidation of TCHQ by molecular oxygen, resulting 
in formation of superoxide anion, is not involved. In that case addition 
of superoxide dismutase would increase the amount of benzoquinone 
formation, as was shown for 1,2,4-benzenetriol and hydroquinone (27, 33). 
No oxygen was consumed on addition of 1,4-TCBQ, showing that TCBQ was 
unable to undergo redox cycling in a microsomal system. 
We have previously shown that covalent binding in a microsomal incubation 
of PCP was the result of the formation of tetrachlorobenzoquinone (19). 
The observation that superoxide dismutase and catalase did not inhibit 
covalent binding as a result of PCP-metabolism might be explained by 
assuming that TCHQ, formed from PCP in the active site of cytochrome 
P-450, is oxidized by P-450 generated superoxide anion radicals before it 
leaves the active site. The finding that THCQ promotes the uncoupling of 
cytochrome P-450 supports this hypothesis. The active site would then have 
to be inaccessable to superoxide dismutase. This mechanism is invalid if 
superoxide anion is not involved in the oxidation of 1,4-TCHQ, formed by 
hydroxylation of PCP. However, if this assumption is correct, the 
consequence for the in vivo situation is that hydroquinones generated by 
cytochrome P-450 may more easily be oxidized to quinones and thus exert 
possible toxic actions linked to covalent binding than hydroquinones which 
are not metabolically produced. 
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CHAPTER 6 
THE INVOLVEMENT OF DIFFERENT CYTOCHROME P-450 ISOENZYMES IN THE 
HYDROXYLATION OF HEXACHLOROBENZENE AND PENTACHLOROPHENOL. 
THE USE OF SPECIFIC MONOCLONAL ANTIBODIES AND PURIFIED 
CYTOCHROME P-450 ISOENZYMES 
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Dreyen 12, 6703 BC Wageningen, The Netherlands, and *Laboratory of 
Experimental Carcinogenesis and Metabolism, Roche Institute of Molecular 
Biology, Nutley, New Jersey 07110, USA. 
ABSTRACT 
The toxicity of hexachlorobenzene has been shown to be cytochrome P-450 
mediated. In order to determine the identity of the cytochrome P-450 
isoenzyme(s) involved in the hydroxylation of hexachlorobenzene and its 
primary hydroxylation product pentachlorophenol, both compounds were 
incubated with the four purified cytochromes P-450b - P-450e. Also, in 
incubations of hexachlorobenzene and pentachlorophenol with microsomes 
from rats treated with different cytochrome P-450 inducers, monoclonal 
antibodies against cytochromes P-450b and P-450e, and cytochrome P-450c 
were used to selectively inhibit these isoenzymes. 
At least 3 different isoenzymes were involved in the hydroxylation of 
hexachlorobenzene. This compound was very slowly hydroxylated by purified 
cytochromes P-450b and P-450e (0.8 and 0.7 pinole PCP formed per minute per 
nmole P-450, respectively). Partial suppression of the hydroxylation of 
hexachlorobenzene in microsomes from rats treated with phenobarbital or 
hexachlorobenzene by a monoclonal antibody against P-450b+e agreed with 
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this observation. Microsomes from rats treated with dexamethasone showed 
by far the highest catalytic activity toward hexachlorobenzene 
hydroxylation, suggesting the involvement of cytochrome P-450p. The 
remaining activity after inactivation of P-450b and P-450e in microsomes 
from rats induced by phenobarbital may be due to P-450p, since this 
isoenzyme is also present in these microsomes. 
In a reconstituted system, pentachlorophenol was converted to 
tetrachloro-1,4-hydroquinone and tetrachloro-1,2-hydroquinone by purified 
cytochromes P-450c and P-450d, and to a lesser extent by cytochromes 
P-450b and P-450e (450, 440, 180 and 120 pmole diols/min/nmole P-450, 
respectively). However, inhibition of the catalytic activity of 
cytochrome P-450b in microsomes from phenobarbital treated rats, and 
inhibition of cytochrome P-450c in microsomes from rats treated with 
3-methylcholanthrene did not affect the rate of conversion of 
pentachlorophenol. This illustrates that although purified cytochrome 
P-450 isoenzymes may possess catalytic activity towards a compound, this 
not necessarilly implies that they contribute to their microsomal 
conversion. Microsomes from dexamethasone and hexachlorobenzene induced 
rats were the most active in catalyzing the hydroxylation of 
pentachlorophenol. Probably, cytochrome P-450p is the major enzyme 
involved in the microsomal hydroxylation of PCP. 
INTRODUCTION 
The cytochrome P-450 isoenzymes are involved in the metabolism of drugs 
and endogenous compounds. At least 10 isoenzymes have been purified from 
rat liver and characterized (Ryan, 1979, 1980, 1982, 1984, 1985), all 
showing different substrate specificities. 
Although numerous reports have appeared on the induction of cytochrome 
P-450 isoenzymes by HCB (Stonard, 1976, Goldstein, 1978, Vizethum, 1980, 
Holme and Dybing, 1982, Li, 1987), relatively little attention has been 
paid to the identity of the cytochrome P-450 isoenzymes involved in its 
metabolism. Studies with microsomes of rats treated with different 
inducers suggest the involvement of cytochrome P-450b in the hydroxylation 
of HCB to its primary metabolite pentachlorophenol (PCP) (Van Omraen, 1985, 
S t e w a r t , 1 9 8 6 ) . PCP i n t u r n i s h y d r o x y l a t e d to t e t r a c h l o r o - 1 , 4 - and 
- 1 , 2 - h y d r o q u i n o n e , and microsomes of r a t s t r e a t e d w i t h i n d u c e r s of 
cy toch romes P-450c and P-450d ( 3 - m e t h y l c h o l a n t h r e n e and i s o s a f r o l e ) have 
been shown t o c a t a l y z e t h i s r e a c t i o n ( A h l b o r g , 1978 , Van Ommen, 1986, 
S t e w a r t , 1 9 8 6 ) . The r a t i o be tween 1 , 4 - d i o l - and 1 , 2 - d i o l - f o r r a a t i o n 
a p p e a r e d t o be d e p e n d e n t on t h e t ype of i n d u c e r u s e d , s u g g e s t i n g t h e 
i n v o l v e m e n t of more t h a n one isoenzyme in i t s m e t a b o l i s m (Van Ommen, 
1 9 8 6 ) . The h y d r o q u i n o n e s formed can be o x i d i z e d to t h e i r qu inone fo rms , 
which b ind c o v a l e n t l y to p r o t e i n and UNA (Van Ommen, 1 9 8 6 ) , and may be 
r e s p o n s i b l e fo r some of t h e a d v e r s e e f f e c t s of HCB, such as i t s 
c a r c i n o g e n i c i t y and p o r p h y r i n o g e n i c a c t i o n . 
Cytochrome P-450 h a s been shown to be i n v o l v e d in t h e deve lopment of 
p o r p h y r i a as a r e s u l t of e x p o s u r e to h e x a c h l o r o b e n z e n e (HCB). S e v e r a l 
s t u d i e s have shown t h a t t r e a t m e n t of r a t s w i t h p h e n o b a r b i t a l enhanced t h e 
p o r p h y r i n o g e n i c a c t i o n of HCB ( G o l d s t e i n , 1978, K e r k l a a n , 1979, Wains tock 
de C a l m a n o v i c l , 1 9 8 4 ) . I n t h e J a p a n e s e q u a i l t h e same r e s u l t was o b t a i n e d 
w i t h b e t a - n a p h t h o f l a v o n e , bu t no t w i t h p h e n o b a r b i t a l ( C a r p e n t e r , 1 9 8 4 ) . I n 
a p r i m a r y c u l t u r e of c h i c k embryo h e p a t o c y t e s , s i m u l t a n e o u s t r e a t m e n t w i t h 
HCB and 3 - m e t h y l c h o l a n t h r e n e ( S i n c l a i r , 1974, 1984) o r b e t a - n a p t h o f l a v o n e 
( D e b e t s , 1981) s t i m u l a t e d t h e a c c u m u l a t i o n of p o r p h y r i n s , w h i l e p i p e r o n y l 
b u t o x i d e ( a n i n h i b i t o r of P-450 a c t i v i t y ) d e c r e a s e d t h i s amount . I t h a s 
been s u g g e s t e d t h a t a r e a c t i v e i n t e r m e d i a t e or m e t a b o l i t e of HCB, p roduced 
by cy tochrome P - 4 5 0 , i s r e s p o n s i b l e f o r t h e p o r p h y r i n o g e n i c a c t i o n of HCB. 
T h i s s t u d y i s aimed a t c h a r a c t e r i z i n g t h e cy tochrome P-450 i soenzymes 
i n v o l v e d i n t h e h y d r o x y l a t i o n of HCB and PCP. The two methods used f o r 
t h i s pu rpose a r e i ) t h e use of p u r i f i e d cy tochrome P-450 i s o e n z y m e s , i n 
o r d e r t o d i r e c t l y d e t e r m i n e t h e i r c a p a c i t y t o h y d r o x y l a t e HCB and PCP, and 
i i ) t h e u s e of s p e c i f i c monoclona l a n t i b o d i e s a g a i n s t P-450 i s o e n z y m e s , 
t h u s s e l e c t i v e l y i n h i b i t i n g i soenzymes i n o r d e r t o e s t i m a t e t h e i r 
c o n t r i b u t i o n to t h e h y d r o x y l a t i o n of HCB and PCP i n microsomes from r a t s 
t r e a t e d w i t h d i f f e r e n t i n d u c e r s . 
METHODS 
Chemicals. U-[ C]-Hexachlorobenzene (S.A. 70 mCi/mmole) was purchased 
93 
from Amersham (UK). The radiochemical contamination with 
pentachlorobenzene was reduced from 0.12% to 0.06% by preparative HPLC 
using the method described below for analysis of the metabolites. 
U-[ C]-pentachlorophenol (S.A. 37.5 mCi/mmole) was from CEA, 
Gif-sur-Yvette, France, and contained 0.8% tetrachlorophenol as a 
radiochemical impurity. Dexamethasone was from Sigma. The origin of all 
other chemicals has been described elsewhere (Van Ommen, 1986). 
Microsomes, purified enzymes and antibodies. Microsomes were prepared as 
described previously (Van Ommen, 1985, 1986), except for dexamethasone: 4 
daily i.p. injections of 300 mg/kg bodyweight. The purification of 
cytochrome P-450b, c, d and e has been published previously (Ryan, 1979, 
1980, 1982). The monoclonal antibodies (MAb) C7, C8 and C9 have been 
characterized and described by Thomas et al (1984). C7 and C9 bind to 
cytochrome P-450c without inhibiting its catalytic activity, while C8 
binds and completely inhibits this isoenzyme. BE 52 has been described by 
Reik, (1985). This monoclonal binds and inhibits cytochromes P-450b and 
P-450e. 
Incubations with microsomes and monoclonal antibodies. Liver microsomes 
from male rats treated with different inducing agents were incubated in 
the presence of antibodies with C-HCB or C-PCP, using the following 
method: in a volume of 0.27 ml the microsomes (2 mg) were preincubated for 
10 minutes at 21°C with 0.20 mg/nmole P-450 of the appropriate antibody, 
after which, at 4°C, the remaining constituents were added, resulting in 
final concentrations of 0.1 M potassium phosphate buffer, pH 7.4, 3 mM 
MgClo and 1 mM ascorbic acid, in a 1.75 ml volume. After temperature 
equilibration (2 minutes at 37°C) , this volume was added to 50 ul of 
acetone, containing the substrate (50 nmoles of HCB, 1 pCi, or 200 nmoles 
of PCP, 0.25 uCi), and the reaction was started by the addition of NADPH 
to a final concentration of 1 mM in a 2 ml total incubation volume. After 
5 minutes incubation at 37°C, the reaction was terminated by addition of 
0.2 ml 6N HC1, and 1 ml 30 mM ascorbic acid (for the PCP incubations). 
After extraction (with 3x3ml diethylether for HCB and 3x3 ml 
ethylacetate/acetone 2:1 for PCP), the extracts were dried with Na2S0^, 
the solvents evaporated in a stream of nitrogen and the residues, 
dissolved in 50 ul of methanol, subjected to HPLC-analysis. All 
incubations were performed in duplicate. Blancs consisted of zerotime 
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incubations and incubations without NADPH. 
The dealkylation of pentoxy- and ethoxyresorufin was performed according 
to Burke (1986). 
Incubations with purified cytochrome P-450 isoenzymes. Incubations with 
purified cytochrome P-450 were performed similarly to microsomal 
incubations, with the replacement of the microsomes/antibody mixture by a 
reconstituted system consisting of 1 nmole cytochrome P-450b, c, d or e, 3 
nmoles of NADPH dependent cytochrome P-450 reductase and 40 ug of 
dilauroylphosphatidylcholine, preincubated for 3 minutes at 37°C, in a 
volume of 0.2-0.25 ml. No ascorbic acid was added to these incubations. As 
blanc, an incubation without cytochrome P-450 was performed. 
HPLC-analysis of metabolites. HPLC-analysis of the extracts of the 
incubations was performed on a Perkin Elmer series 4 HPLC, equipped with a 
Chrompack Lichrosorb 150x4.6mm 5RP18 column and UV (254nm) detection. 50 
pi of the extract together with 10 ul of methanol containing marker 
metabolites was injected. Radiochemical detection was carried out by 
collecting 0.6 ml fractions, of which the radioactivity was measured in 4 
ml of Atomlight (NEN) in a Tricarb III liquid scintillation spectrometer 
(Packard). Separation of HCB and its metabolites (PCP, pentachlorobenzene 
as radiochemical impurity and 1,4-TCHQ) was achieved with a gradient of 
90% methanol against water containing 1% acetic acid, to 100% methanol in 
5 minutes, followed by 7 minutes of 100% methanol, k'-values were 8, 3.8, 
6 and 2.3, respectively. Separation of PCP, 1,4-TCHQ, 1,2-TCHQ and 
tetrachlorophenol was achieved by isocratic elution for 3 minutes at 65% 
methanol against water containing 1% acetic acid, followed by a gradient 
to 100% methanol in 8 minutes, followed by 7 minutes of 100% methanol, 
k'-values were 10.7, 3.3, 7.8 and 9.7, respectively. 
Apart from the diols, an unknown metabolite was formed in the microsomal 
incubations of PCP,'with a rate of 30-160 pmole/min/mg protein, depending 
on the type of microsomes used. This formation was independent of 
cytochrome P-450, since incubations without NADPH or without oxygen gave 
the same amount of this metabolite. The MAb used did not affect its 
formation. Hydrolysis of this unknown compound resulted in reappearance of 
PCP. Since it has no connection with the cytochrome P-450 supported 
biotransformation, this unknown metabolite is not included in the 
discussion. 
RESULTS 
1) Conversion of hexachlorobenzene and pentach loropheno l by p u r i f i e d 
cytochrome P-450 i s o e n z y m e s . 
The r a t e of p r o d u c t f o r m a t i o n f o r HCB and PCP was measured i n a sys tem 
c o n t a i n i n g p u r i f i e d r a t l i v e r mic rosomal cy tochromes P - 4 5 0 b , P - 4 5 0 c , 
P-450d o r P - 4 5 0 e , NADPH d e p e n d e n t cy tochrome P -450 r e d u c t a s e and 
d i l a u r o y l p h o s p h a t i d y l c h o l i n e (1 nmole , 3 nmoles and 40 u g , r e s p e c t i v e l y ) . 
The r e s u l t s a r e p r e s e n t e d i n t a b l e 1 . F o r m a t i o n of PCP a s a r e s u l t of 
TABLE l a 
CONVERSION OF HEXACHLOROBENZENE BY PURIFIED CYTOCHROME P-450 ISOENZYMES 
ISOENZYME 
b c d e 
rate of PCP formation 0.8 0 0 0.7 
TABLE lb 
CONVERSION OF PENTACHLOROPHENOL BY PURIFIED CYTOCHROME P-450 ISOENZYMES 
b 
80 
100 
0.7 
ISOENZYME 
c 
310 
140 
2.1 
d 
290 
150 
1.9 
e 
50 
70 
0.7 
rate of 1,4-diol formation 
rate of 1,2-diol formation 
ratio between 1,4 and 1,2 
1 nmole of cytochrome P-450, 3 nmoles of reductase and 40 ug of lipid 
were mixed, incubated for 3 minutes at 37°C and returned to ice. The' 
other components were added (0.1 M potassium phosphate buffer pH 7.4, 3 
mM MgCl2) to a volume of 1.75 ml. After temperature equilibration the 
sample was added to 50 pi of acetone containing 50 nmoles of HCB or 200 
nmoles of PCP, and the reaction was started by the addition of 1 mM 
NADPH. After 5 minutes incubation at 37° the reaction was stopped and 
the product formation was measured by HPLC/scintillation spectrometry. 
The rate is expressed as pmole product per minute per nmole cytochrome 
P-450. 
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h y d r o x y l a t i o n of HCB was found in i n c u b a t i o n s w i t h cy t o ch ro mes P-450b and 
P - 4 5 0 e . The amount of PCP p roduced was v e r y low ( 0 . 8 and 0 .7 
pmole /min /nmole P - 4 5 0 , r e s p e c t i v e l y ) No f o r m a t i o n of d i o l s a s s e c o n d a r y 
h y d r o x y l a t i o n p r o d u c t s of HCB was d e t e c t e d . P -450c and P-450d d i s p l a y e d no 
c a t a l y t i c a c t i v i t y t owards HCB, a t a d e t e c t i o n l i m i t of 0 . 2 
pmole / ra in /nmole P - 4 5 0 . 
I n c u b a t i o n of C-PCP w i t h cy toch romes P - 4 5 0 b , P - 4 5 0 c , P-450d and P-450e 
r e s u l t e d i n f o r m a t i o n of t e t r a c h l o r o - 1 , 4 - and t e t r a c h l o r o - 1 , 2 - h y d r o q u i n o n e 
f o r a l l i s o e n z y m e s . However, cy toch romes P-450c and P-450d showed a h i g h e r 
c a t a l y t i c a c t i v i t y t owards h y d r o x y l a t i o n of PCP t h a n P-450b and P-450e 
( t a b l e l b ) . The r e l a t i v e amounts of t h e 1 , 4 - d i o l and 1 , 2 - d i o l a l s o 
d i f f e r e d f o r t h e i soenzymes u s e d . Cytochrome P-450c and d p roduced more 
1 , 4 - d i o l t h a n 1 , 2 - d i o l , w h i l e cy toch romes P-450b and P-450e p roduced more 
of the t e t r a c h l o r o - 1 , 2 - h y d r o q u i n o n e . No o t h e r c o n v e r s i o n p r o d u c t s were 
d e t e c t e d . 
2) i n h i b i t i o n w i t h monoclonal a n t i b o d i e s of the c a t a l y t i c a c t i v i t y of 
cytochrome P-450 i soenzymes towards HCB and PCP i n microsomes . 
I n o r d e r t o e s t i m a t e t h e c o n t r i b u t i o n of t h e d i f f e r e n t cy tochrome P-450 
i soenzymes i n t h e h y d r o x y l a t i o n of HCB and PCP i n mic ro somes , t h e 
i soenzymes P-450b and P-450c were s e l e c t i v e l y i n h i b i t e d by monoc lona l 
a n t i b o d i e s (MAb). I n t h e p r e s e n c e of t h e s e a n t i b o d i e s , t h e c o n v e r s i o n of 
HCB to PCP and d i o l s , and t h e c o n v e r s i o n of PCP to t h e t e t r a c h l o r o - 1 , 4 -
and - 1 , 2 - h y d r o q u i n o n e were measured u s i n g microsomes from male r a t s 
t r e a t e d w i t h d i f f e r e n t i n d u c e r s of cy tochrome P-450 i s o e n z y m e s . The 
a n t i b o d i e s used were d e s c r i b e d p r e v i o u s l y (Thomas e t a l , 1984, Reik a t a l , 
1 9 8 5 ) . The BE52 a n t i b o d y c o m p l e t e l y i n h i b i t s cy tochrome P - 4 5 0 b , C8 
i n h i b i t s P - 4 5 0 c , and t h e C7 and C9 MAb b ind to P-450c w i t h o u t a f f e c t i n g 
i t s c a t a l y t i c a c t i v i t y . The l a t t e r two were used a s a c o n t r o l f o r t h e 
a d d i t i o n of t h e e x t r a amount of p r o t e i n t o t h e i n c u b a t i o n s . To i l l u s t r a t e 
t h e i r f u n c t i o n i n g , and to t e s t t h e i r a b i l i t y to i n h i b i t cy tochrome P-450 
i soenzymes from t h e W i s t a r s t r a i n of r a t s ( t h e a n t i b o d i e s were r a i s e d 
a g a i n s t cy tochrome P-450 i soenzymes from Long Evans r a t s ) , t h e 
d e a l k y l a t i o n of e t h o x y r e s o r u f i n and p e n t o x y r e s o r u f i n , s p e c i f i c s u b s t r a t e s 
f o r P-450c and P - 4 5 0 b , r e s p e c t i v e l y ( B u r k e , 1986) was d e t e r m i n e d i n t h e 
p r e s e n c e and a b s e n c e of t h e MAb ( t a b l e 2 ) . C7 has no e f f e c t on t h e 
c a t a l y t i c a c t i v i t y , BE52 c o m p l e t e l y i n h i b i t s t h e p e n t o x y r e s o r u f i n 
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TABLE 2 
EFFECT OF SPECIFIC MONOCLONAL ANTIBODIES ON THE DEALKYLATION OF 
PENTOXY- AND ETHOXYRESORUFIN. 
INDUCER/ANTIBODY O-dealkylase activity (pmole/min/mg) 
pentoxyresorufin ethoxyresorufin 
PB 560 (100) 
C7 662 (118) 
BE52 0 (0) 
3MC 1040 (100) 
C7 1066 (103) 
C8 195 (18) 
HCB 57 (100) 273 (100) 
C7 54 (95) 273 (100) 
BE52 0 (0) 
C8 - 91 (33) 
The incubation of the antibodies with microsomes was performed 
similarly to the HCB and PCP microsomal incubations. With these 
preincubated microsomes the formation of resorufin was measured 
fluorimetrically, in a 2 ml assay with 0.15 mg of microsomal protein. 
The numbers in brackets represent the percentage of activity as 
compared to the activity of the microsomes without antibody. 
dealkylation in both phenobarbital and HCB induced microsomes, and C8 
inhibits most of the ethoxyresorufin deethylation activity in 
3-methylcholanthrene and HCB induced microsomes. 
The effect of the antibodies on the hydroxylation of HCB by microsomes of 
rats treated with different inducers is presented in table 3. The 
microsomes from dexamethasone induced rats appeared to be by far the most 
active in the conversion of HCB. Furthermore, microsomes from rats treated 
with HCB, phenobarbital and isosafrole showed catalytic activity (in 
decreasing order) towards HCB. The amount of product formation by 
microsomes from 3-methylcholanthrene induced rats and from untreated rats 
was negligible. Inhibition of P-450c had no effect on the activity. The 
BE52 MAb inhibited the formation of PCP in microsomes from HCB and 
phenobarbital induced rats with 58% and 44%, respectively. In these 
TABLE 3 
MICROSOMAL CONVERSION OF HEXACHLOROBENZENE. 
INDUCERS AND SPECIFIC MONOCLONAL ANTIBODIES 
EFFECT OF DIFFERENT 
INDUCERS/ 
ANTIBODY 
NONE 
( ma le ) 
NONE 
(female) 
HCB 
C9 
BE 52 
C8 
PB 
C9 
BE 52 
C8 
RATE 
PCP 
0.8 
1.8 
42.0 
40.3 
18.5 
41.1 
24.9 
24.4 
14.3 
23.9 
(100) 
(100) 
(96) 
(44) 
(98) 
(100) 
(98) 
(57) 
(96) 
DIOLS 
0.1 
0 
4.2 
2.8 
1.4 
4.4 
1.2 
1.3 
0.2 
1.2 
(100) 
(100) 
(68) 
(33) 
(106) 
(100) 
(105) 
(13) 
(100) 
3-MC 
ISF 
C9 
BE 52 
C8 
0.8 
8.5 (100) 
8.9 (105) 
10.2 (121) 
10.6 (125) 
0.1 (100) 
0.1 (127) 
0 (20) 
0.1 (149) 
DEX 109.8 14.9 
The Incubation conditions were: 5 minutes incubation with 2 mg of 
microsomal protein, 0.2 mg per nmole P-450 of the appropriate antibody, 
50 nmoles of ^C-HCB, and 1 mM NADPH in a 2 ml volume. For details, see 
method section. The rate is expressed as pmole product per minute per 
mg microsomal protein. Between brackets the rate as a percentage of the 
rate of the incubations without antibody is presented. The C9 MAb binds 
to cytochrome P-450c without affecting its catalytic acitlvity, C8 binds 
and inhibits P-450c, and BE52 inactivates cytochromes P-450b and P-450e. 
The rate of formation of PCP and diols together always was within 90% 
of the total rate of conversion, as derived from the total amount of 
radioactivity eluting before the substrate. The values represent the 
average of duplicate incubation. 
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TABLE 4 
MICROSOMAL CONVERSION OF PENTACHLOROPHENOL. 
INDUCERS AND SPECIFIC ANTIBODIES 
EFFECT OF DIFFERENT 
INDUCERS/ANTIBODY 
NONE (male) 
C7 
BE52 
C8 
NONE (female) 
HCB 
C7 
BE52 
C8 
PB 
C7 
BE52 
C8 
3-MC 
C7 
BE52 
C8 
ISF 
C7 
BE52 
C8 
DEX 
C7 
BE 52 
C8 
RATF 
1,4-
120 
107 
94 
103 
77 
469 
425 
337 
519 
219 
190 
221 
188 
187 
177 
175 
225 
344 
326 
276 
319 
618 
626 
634 
594 
(pmole 
DIOL 
(100) 
(89) 
(78) 
(86) 
(100) 
(91) 
(72) 
(111) 
(100) 
(87) 
(101) 
(86) 
(100) 
(95) 
(94) 
(120) 
(100) 
(95) 
(80) 
(93) 
(100) 
(101) 
(103) 
(96) 
j/min/mg prot 
1,2-
29 
33 
29 
24 
33 
162 
144 
61 
141 
101 
82 
79 
80 
114 
88 
112 
135 
72 
62 
49 
58 
54 
45 
43 
54 
ein) 
DIOL 
(100) 
(1U) 
(100) 
(83) 
(199) 
(89) 
(38) 
(87) 
(100) 
(81) 
(78) 
(79) 
(100) 
(77) 
(98) 
(118) 
(100) 
(86) 
(68) 
(81) 
(100) 
(83) 
(80) 
(100) 
RATIO BETWEEN 
1,4 AND 1,2 
4.1 
3.2 
3.2 
4.3 
2.3 
2.9 
3.0 
5.5 
3.7 
2.2 
2.3 
2.8 
2.4 
1.6 
2.0 
1.6 
1.7 
4.8 
5.3 
5.6 
5.5 
11.4 
13.9 
14.7 
11.0 
The rate is expressed as pmole product per minute per mg of microsomal 
protein. Between brackets the rate as percentage of the rate of the 
incubations without antibody is presented. Incubation conditions as 
stated in Table 2, with 200 nmoles of C-PCP. Excluding the unknown 
metabolite produced independently from cytochrome P-450, the total diol 
formation always was within 85% of total product formation, as derived 
from the total amount of radioactivity eluting before the substrates. 
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incubations, the diol formation was also greatly reduced. Using microsomes 
from isosafrole treated rats, no decrease in activity was affected by 
BE 52. 
The microsomal conversion of PCP, and the influence of the MAb on the 
formation of tetrachloro-1,4- and tetrachloro-1,2-hydroquinone was 
measured (table 4). Again, microsomes from dexamethasone treated rats 
showed the highest rate of conversion (4.5 times the amount of product as 
compared to microsomes from untreated rats) , while microsomes from HCB 
treated rats were 4.2 times as active as microsomes from untreated rats. 
Microsomes from isosafrole induced rats gave a 2.8 fold induction, and 
both 3-methylcholanthrene and phenobarbital treatment resulted in a 
twofold induction as compared to untreated microsomes. The only clear 
inhibitory effect of the added antibodies is a 62% decrease in formation 
of 1,2-diol after addition of BE52 to microsomes from HCB treated rats. In 
these incubations, the 1,4-formation is also slightly lowered (38%). No 
inhibition was measured when cytochrome P-450b was inhibited in microsomes 
from phenobarbital treated rats, nor was any decrease in catalytic 
activity detected when cytochrome P-450c was inhibited in microsomes from 
3-methylcholanthrene treated rats. 
DISCUSSION 
1) the hydroxylation of hexachlorobenzene 
The data obtained from the incubat ions with pur i f ied cytochrome P-450 
isoenzymes and from the microsomal incubat ions , using microsomes from r a t s 
t r ea ted wi th d i f f e ren t inducing agents , and s e l e c t i v e i n h i b i t i o n of 
cytochrome P-450b and P-450c, suggest the involvement of at l e a s t 3 
d i f f e r en t P-450 isoenzymes in the hydroxylat ion of HCB, namely P-450p, 
P-450b and P-450e. The c a t a l y t i c a c t i v i t y of pur i f ied cytochromes P-450b 
and P-450e i s in agreement wi th the decrease of a c t i v i t y caused by the 
BE52 MAb in microsomes from r a t s t r ea ted with HCB and phenobarb i ta l . 
However, the r a t e of conversion of HCB by pur i f ied P-450b and P-450e i s 
lower than would be expected from t h i s i n h i b i t i o n . This i s most l i k e l y due 
to the very poor s o l u b i l i t y of HCB in aqueous s o l u t i o n s . In microsomal 
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suspensions the solubility is related to the microsomal concentration, and 
is about 25 uM at 1 mg protein per ml. 
The involvement of P-450p in the hydroxylation of HCB is indicated by the 
high rate of conversion displayed by microsomes from dexamethasone induced 
rats. Dexamethasone induces cytochrome P-450p more than 100-fold as 
compared to untreated female rats (Wrighton, 1984). Phenobarbital 
treatment results in a 20-fold induction of P-450p (Wrighton et al, 1985). 
The presence of P-450p in microsomes from phenobarbital treated rats 
probably accounts for the remaining activity after inhibition of P-450b 
and P-450e. Microsomes from isosafrole induced rats have also been shown 
to contain a small amount of cytochrome P-450p (Guengerich, 1982). HCB 
treatment causes induction of cytochromes ?-450b, P-450c and P-450d (in 
decreasing order), as established by immunoquantitation (Li, 1987). The 
amount of P-450p has not been determined after treatment of rats with HCB. 
2) the hydroxylation of pentachlorophenol 
Although purified cytochromes P-450b and P-450e, and to an even larger 
extent, P-450c were able to hydroxylate PCP, the use of MAb indicated that 
these isoenzymes are not, or only to a small extent, involved in the 
microsomal conversion. Treatment of rats with 3-methylcholanthrene 
resulted in a twofold increase in the rate of microsomal hydroxylation of 
PCP, but inhibition of cytochrome P-450c in these microsomes had no 
inhibitory effect on product formation. Only in HCB-microsomes inhibition 
of P-450b and P-450e clearly decreased the formation of 
tetrachloro-l,2-hydroquinone, while tetrachloro-1,4-hydroquinone formation 
was hardly affected. The fact that the formation of the 1,2-isomer is more 
suppressed than the formation of the 1,4-diol is in agreement with the 
finding that P-450b and P-450e produce more 1,2-diol than 1,4-diol. 
Apparently, the rate of hydroxylation shown by purified isoenzymes is 
higher than their activity in microsomes. This is also illustrated by the 
rate of N-demethylation of benzphetamine by purified cytochrome P-450b, 
which is at least 3 times higher than the activity towards benzphetamine 
by P-450b in microsomes from phenobarbital induced rats (Reik, 1985). 
Cytochrome P-450p probably has a high catalytic activity towards PCP, as 
can be concluded from the incubations with liver microsomes from 
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dexamethasone treated rats. Cytochrome P-450p may be partly responsible 
for the hydroxylation of PCP by microsomes from rats treated with 
phenobarbital, HCB or isosafrole, but it is unlikely that cytochrome 
P-450p is present in microsomes from 3-methylcholanthrene treated rats, 
since these microsomes have no catalytic activity towards HCB 
hydroxylation. The isoenzyme responsible for the turnover of PCP in 
microsomes from 3-methylcholanthrene and isosafrole treated rats may be 
cytochrome P-450d, which is also active in a reconstituted system, and is 
more strongly induced by isosafrole than by 3-methylcholanthrene (Thomas, 
1983). This is in agreement with the higher rate of product formation by 
microsomes from rats treated with isosafrole than with 
3-methylcholanthrene. However, the possibility remains that another, as 
yet unidentified cytochrome P-450 isoenzyme is involved. 
As noted previously for microsomal incubations (Van Ommen, 1986), the 
ratio between formation of tetrachloro-1,4-hydroquinone and 
tetrachloro-1,2-hydroquinone differed for the various cytochrome P-450 
isoenzymes. Purified cytochromes P-450b and P-450e predominantly produce 
the 1,2-diol, while the cytochromes P-450c and P-450d have a preference 
for the 1,4-diol. Microsomes from dexamethasone treated rats almost 
exclusively form the 1,4-diol. The finding that in microsomes of rats 
treated with HCB or phenobarbital an excess of the 1,4-diol is detected 
may be attributed to the activity of P-450p in these microsomes. 
Concluding, the hydroxylation of HCB in microsomes is most likely 
catalyzed by cytochrome P-450p, and to a lesser extent by cytochromes 
P-450b and P-450e. The hydroxylation of PCP is also predominantly 
supported by cytochrome P-450p. It is clear that studies using specific 
inducers of cytochrome P-450 can be misleading in that small amounts of 
other P-450 isoenzymes can be of relatively major importance, and that the 
ability of purified cytochrome P-450 isoenzymes to convert compounds not 
necessarilly implicates that they contribute to the microsomal conversion. 
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CHAPTER 7 
BIOTRANSFORMATION OF 14C-HEXACHL0R0BENZENE AND ITS MAJOR 
OXIDATIVE METABOLITES BY PRIMARY CULTURES OF CHICK EMBRYO 
HEPATOCYTES 
Ben van Ommen, Pe t e r J . van Bladeren, Anton E.P . Adang, Jos G.M. Besseras and Jan 
H. Koeman 
Department of Toxicology, Agricultural University, De Dreijen 12, 6703 BC 
Wageningen, The Netherlands. 
ABSTRACT 
Using radiolabeled compounds, the biotransformation of hexachlorobenzene and i t s 
major oxidative metabolites, pentachlorophenol and tetrachloro-l,4-hydroquinone, 
has been investigated quantitatively in primary cultures of chick embryo hepato-
cytes. 
Hexachlorobenzene biotransformation resulted in formation of pentachlorophenol as 
the major product. The formation of PCP could be influenced by treatment of the 
cultures with different types of inducers of cytochrome P^450. The most potent 
inducer, dexamethasone, which induces cytochrome P-450p in the r a t , increased the 
PCP-fortnation threefold (238 pmole/culture/24 hrs) as compared to none-induced 
cultures. 
Pentachlorophenol metabolism mainly resulted in formation of conjugates. More than 
85% of to ta l product formation was at tr ibuted to an unidentified, extractable 
conjugate. No tetrachloro-l,4-hydroquinone could be detected. Addition of the 
l a t t e r compound to cultures resulted in a par t ia l oxidation to the benzoquinone, 
together with the formation of a more polar extractable metabolite. For a l l three 
compounds evidence was obtained for the formation of glutathione conjugates, 
which, at least in the case of PCP and TCHQ metabolism, most l ikely are conjugates 
of tetrachloro-l,4-benzoquinone. Incubations with HCB, PCP and TCHQ al l resulted 
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In the appearance of radioactivity covalently bound to cellular protein, with TCHQ 
giving the most and HCB giving the least binding. In no case, however, did cova-
lent binding reach the level found in microsomal incubations. 
In conclusion, the biotransformation of HCB in primary cultures of chick embryo 
hepatocytes is only partly oxidative, leading to covalent binding to protein. 
Other pathways, presumably conjugation reactions, to a large extent prevent the 
hydroxylation products of HCB from forming benzoquinones, thus protecting against 
toxic effects due to covalent binding. 
INTRODUCTION 
The fungicide hexachlorobenzene (HCB) i s known for i t s porphyrinogenic and c a r c i -
nogenic ac t i on (Koss, 1978; Smith and Cabra l , 1980). A s t a t e of HCB-induced 
chemical porphyr ia i s cha rac t e r i zed by an accumulation of uroporphyrin in l i v e r 
and u r i n e , caused by a s e l e c t i v e I n h i b i t i o n of the enzyme uroporphyrinogen decar -
boxylase (E lde r , 1978). Biot ransformat ion of HCB seems to be a p r e r e q u i s i t e for 
t h i s i n a c t i v a t i o n : induct ion and s e l e c t i v e i n h i b i t i o n of the cytochrome P-450 
system leads to an enhancement and a decrease of the porphyrinogenic a c t i o n , 
r e s p e c t i v e l y (Walnstock de Calmanovici, 1984; Smith, 1986). Microsomal s t u d i e s 
have shown t h a t HCB i s hydroxylated by cytochrome P-450 to pentachlorophenol 
(PCP), which in t u rn i s hydroxylated to t e t r a c h l o r o - 1 , 4 - and -1 ,2-hydroquinone. 
These hydroquinones can be oxidized to t h e i r quinone forms, which d i sp lay a high 
r e a c t i v i t y towards p r o t e i n and DNA (Van Ommen, 1985, 1986, 1986a). This covalent 
binding may be involved in the i n a c t i v a t i o n of uroporphyrinogen decarboxylase . 
The chick embryo hepatocyte c u l t u r e system has proven to be a s e n s i t i v e system for 
mechanis t ic s t u d i e s of HCB-induced porphyr ia (Debets , 1981; F e r i o l i , 1984; 
S i n c l a i r , 1987; Wainstock de Calmanovici, 1980). These c e l l s uniquely combine the 
presence of an i n t a c t porphyrin b io syn thes i s pathway ( S i n c l a i r and Granick, 1974) 
wi th an inducable cytochrome P-450 system (Al thaus , 1979, Topp and Van Bladeren, 
1986), thus of fe r ing the p o s s i b i l i t y of l i nk i n g the in vivo s t u d i e s on chemical 
porphyria ( e . g . Koss, 1978) wi th mechan is t i c microsomal s t u d i e s on HCB metabolism 
(Van Ommen, 1985, 1986, 1986a). The induct ion of the P-450 system as we l l as the 
porphyrinogenic a c t i o n of HCB in chick embryo hepatocytes have been s tud ied i n 
d e t a i l . 
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In the present paper the biotransformation of HCB and its primary oxidative 
metabolites PCP and 1,4-TCHQ is described, with special attention to the cyto-
chrome P-450 dependent biotransformation leading to covalent binding to protein. 
METHODS 
CHEMICALS U-C1 C)-hexachlorobenzene (Amersham UK), 70 mCi/mmol, contained 0.12% 
pentachlorobenzene as a radiochemical impurity as determined by the • HPLC method 
described below. U-( C)-pentachlorophenol, with a specific activity of 37.5 
mCi/mmole, was purchased from CEA, Gif-sur-Yvette, France. The 2.2% radiochemical 
impurity of tetrachlorophenol was removed by preparative HPLC with a method 
14 described in chapter 5. ( C)-tetrachloro-l,4-hydroquinone was synthesized enzyma-
tically from ( C)-PCP as described in chapter 5. Williams E culture medium 
containing 2 mM glutamine and 10% newborn calf serum was from Gibco biocult, 
Scotland, dispase grade 2 from Boehringer Mannheim FRG, phenobarbital from OPG, 
the Netherlands, aroclor 1254 from Monsanto, St. Louis USA, isosafrole from Fluka 
and beta-naphthoflavone from Aldrich, dexamethasone was from Sigma. .All other 
chemicals used were of analytical grade. 
HEPATOCYTE ISOLATION AND CULTIVATION Hepatocytes were obtained from 14 day old 
chick embryos. The livers were perfused in situ with Hank's solution without 
calcium and magnesium, containing 20 mM HEPES and 0.04% EDTA to wash out red blood 
cells. After cutting the collected livers into small pieces, the cells were dis-
sociated enzymatically in Hank's HEPES pH 7.4 containing 1 U/ml dispase. The 
dissociated cells were sedimented by centrifugation at 1200 g for 4 minutes. Red 
blood cells were lysed by washing the cells with buffered ammonium chloride pH 
7.65 during 4 minutes. Dissociation, centrifugation and lysis were repeated two 
more times. The isolated hepatocytes were resuspended in Williams E medium 
containing 10% serum (10 livers/100 ml). 5 cm plastic culture dishes (Costar) were 
filled with 5 ml of this suspension, containing 4-6x10 cells. The dishes were 
incubated at 37°C in a humidified atmosphere of 5% CO2 in air. A monolayer was 
established in 4 hr. Non-attached cells were removed after 22 hr by renewing the 
medium. 
STANDARD INDUCTION AND EXPOSURE PROCEDURE 24 hr after isolation of the hepato-
cytes, treatment with drug inducing agents was started. Phenobarbital (dissolved 
in water), beta-naphthoflavone (dissolved in DMS0), dexamethasone, isosafrole or 
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aroclor 1254 (all dissolved in acetone) were added. The concentrations used are 
given in the legends to figures and tables. The maximum concentration of the 
solvents in medium was 0.2%. After 24 hr the medium was replaced by medium without 
serum containing the same inducers, together with 7.1 pM C-HCB (2.5 uCi), 1 pM 
14C-PCP (0.16 uCi) or 1 pM 14C-TCHQ (12.5 nCi) dissolved in 25 pi acetone. The 
solution of HCB PCP or TCHQ in medium was prepared by injecting 25 pi of a 
solution in acetone into a tube containing 5 ml of medium, after which the tube 
was vigourously vortexed. The HCB appeared to be dissolved since microscopic 
examination revealed no crystals in the culture dishes (as can be observed when 
HCB is added in DMSO or ether). After 24 hr the cells were harvested. Blancs 
consisted of zero time incubations for metabolism and covalent binding experiments 
and of 24 hr incubations without cells to determine the radiochemical impurity. 
Incubations were stopped by separating the medium from the cells, harvesting the 
cells with a rubber policeman in 2x0.5 ml Tris/HCl buffer, pH 7.8 (100 inM) and 
finally rinsing the dish with a small volume of methanol. Medium, cells and 
methanol wash were combined and, after addition of HC1 to a final concentration of 
0.6 N, extracted with 3x3 ml of diethylether in the case of HCB, or ethyl-
acetate/acetone (2:1) in the cae of PCP and 1,4-TCHQ. The extracts were dried with 
anhydrous Na2S0/, solvent was removed in a stream of nitrogen and the residue dis-
solved in 50 pi of methanol and analysed by HPLC. 
ANALYSIS OF METABOLITES AND COVALENT BINDING The HPLC system used and HPLC analy-
sis of HCB metabolites have been described previously (Van Ommen, 1986). 
PCP metabolism was quantitated by separating PCP and metabolites on HPLC with a 
gradient of 50 to 85% methanol against water containing 1% acetic acid in 30 
minutes, followed by 5 minutes isocratic elution of 85% methanol. TCHQ metabolism 
was analysed as described elsewhere (chapter 5). 
After the ether extraction the precipitated protein was separated from the water 
phase and covalent binding to protein was determined as described previously (Van 
Ommen, 1985). The aqueous phase was treated with HC1 (pH 1) for one hour at 95°C 
(Ahlborg, 1978), after which ether extraction and HPLC separation was performed 
again to estimate the amount of glucuronidated and sulfated metabolites formed 
during the incubation (Lilienblum, 1985). The amount of radioactivity after this 
second extraction procedure was determined in order to estimate the amount of 
glutathione conjugates produced. 
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RESOUS 
1) Biot ransformat ion of C-hexachlorobenzene 
HCB was mainly converted in to pentachlorophenol '(PCP) by chick embryo hepatocytes 
i n c u l t u r e ( t a b l e 1 ) . A decrease in the amount of pentachlorobenzene, present as a 
radiochemical impuri ty (0.12%) was a l s o observed. Concomitant appearance of t e t r a -
chlorophenol explained t h i s f a c t . The sum of t e t r ach lo ropheno l and pen tach lo ro -
benzene remained cons tant in a l l exper iments , i n d i c a t i n g t h a t no pen tach lo ro -
benzene was formed from HCB under these c o n d i t i o n s . 
In order to e s t ima te the amount of g lucuronidated or su l f a t ed m e t a b o l i t e s , ac id 
hyd ro ly s i s was performed on the aqueous phase a f t e r e the r e x t r a c t i o n (Li l ienblum, 
1985). Repeated e t h e r e x t r a c t i o n a f t e r hydro lys i s r e s u l t e d i n p a r t i a l removal of 
r a d i o a c t i v i t y from the water phase ( t a b l e 1 ) . HPLC a n a l y s i s of e t h e r e x t r a c t s 
a f t e r acid hydro lys i s showed t h a t the a c t i v i t y cons i s t ed almost exc lus ive ly of 
HCB, whereas about 8.9% of t o t a l recovered PCP coeluted wi th the PCP marker. The 
method of d e t e c t i o n and q u a n t i t a t i o n of the me tabo l i t e s we used was not app l i cab l e 
for the d e t e c t i o n of the p rev ious ly descr ibed me tabo l i t e s pentachloro th iophenol 
TABLE 1 . BIOTRANSFORMATION OF HEXACHLOROBENZENE IN A PRIMARY CULTURE OF 
CHICK EMBRYO HEPATOCYTES 
METABOLITE AMOUNT (pmol) 
p e n t a c h l o r o p h e n o l 69 
P C P - g l u c u r o n i d e o r s u l f a t e e s t e r 1.7 
g l u t a t h i o n e c o n j u g a t e 1 5 . 3 
m e t a b o l i t e s c o v a l e n t l y bound t o p r o t e i n 0 .7 
14 35 nmoles of C-HCB were i n c u b a t e d f o r 24 h o u r s w i t h a mono laye r of 
embryonal c h i c k , h e p a t o c y t e s , a s d e s c r i b e d i n t h e method s e c t i o n . The 
amount of PCP formed was d e t e r m i n e d by HPLC of t h e e t h e r e x t r a c t of t h e 
medium and l y s e d c e l l s , g l u c u r o n i d e s and s u l f a t e e s t e r s were e s t i m a t e d 
from t h e amount of PCP e x t r a c t e d from t h e medium a f t e r a c i d h y d r o l y s i s 
( a s d e t e r m i n e d by HPLC), g l u t a t h i o n e c o n j u g a t e s were e s t i m a t e d from t h e 
amount of r a d i o a c t i v i t y r e m a i n i n g i n t h e aqueous phase a f t e r a c i d 
h y d r o l y s i s / e x t r a c t i o n , and t h e amount of c o v a l e n t b i n d i n g was 
d e t e r m i n e d a f t e r e x t e n s i v e wash ing w i t h o r g a n i c s o l v e n t s of t h e 
p r e c i p i t a t e d c e l l u l a r p r o t e i n s . V a l u e s a r e t h e a v e r a g e of d u p l i c a t e 
i n c u b a t i o n s of a r e p r e s e n t a t i v e e x p e r i m e n t , c o r r e c t e d f o r z e r o t i m e 
i n c u b a t i o n s . 
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and pentachlorothioanisol (Debets, 1981). Pentachlorothiophenol does not elute as 
a distinct peak from reversed phase columns in our hands and pentachlorothioanisol 
almost coelutes with HCB. Therefore, since the thioether bond is relatively stable 
under acid hydrolysis, glutathione conjugates were estimated as the residual 
radioactivity left in the aqueous phase after acid hydrolysis and extraction 
(table 1). 
The biotransformation of HCB appeared to be linear with time for at least 24 hours 
(fig. 1 ). The relationship between the concentration and the amount of PCP formed 
is presented in figure 2. Biotransformation of HCB was linear up to 7 pM. This 
concentration of HCB was therefore chosen for all subsequent incubations. 
The effect of exposure of the culture system to different cytochrome P-450 
inducing agents on the biotransformation of HCB is presented in table 2. Dexa-
methasone appeared to be by far the most potent inducer of HCB-hydroxylation. 
Isosafrole, aroclor 1254 and phenobarbital induced PCP-formation in decreasing 
order, while beta-naphthoflavone decreased the hydroxylation as compared to non-
induced cultures. Figure 3 shows the dependency of the hydroxylation on the dexa-
methasone concentration. At high concentrations of dexamethasone the amount of 
PCP-formation was the same in cultures with and without serum. The covalent 
binding as a result of biotransformation of HCB also varied with the different 
100 
I 75 
a 
E 
•f 50 
Q_ 
1_J 
CL 
25 
01 24 
time (hr) 
figure 1. Dependency of the formation of pentachlorophenol as a result 
of HCB-biotransformation on the incubation time, in a primary culture 
of chick embryo hepatocytes, treated with phenobarbital (400 pg/ml). 
For details, see method section. 
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TABLE 2. BIOTRANSFORMATION OF HEXACHLOROBENZENE IN A PRIMARY CULTURE OF 
CHICK EMBRYO HEPATOCYTES. 
EFFECT OF TREATMENT WITH DIFFERENT INDUCERS OF CYTOCHROME P-450. 
INDUCER FORMATION 
PENTACHLOROP1 
(pmol) 
77 
81 
98 
35 
105 
238 
OF 
1ENOL 
COVALENT BINDING 
(pmol) 
0.7 
0.4 
0.4 
1.1 
0.9 
0.6 
none 
phenobarbital (400)a 
aroclor 1254 (2) 
B-naphthoflavone (6) 
isosafrole (18) 
dexamethasone (39) 
14 35 nmoles of C-HCB were incubated with a monolayer of embryonal chick 
hepatocytes, as described in the method section. The amount of PCP 
formed after 24 hours of incubation was determined by HPLC of the ether 
extracts of medium and lysed cells. Covalent binding was quantified 
after extensive washing of the cellular protein pellet after ether 
extraction. The values (average of duplicate incubations) of a 
representative experiment are presented, and are corrected for zerotime 
incubations. 
a) In brackets the concentration of the inducer is stated, in ug/ml. 
~ 120i 
10 20 30 
[HCB](uM) 
figure 2. Dependency of the formation of pentachlorophenol on the 
concentration of hexachlorobenzene in a primary culture of chick embryo 
hepatocytes, treated with phenobarbital (400 ug/ml). For details, see 
method section. 
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f igure 3 . Effect of the concent ra t ion of dexamethasone on the formation 
of PCP from HCB, in a primary c u l t u r e of chick embryo hepatocytes , in 
the presence and absence of serum. For d e t a i l s , see method s ec t i on . 
inducers used ( table 2). Beta-naphthoflavone induction resulted in the largest 
amount of covalent binding to protein (1.1 pmole). 
2) Biotransformation of ( C)-pentachlorophenol 
The dependency of formation of extractable products in primary cultures of chick 
embryo hepatocytes on the concentration of PCP is presented in figure 4 for beta-
naphthoflavone induced cultures. Conversion was linear with the concentration up 
to 10 uM, while a maximal product formation of 15 nmoles was reached at 50 uM PCP. 
Most experiments were performed using a PCP concentration of 1 uM. Contrary to the 
microsomal metabolism of PCP, in cultures no formation of hydroxylated products 
(tetrachloro-l,2-hydroquinone and tetrachloro-l,4-hydroquinone) was detected 
(table 3). The major product (85% of total product formation) was an ethyl 
acetate/acetone extractable conjugate of PCP, of which the structure could not be 
identified. Acid hydrolysis of this compound resulted in reappearance of PCP, 
while its instability prevented identification by MS or GC-MS: this technique also 
only indicated the presence of PCP. The amount of this conjugate formed in 
cultures was dependent on the inducer used (table 3). Beta-naphthoflavone was the 
best inducer of the biotransformation of PCP. The amount of non-extractable glucu-
ronides and sulfate esters, as estimated by the amount of extractable label after 
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n.d. 
360 
1 
46 
2.1 
n.d. 
700 
4 
84 
16.8 
n.d. 
480 
1 
40 
6.3 
TABLE 3. BIOTRANSFORMATION OF PENTACHLOROPHENOL IN A PRIMARY CULTURE OF 
CHICK EMBRYO HEPATOCYTES. 
METABOLITE AMOUNT (pmol) 
INDUCER 
none B-NF DEX 
1,4-TCHQ and 1,2-TCHQ 
extractable conjugate 
glucuronide or sulfate ester 
glutathione conjugate 
metabolites covalently bound to protein 
14 5 nmoles of C-PCP were incubated for 24 hours with a monolayer of 
embryonal chick. hepatocytes , t r ea t ed with d i f f e r en t inducers . 
Dexamethasone was added to 20 pg/ml, beta-naphthof lavone to 6 pg/ml. 
Metabolites were quantitated as described under table 1. The values are 
the average of duplicate incubations, corrected for zerotime 
incubations, (n.d.: non-detectable) 
acid hydrolysis, was very low (4 pmole). In beta-naphthoflavone treated cel l 
cultures 84 pmole of the added PCP was not extracted from the medium even after 
acid hydrolysis, and denoted as "glutathione conjugates". Covalent binding to 
protein was considerably higher than in HCB-exposed ce l l s . Beta-naphthoflavone 
treatment resulted in 16.8 pmoles of binding, 8 times higher than measured in non-
induced ce l l s . 
3) Biotransformation of ( C)-tetrachloro-l,4-hydroquinone 
The tetrachlorobenzoquinones are the ultimate covalent binding agents in micro-
somal HCB metabolism. In order to determine whether in primary cultures of chick 
embryo hepatocytes exposure to the hydroquinones would also resul t in covalent 
binding, small amounts (1 pM) of ( C)-tetrachloro-l,4-hydroquinone were incubated 
with these cultures. After 24 hours of incubation 75% of the added 1,4-TCHQ was 
metabolized, while only 2.6% (130 pmole) was found to be covalently attached to 
protein ( table 4) . 3.8% was detected in the benzoquinone form, while the major 
part of the extractable radioactivity (35% of added label) eluted frcm the HPLC as 
a discrete peak before 1,4-TCHQ and 1,4-TCBQ, indicating a more polar structure. 
Conjugates with glucuronic acid or sulfate, and conjugates with glutathione were 
estimated to be formed to a maximal amount of 16% and 18%, respectively. 
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TABLE 4. BIOTRANSFORMATION OF TETRACHLORO-1,4-HYDROQUINONE IN A PRIMARY 
CULTURE OF CHICK EMBRYO HEPATOCYTES. 
METABOLITE AMOUNT (pmol) 
extractable metabolites: 1,4-TCBQ 190 
unknown 1740 
glucuronide or sulfate ester 800 
glutathione conjugate 900 
metabolites covalently bound to protein 130 
5 nmoles of 1,4-TCHQ were incubated for 24 hours with a monolayer of 
embryonal chick hepatocytes, induced with isosafrole. The metabolites 
were determined as described under table 1. The values are the average 
of duplicate incubations, corrected for zerotime incubations. 
product formation 
(nmole) 
15l 
10-
5-
10 50 100 
[PCPKpM) 
f i g u r e 4 . Dependency of t h e t o t a l ( e x t r a c t a b l e ) p r o d u c t f o r m a t i o n on 
t h e c o n c e n t r a t i o n of PCP, i n a p r i m a r y c u l t u r e of c h i c k embryonal 
h e p a t o c y t e s , t r e a t e d w i t h b e t a - n a p h t h o f l a v o n e (6 u g / m l ) . For d e t a i l s , 
s ee method s e c t i o n . 
DISCUSSION 
The chick embryo hepatocyte c u l t u r e system provides a t o o l for q u a n t i t a t i v e 
i n v e s t i g a t i o n of the in v i t r o b io t rans format ion of HCB. Although the r a t e of 
conversion i s extremely low, the amounts of me tabo l i t e s a r e reproducable and we l l 
above the d e t e c t i o n l i m i t of 1 pmole. The f i r s t pa r t of the b io t ransformat ion of 
HCB i s s imi l a r for microsomal incubat ions and hepatocyte c u l t u r e s . Both systems 
y i e l d PCP as the major product , toge ther wi th a small amount of covalent b ind ing . 
1 1( 
In studies with rat liver microsomes and purified cytochrome P-450 isoenzymes 
(chapter 6) it appeared that P-450p is the major cytochrome P-450 isoenzyme 
involved in the hydroxylation of HCB. Cytochrome P-450 isoenzymes can be induced 
in the chick embryo culture system (Althaus, 1979; Topp and Van Bladeren, 1986) 
and the results obtained are in good agreement with the microsomal data: Oexa-
methasone pretreatment resulted in the highest conversion of HCB. The negative 
effect of serum on the metabolic capacity of this culture system has been 
described earlier for benzo(a)pyrene metabolism (Topp and Van Bladeren, 1986). 
The biotransformation of HCB and PCP in chick embryo hepatocytes differs from that 
by rat liver microsomes in that no diols could be detected from the hepatocytes. 
In microsomal incubations the cytochrome P-450 dependent diol formation was the 
major route of metabolism of HCB, ultimately leading to covalent binding of 
quinones to protein (Van Ornmeri, 1986a, chapter 5). It is possible that all diols 
formed in these cultures have been oxidized to their quinone forms and were 
recovered as covalently bound label or as the glutathione conjugates of their 
benzoquinones. The high reactivity of glutathione towards tetrachloro-1,4-
benzoquinone has been shown previously (Van Ommen, 1986). 
Covalent binding as a result of biotransformation of HCB and PCP was best induced 
by beta-naphthoflavone. However, levels were considerably lower than in microsomal 
incubations (Van Ommen, 1986, 1986a). In agreement with this finding, the relative 
amount of 1,4-TCHQ which became covalently bound to protein when this compound was 
incubated with chick hepatocytes is very low (2.6%), as compared to the 45% 
binding in a 5 minute microsomal incubation in the presence of NADPH (chapter 5). 
Conjugation mechanisms apparently are effective in removing the benzoquinone, 
since also upon incubation of C-TCHQ, almost three times more non-extractable 
radioactivity than benzoquinone or covalently bound metabolites was detected. 
Similarly, the major metabolite of PCP produced by the hepatocytes was an as yet 
unidentified conjugate. 
In conclusion, the biotransformation of HCB and its major oxidative metabolites 
PCP and 1,4-TCHQ in primary cultures of chick embryo hepatocytes shows similari-
ties with the biotransformation by rat liver microsomes, especially for the cyto-
chrome P-450 dependent hydroxylation of HCB. However, the presence of other 
biotransformation routes and of efficient protective mechanisms results in much 
less covalent binding to protein. 
Chick embryo hepatocytes in primary culture have proven to be a sensitive tool for 
observing the development of porphyria after exposure to HCB (Debets et al., 
117 
1981). An earlier onset and Increase of porphyrin accumulation was observed after 
pretreatment of the cultures with.beta-naphthoflavone, 3-methylcholanthrene and 
phenobarbital, as compared with non-induced cultures. Now that it is possible to 
quantitatively investigate HCB biotransformation and porphyrinogenic action in the 
same culture system, it will be possible to combine results of mechanistic studies 
on the biotransformation with data on development of porphyria. 
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CHAPTER 8 
DISCUSSION 
THE RELATION BETWEEN BIOTRANSFORMATION AND PORPHYRINOGENS ACTION OF 
HEXACHLOROBENZENE 
At the onset of the investigations presented in this thesis, the 
involvement of cytochrome P-450 in the development of HCB-induced 
porphyria had been firmly established (chapter 1). However, no metabolite 
or reactive intermediate of HCB had been identified as the ultimate 
porphyrinogenic compound. The aim of this study was to investigate the 
mechanisms of the oxidative in vitro biotransformation of HCB, in order to 
identify possible reactive intermediates. 
The route of microsomal biotransformation of HCB as established in the 
present study is shown in figure 1. Hydroxy lation of HCB and PCP results 
in formation of two tetrachlorohydroquinone isomers. These hydroquinones 
can be oxidized to their semiquinone and quinone forms, which are highly 
reactive towards protein and DNA. A mechanism is presented in which 
biotransformation of HCB leads to the generation of compounds which are 
potentially (geno)toxic. In this chapter the following questions will be 
discussed: 
1 Are these quinones the only reactive species involved in the 
oxidative biotransformation of HCB? 
2 What is the relevance of this covalent binding in vivo? 
3 Is there a relation between this covalent binding and the toxic 
action of HCB.? 
CI OH 
Cl CI 
HCB PCP 
P-450 p,? 
OH 
C C ^ ^ C I "asc acid 
OH 
1.4-TCHQ 
(•1,2 -isomer I 
::i 
f 
0-
OH 
covalent" binding 
to protein and DNA 
0 J , E 0 < p Cl 
asc. acid ci 
1,4 
! 
0 
Y-a 
0 
TCBQ 
GSH 
-i\Xi 
figure 1. Route of oxidative biotransformation of hexachlorobenzene. 
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1) The experiments described in this thesis clearly demonstrate that 
quinone-mediated covalent binding to protein is the only alkylating 
process originating from microsomal biotransformation of HCB. The amount 
of covalent binding produced during the microsomal metabolism of HCB can 
almost exclusively be attributed to reactions occurring after the 
formation of PCP (chapter 3). This rules out the possible involvement of 
radicals generated during reductive dechlorination of HCB, as mentioned in 
chapter 1. Anaerobic conditions, which would stimulate this route, did not 
result in an increase of covalent binding or formation of 
pentachlorobenzene. These results have been confirmed by Stewart and Smith 
(1986). Epoxidation, resulting in a hexachlorocyclodienone structure, 
analogous to the NIH-shift described for benzene (Jerina and Daly, 1974), 
followed by loss of a positively charged chlorine ion, probably is the 
mechanism of hydroxylatlon of HCB. Although the epoxide has alkylating 
properties, the absence of covalent binding during the formation of PCP 
suggests that no such process occurs. 
The quinones derived from HCB are unique in their reactivity in that their 
quinone structure remains intact after reaction with a nucleofile. This is 
due to the perhalogenated character of the tetrachlorobenzoquinones. The 
reaction with a sulfhydryl group results in loss of HC1, without reduction 
of the quinone. Other quinones which have been described to be reactive 
towards protein, undergo a Michael-type addition, resulting in a stable 
hydroquinone adduct (Lau, 1984), which has to be reoxidized before being 
able to react again (figure 2). As a consequence, e.g. glutathione 
conjugates of tetrachlorobenzoquinones are still reactive towards protein. 
This is illustrated by the fact that, in a reaction of 
tetrachloro-1,4-benzoquinone with glutatione not only monosubstituted 
conjugates are formed, but also di- and tri-, and possibly fully 
substituted conjugates. 
2) The experiments with primary cultures of chick embryo hepatocytes, as 
described in chapter 7, have shown that 1) the major route of 
biotransformation of HCB in intact cells does not lead to 
tetrachlorobenzoquinones, as was found for microsomal incubations. This is 
mainly due to a different route of PCP-biotransforraation, competing with 
the oxidative route, and resulting in conjugation, ii) There are efficient 
protective mechanisms (reduction and conjugation) present in these cells 
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3) Are the tetrachlorobenzoquinones responsible for the porphyrinogenic 
and carcinogenic action of HCB in vivo? The amount of covalent binding as 
a result of biotransformation of HCB in primary cultures of embryonal 
chick hepatocytes is extremely low (about 1 praole, 35 ppm of the added 
HCB). Moreover, Smith (1986) partly purified URO-D after exposure of 
female mice to C-HCB, and was not able to detect radiolabel on the 
enzyme. 
The fact that PCP is not porphyrinogenic would suggest that 
tetrachlorobenzoquinones, as metabolites of PCP, have no relation with 
porphyria. There may be some differences between PCP given orally and PCP 
as a hydroxylation product of HCB. Firstly, PCP does not induce cytochrome 
P-450. Therefore, the possibilities for hydroxylation to hydroquinones are 
limited, and the route of glucuronidation might be favoured. Secondly, the 
site of hydroxylation of PCP, the liver endoplasmatic reticulum, is also 
the site of formation of PCP as a product of HCB. It is even possible that 
PCP, formed from HCB by cytochrome P-450p, does not leave the active site, 
but instead is hydroxylated by the same cytochrome P-450-molecule to TCHQ, 
which is, again in the active site, oxidized to the benzoquinone (chapter 
5). Tetrachloro-l,4-hydroquinone has not been tested for its 
porphyrinogenic capacities in the rat. In the Japanese quail, a species 
very sensitive towards chemical porphyria, 1,4-TCHQ also proved to be 
non-porphyrinogenic (Carpenter, 1985), although this compound was able to 
increase the HCB-induced porphyrin excretion when administered 
simultaneously. 
Summarizing and concluding, it is probable that covalent binding to 
protein, as caused by oxidative biotransformation of HCB, is of minor 
importance in vivo. Direct alkylation of uroporphyrinogen decarboxylase by 
quinone metabolites is most .likely not a key mechanism in the 
porphyrinogenic action of HCB. Since no evidence for the occurrence of 
other reactive intermediates was obtained, it is unlikely that the 
inactivation of URO-D is caused by covalent modification by a metabolite 
of HCB. The role of cytochrome P-450 in the process of HCB-induced 
porphyria will then have to be reevaluated. Phenobarbital treatment of 
female rats enhances the porphyrinogenic action of HCB in vivo. However, 
no direct evidence for a higher degree of oxidative biotransformation was 
found: no increase in hepatic levels of oxidative metabolites has been 
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figure 2. The reaction of glutathione with tetrachloro-1,4-benzoquinone 
and 2-broraobenzoquinone. 
to protect against covalent binding to protein of TCBQ. Probably the 
cellular antioxidants play an important role. As a result of these two 
phenomena, the amount of covalent binding as a percentage of total 
metabolites, formed from HCB is much smaller in these cultures than in 
microsomal incubations (appr. 1% and 7%, respectively). In agreement with 
this finding, incubation of 1 uM C-1,4-TCHQ with microsomes and NADPH 
results in 45% binding of radioactivity in 5 minutes, while in a 
hepatocyte culture only 3% binding is detected after 24 hours of 
incubation. 
Koss (1980) detected a small amount of radioactivity attached to rat liver 
cytosolic proteins after a single oral dose of C-HCB. However, since no 
control experiments were performed, it is not possible to conclude that 
this binding stems solely from covalent binding of metabolites of HCB to 
protein. 
The above mentioned facts suggest that the amount of covalent binding of 
TCBQ will be much smaller in vivo than in microsomes. It cannot be 
excluded that even a small amount of binding may cause toxicity, provided 
that a high degree of selectivity of the alkylating agent towards the site 
of modification exists. However, studies with benzene, phenol and 
chlorobenzene indicated that the covalent binding of these compounds, 
which afterwards was proven to be due to quinone metabolites, was 
relatively non-selective (Tunek, 1979). 
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detected (Debets, thesis). It is possible that cytochrome P-450 is not 
involved as a monooxygenase, hydroxylating HCB, but as an oxidase, 
generating reactive oxygen species, as postulated by Ferioli (1984), 
Sinclair (1987) and others. However, besides HCB there are a large number 
of other compounds which stimulate the oxidase function of cytochrome 
P-450, and many of these are non-porphyrinogenic. Other mechanisms must be 
involved which deterrainine the relative specificity of the group of 
chlorinated aromatic compounds in inducing porphyria. 
It may be possible, however, that covalent binding is involved in the 
HCB-induced tumor formation. Although the data on the carcinogenicity of 
PCP are conflicting, this compound has been shown to provoke chromosome 
changes after occupational exposure (Bauchinger, 1982), In chapter 4 the 
ability of the TCBQ to bind to DNA was established, while TCHQ causes 
DNA-breaks (Witte, 1985). 
In the present study (partly) purified enzyme systems were shown to be a 
powerful tool in studies on the relation between biotransformation and 
toxicity, and provide information on the mechanism of single reactions 
involved in metabolic routes and their consequences, and are thus of major 
importance in unravelling the metabolism of HCB. However, one should keep 
in mind that the in vivo situation is more complex than a number of single 
reactions placed one after the other, and that in vitro findings should be 
validated by in vivo studies. 
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DE IN VITRO BIOTRANSFORMATIE VAN HEXACHLOORBENZEEN IN RELATIE 
TOT ZIJN TOXICITEIT 
SAMENVATTING 
Hexachloorbenzeen (HCB) wordt in grote hoeveelheden in het raillieu 
aanget rof fen . Dit i s een gevolg van het f e i t dat HCB gevormd wordt a l s 
bi jproduct in de i n d u s t r i e l e product ie van ve r sch i l l ende gechloreerde 
verbindingen, en dat het tot voor kor t gebruikt werd a l s fungic ide . 
In proefdieren induceert HCB tumorvorming. Zowel in de mens a l s in 
proefdieren v e r s t o o r t HCB de hepat lsche biosynthese van haera, met a l s 
gevolg een s t e rk verhoogde e x c r e t i e van por fyr ines . Deze po r fy r inogen i t e i t 
van HCB bleek te worden veroorzaakt door s e l ec t i eve remming van het enzym 
uroporfyrinogeen decarboxylase . Aangetoond i s dat cytochroom P-450 
betrokken i s b i j de po r fy r inogen i t e i t van HCB: In vivo induc t i e van d i t 
enzym met fenobarb i ta l verhoogt, en i n h i b i t i e met met piperonyl butoxide 
ver laag t de e x c r e t i e van por fy r ines . Dit le idde tot de ve ronde r s t e l l i ng 
dat de i n a c t i v a t i e van uroporfyrinogeen decarboxylase zou kunnen worden 
toegeschreven aan een metabol ie t of r e a c t i e f i n t e rmed ia i r , gevormd t i j d e n s 
de oxidat ieve b io t rans format ie van HCB. 
Het doel van d i t onderzoek was de bestudering van de oxidat ieve 
b io t ransformat ie van HCB in v i t r o , waarbij de aandacht vooral ge r ich t was 
op de vorming van reac t i eve in t e rmed ia i r en . Bi j de bestuder ing van de 
b io t ransformat ie van HCB werd gebruik gemaakt van r a t t e l e v e r microsomen 
(delen van het endoplasmatisch re t iculum welke het cytochroom P-450 
bevat ten) en gezuiverde cytochroom P-450 enzymen, evenals een primaire 
cul tuur van kippe-embryo hepatocyten. Bij het gehele onderzoek werd 
gebruik gemaakt van r ad ioac t i e f gelabeld HCB en metabol ie ten . Hiermee 
bleek het goed mogelijk zeer k l e ine hoeveelheden producten op te sporen 
en te kwant i f iceren . 
Aangetoond werd dat rat televermicrosomen in s t a a t z i jn HCB te 
hydroxyleren. Pentachloorphenol (PCP) werd in zeer geringe hoeveelheden 
gedetecteerd (10-350 pmol, a fhankel i jk van de herkomst van de gebruikte 
microsomen, in een 30 minuten durende incuba t le van 50 nmol HCB). De 
hydroxyla t ie van HCB bleek a fhankel i jk van cytochroom P-450, aangezien 
verzadiging van de microsomen met koolmonoxide, een remmer van het 
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cytochroom P-450, de reactie bijna geheel blokkeerde. De hoeveelheld PCP 
bedroeg 80-90% van de totale gevormde hoeveelheid metabolieten. Als tweede 
raetaboliet werd tetrachloor-1,4-hydrochinon (1,4-TCHQ) geidentificeerd. De 
Km-waarden voor de vorraing van PCP en 1,4-TCHQ waren voor beide 34 uM, met 
Vmax-waarden van 24 pmol PCP/min/mg eiwit en 1,9 pmol 1,4-TCHQ/min/mg 
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eiwit. Experimenten met O-gelabeld water raaakten duidelijk dat de 
zuurstofatotnen die in PCP en 1,4-TCHQ worden geincorporeerd afkomstig 
waren van raoleculair zuurstof. Dlt duidt op twee opeenvolgende 
hydroxylaties door cytochroom P-450. Bovendien werd gevonden dat een 
geringe hoeveelheid radioactiviteit (5-10% van alle metabolieten) covalent 
bond aan microsomaal eiwit. Aangezien deze binding duidelijk een gevolg 
was van de biotransformatie van HCB, werd de aandacht gericht op de 
identiteit van de betrokken metaboliet of reactieve intermediair. 
Reductieve dechlorer ing van HCB a l s gevolg van een 1 -e l ec t ron - reduc t i e van 
HCB door cytochroom P-450 en resu l t e rend in een pentachloorphenyl 
radicaal, bleek niet betrokken bij het proces van covalente binding. Onder 
anaerobe condities, die in het algemeen reductieve dehalogenering 
stimuleren, werd de enzymatische hydroxylatie sterk geremd, terwijl 
covalente binding niet meer optrad. Pentachloorbenzeen, als product van 
reductieve dechlorering, kon niet worden gedetecteerd. 
Covalente binding aan microsomaal eiwit werd ook gevonden als gevolg van 
microsomale PCP-hydroxylatie. Wanneer PCP werd geincubeerd bij 
concentraties zoals gevormd tijdens HCB-incubaties, was de mate van 
covalente binding ongeveer gelijk aan de hoeveelheid gedetecteerd na 
HCB-incubaties. Dit duidt erop dat de covalente binding ten gevolge van de 
microsomale conversie van HCB wordt veroorzaakt door een in deze 
incubaties gevormd reactieproduct van PCP. Omdat geen covalente binding 
toegeschreven kon worden aan de hydroxylatie van HCB tot PCP, was vorming 
van reactieve verbindingen tijdens deze reactie onwaarschijnlijk. 
De covalente binding ten gevolge van microsomale omzetting van HCB kon 
worden voorkomen door toevoeging van ascorbinezuur aan de incubaties. Het 
verdwijnen van covalente binding ging vergezeld van een evenredige toename 
in de gevormde hoeveelheid TCHQ. Glutathion remt de covalente binding ook. 
Een stijging in de vorming van 1,4-TCHQ werd echter niet waargenomen. Deze 
resultaten leidden tot de conclusie dat de benzochinon- of 
semichinonvormen van de tetrachloorhydrochinonen verantwoordelijk zijn 
voor de c o v a l e n t e e i w i t b i n d i n g . De r e a c t i e van g l u t a t h i o n met h e t 
b e n z o c h i n o n werd chemisch b e s t u d e e r d , w a a r b i j d u i d e l i j k werd d a t zowel 
mono- , d i - , a l s t r i g e s u b s t i t u e e r d e c o n j u g a t e n gevormd werden . Deze 
c o n j u g a t e n bevonden z i c h i n de g e o x i d e e r d e ( c h i n o n ) v o r m . 
N a a s t c o v a l e n t e b i n d i n g aan e i w i t werden t i j d e n s de mic rosoma le 
h y d r o x y l a t i e v a n PCP ook t e t r a c h l o o r - 1 , 4 - h y d r o c h i n o n en 
t e t r a c h l o o r - l , 2 - h y d r o c h i n o n g e d e t e c t e e r d . De Km-waarden v o o r de vorming 
van deze h y d r o c h i n o n e n was 13 uM. Voor de c o v a l e n t e b i n d i n g aan e i w i t werd 
d e z e l f d e Km-waarde geme ten . A s c o r b i n e z u u r b e i n v l o e d d e de c o v a l e n t e b i n d i n g 
op d e z e l f d e w i j z e a l s b i j H C B - i n c u b a t i e s . I n P C P - i n c u b a t i e s werd een 
m e t a b o l i s m e - a f h a n k e l i j k e c o v a l e n t e b i n d i n g aan DNA geme ten , welke e e n 
v i j f d e van de b i n d i n g aan e i w i t b e d r o e g . 
B i j h e t g e b r u i k van microsomen van r a t t e n d i e b e h a n d e l d waren met 
v e r s c h i l l e n d e i n d u c t o r e n b l e e k n i e t a l l e e n d a t v e r s c h i l l e n o p t r a d e n i n de 
o m z e t t i n g s s n e l h e d e n v o o r HCB en PCP, maar werden ook a a n w i j z i n g e n 
v e r k r e g e n v o o r h e t f e i t d a t v e r s c h i l l e n d e P-450 isoenzyraen de b e i d e 
i s o m e r e n van TCHQ i n v e r s c h i l l e n d e v e r h o u d i n g e n vormden. Op d i t 
v e r s c h i j n s e l i s v e r d e r i n g e g a a n d o o r g e b r u i k t e maken van g e z u i v e r d e 
cy tochroom P-450 i soenzymen en s e l e c t i e v e monoc lona l e a n t i l i c h a m e n t e g e n 
cy tochroom P-450b+e en P - 4 5 0 c . Het b l e e k d a t miniraaal 3 v e r s c h i l l e n d e 
i soenzymen b e t r o k k e n waren b i j de h y d r o x y l a t i e van HCB. Gezu ive rd 
cy tochroom P-450b en P-450e waren i n s t a a t om HCB, z i j h e t z e e r l angzaam, 
om t e z e t t e n . Hiermee In ove reens temming was h e t f e i t d a t s e l e c t i e v e 
remming van d e z e i soenzymen i n v e r s c h i l l e n d e microsomen e e n g e d e e l t e l i j k e 
remming van de h y d r o x y l a t i e van HCB t o t g e v o l g h a d . Microsomen van r a t t e n 
b e h a n d e l d met d e x a m e t h a s o n , een i n d u c t o r van cy tochroom P - 4 5 0 p , v e r t o o n d e n 
e e n 4 , 4 maal h o g e r e o m z e t t i n g s s n e l h e i d dan microsomen van p h e n o b a r b i t a l 
b e h a n d e l d e r a t t e n . Het l i j k t daarom w a a r s c h i j n l i j k d a t cy tochroom P-450p 
h e t b e l a n g r i j k s t e isoenzym i s i n de h y d r o x y l a t i e van HCB. I n een 
g e r e c o n s t i t u e e r d s y s t e e m werd PCP h e t ' m e e s t i n t e n s i e f omgezet door P-450c 
e n P -450d , en i n m i n d e r e mate door P-450b en P - 4 5 0 e . De e e r s t e twee 
i soenzymen vormden v o o r n a m e l i j k h e t 1 , 4 - d i o l , en de l a a t s t e h e t 1 , 2 - d i o l . 
S e l e c t i e v e remming van h e t P-450c i n microsomen van 3 - m e t h y l c h o l a n t r e e n 
b e h a n d e l d e r a t t e n , en remming van P-450b en P-450e i n microsomen van 
f e n o b a r b i t a l b e h a n d e l d e r a t t e n had e c h t e r geen i n v l o e d op de 
o m z e t t i n g s s n e l h e i d van PCP. D i t b e t e k e n t d a t deze enzymen, hoewel i n s t a a t 
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tot het metaboliseren van PCP, in microsomen geen rol van betekenis spelen 
bij deze omzetting. Microsomen van ratten behandeld met dexamethason 
bleken ook voor PCP de hoogste katalytische activiteit te vertonen. Deze 
microsomen vormden bijna uitsluitend het 1,4-diol. 
Het tetrachloor-1,4-benzochinon bleek zeer snel met eiwit te reageren. 
Gezuiverd cytochroom P-450b bleek in staat te zijn de oxidatie van het 
tetrachloro-1,4-hydrochinon te katalyseren. In microsomen bleek dit enzym 
echter niet het enige enzym te zijn dat betrokken is bij de oxidatie van 
TCHQ. Koolraonoxide remde de oxidatie door microsomen slechts gedeeltelijk. 
In afwezigheid van zuurstof trad nog 39% covalente binding op in 
vergelijking met aerobe condities. Superoxide dismutase remde de binding 
in microsomen in vergelijkbare mate als onder anaerobe omstandigheden, 
terwijl in incubaties met gezuiverd P-450 de binding volledig geremd werd. 
Dit betekent dat alle zuurstof-afhankelijke binding via het superoxide 
anion verloopt. De covalente binding als gevolg van microsomaal 
metabolisme van PCP werd echter niet beinvloed door superoxide dismutase. 
Dit zou kunnen betekenen dat TCHQ, wanneer het gevormd wordt uit PCP door 
P-450, op de actieve plaats van dit enzym geoxideerd wordt door superoxide 
anion radicalen gevormd door P-450. De gemeten ontkoppeling van cytochroom 
P-450 door TCHQ ondersteunt deze hypothese. 
Om meer inzicht te verkrijgen in de biotransformatie van HCB en de 
cellulaire beschermingsmechanismen tegen deze alkylerende verbindingen is, 
met behulp van radioactief gelabeld HCB, PCP en 1,4-TCHQ, het metabolisme 
van HCB onderzocht in een primaire cultuur van kippe-embryo hepatocyten. 
Hoewel covalente binding in deze hepatocyten kon worden aangetoond, was 
deze lager dan in microsomale incubaties. Een aantal 
beschermingsmechanismen bleek aanwezig te zijn. Hoewel de hydroxylatie van 
HCB overeenkomsten vertoonde met de reactie gekatalyseerd door rattelever 
microsomen, bleek het metabolisme van PCP niet te leiden tot ophoping van 
diolen. Een aantal conjugatie routes verhinderde covalente binding door 
ofwel een reactie met PCP, ofwel met TCBQ. Ook incubaties met het 1,4-TCHQ 
resulteerden in relatief weinig eiwitbinding. 
Deze resultaten in ogenschouw nemend lijkt het onwaarschijnlijk dat 
covalente eiwitbinding als gevolg van oxidatieve biotransformatie van HCB 
in vivo van groot belang is. Een directe alkylering van het 
uroporfyrinogeen decarboxylase door TCBQ is waarschijnlijk niet de oorzaak 
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van de door HCB geinduceerde porfyrie. Het is echter wel mogelijk dat een 
relatie bestaat tussen de eiwitbinding van TCBQ en de carcinogene 
activiteit van HCB, en de mutageniteit van PCP. 
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